No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
4112 |
4. Check minimum number of eventsNone |
4112 |
5. Include endpointsNone |
4112 |
6. Filter based on genotype QC (FinnGen only) |
3988 |
Control definitions (FinnGen only)
- Control exclude
- AB1_OTHER_VIRAL
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF10
Similar endpoints
↥List of similar endpoints to
Infectious mononucleosis
based on the number of shared cases.
Similar with more cases:
- Infectious mononucleosis, including avohilmo
- Other viral diseases
- Other viral diseases, including avohilmo
- Certain infectious and parasitic diseases
- Certain infectious and parasitic diseases, including avohilmo
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 47049 | 23385 | 23582 |
| Only index persons | 45510 | 22770 | 22740 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.66 | 0.67 | 0.66 |
| Only index persons | 0.85 | 0.84 | 0.87 |
| Median age at first event (years) | |||
| Whole population | 17.86 | 17.23 | 18.46 |
| Only index persons | 17.91 | 17.29 | 18.54 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3988 | 2590 | 1398 |
| Unadjusted period prevalence (%) | 0.82 | 0.92 | 0.64 |
| Median age at first event (years) | 18.76 | 18.12 | 19.93 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 4112
- Matched controls
- 41120
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
B27.0
ICD-10 Finland
Gammaherpesviral mononucleosis
+∞
307.7
1676
*
B27.9
ICD-10 Finland
Infectious mononucleosis, unspecified
+∞
307.7
970
*
B27
ICD-10 Finland
Infectious mononucleosis
+∞
307.7
365
*
07501
ICD-8 Finland
Infectious mononucleosis, Angina monocytotica
+∞
307.7
428
*
0750X
ICD-9 Finland
Infectious mononucleosis[MONONUCLEOSIS INFECTIOSA SINE COMPLICATIONE]
+∞
307.7
355
*
07509
ICD-8 Finland
Infectious mononucleosis, Unspecified
+∞
173.1
165
*
0750A
ICD-9 Finland
Infectious mononucleosis[MONONUCLEOSIS INFECTIOSA CUM COMPLICATIONE]
+∞
159.4
152
*
J03.9
ICD-10 Finland
Acute tonsillitis, unspecified
3.1
141.0
685
2490
07507
ICD-8 Finland
Infectious mononucleosis, Cum alia complicatione
+∞
101.5
97
*
07508
ICD-8 Finland
Infectious mononucleosis, Suspecta
+∞
97.3
93
*
B34.9
ICD-10 Finland
Viral infection, unspecified
5.4
96.3
197
383
B27.8
ICD-10 Finland
Other infectious mononucleosis
+∞
87.8
84
*
R50.9
ICD-10 Finland
Fever, unspecified
2.2
74.8
767
3901
B27.1
ICD-10 Finland
Cytomegaloviral mononucleosis
+∞
71.0
68
*
J02.9
ICD-10 Finland
Acute pharyngitis, unspecified
2.2
61.1
575
2809
J36
ICD-10 Finland
Peritonsillar abscess
3.0
60.7
287
1009
EMB10
NOMESCO Finland
Tonsillectomy
2.2
54.8
510
2474
M01AE03
ATC
ketoprofen; systemic, rectal
1.7
43.9
996
6456
J35.0
ICD-10 Finland
Chronic tonsillitis
2.1
40.3
416
2090
J03.0
ICD-10 Finland
Streptococcal tonsillitis
2.2
38.1
347
1659
J01AA02
ATC
doxycycline; systemic
1.5
35.4
2514
20919
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
33.0
1243
9015
N02AX02
ATC
tramadol; systemic, rectal
1.5
32.9
1216
8780
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
32.7
2796
23971
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.8
30.6
508
2985
J01DB01
ATC
cefalexin; oral
1.6
30.3
3327
29815
H02AB06
ATC
prednisolone; systemic
1.5
29.9
1502
11513
R21
ICPC
Throat symptom/complaint
1.5
29.3
1459
11151
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
28.8
1569
12191
R03AC02
ATC
salbutamol; inhalant
1.4
28.7
2175
17981
A75
ICPC
Infectious mononucleosis
25.5
27.4
38
15
A03
ICPC
Fever
1.5
27.2
1028
7407
J01FA10
ATC
azithromycin; systemic
1.4
26.8
2613
22488
R07.0
ICD-10 Finland
Pain in throat
1.8
25.6
445
2645
J01FF01
ATC
clindamycin; systemic
1.5
25.2
852
5977
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
24.9
1215
9181
J02
ICD-10 Finland
Acute pharyngitis
1.9
23.7
331
1839
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.6
22.7
675
4591
R06AE07
ATC
cetirizine; oral
1.4
22.7
1816
14917
A02BC02
ATC
pantoprazole; systemic
1.4
22.3
2065
17358
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
21.8
633
4280
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
21.5
1575
12716
J01CE02
ATC
phenoxymethylpenicillin; oral
1.4
21.4
2912
25993
N02BE01
ATC
paracetamol; systemic, rectal
1.5
21.3
3301
30157
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.5
21.3
901
6593
J01FA06
ATC
roxithromycin; oral
1.4
21.1
1150
8816
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
20.6
1139
8750
R51.80
ICD-10 Finland
Headache
1.5
20.4
756
5380
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.8
19.4
294
1674
J01DA01
ATC
[U] cefalexin
1.3
19.1
2113
18081
R01AD12
ATC
fluticasone furoate; nasal
1.4
18.6
1431
11568
R01AD09
ATC
mometasone; nasal
1.3
18.0
1808
15198
07997
ICD-8 Finland
Other viral diseases, Viroses suspectae
+∞
17.7
17
*
J03
ICD-10 Finland
Acute tonsillitis
1.9
17.6
220
1179
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
16.7
1321
10685
R01AD08
ATC
fluticasone; nasal
1.4
16.2
1052
8241
03400
ICD-8 Finland
Streptococcal sore throat and scarlet fever, Streptococcal sore throat
6.0
16.0
28
47
P01AB01
ATC
metronidazole; oral, rectal
1.3
16.0
1287
10418
R01AD58
ATC
fluticasone, combinations; nasal
1.4
15.8
1165
9303
07999
ICD-8 Finland
Other viral diseases, Viral infection, unspecified
+∞
15.6
15
*
J01FA09
ATC
clarithromycin; systemic
1.4
15.6
1098
8706
J01MA12
ATC
levofloxacin; systemic
1.6
15.2
389
2547
J01MA02
ATC
ciprofloxacin; systemic
1.4
14.6
977
7670
M01AE01
ATC
ibuprofen; systemic, rectal
1.5
14.3
3678
34908
R05
ICPC
Cough
1.4
14.3
955
7492
M03BX02
ATC
tizanidine; oral
1.3
14.1
2103
18428
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.4
13.8
626
4601
H02AB04
ATC
methylprednisolone; systemic
1.6
13.6
343
2237
J02AC01
ATC
fluconazole; systemic
1.3
12.6
1305
10861
M79.6
ICD-10 Finland
Pain in limb
1.3
12.6
1474
12464
L04.0
ICD-10 Finland
Acute lymphadenitis of face, head and neck
2.7
12.5
64
236
N05BA04
ATC
oxazepam; oral
1.3
12.5
831
6498
07502
ICD-8 Finland
Infectious mononucleosis, cum meningoencephalitidie
+∞
12.5
12
*
J02.0
ICD-10 Finland
Streptococcal pharyngitis
1.7
12.5
206
1203
J01FA01
ATC
erythromycin; systemic
1.4
12.4
584
4319
R03BA05
ATC
fluticasone; inhalant
1.4
12.1
649
4902
4452
FHL
Tonsil surgery
2.1
12.1
119
587
ZXD05
NOMESCO Finland
Urgent procedure
1.3
12.1
966
7757
M01AH05
ATC
etoricoxib; oral
1.3
12.0
2010
17715
R03DC03
ATC
montelukast; oral
1.4
11.5
572
4267
J01FA15
ATC
telithromycin; oral
1.6
11.3
251
1586
M01AE02
ATC
naproxen; oral, rectal
1.3
11.3
2236
20029
SPAT1263
SPAT
Sampling
1.3
11.3
1565
13461
R03AK07
ATC
formoterol and budesonide; inhalant
1.3
11.2
728
5663
E0000UV, ,
ATC
1.3
11.2
1562
13443
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
2.9
10.9
51
180
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
1.9
10.9
136
731
J01DA09
ATC
[U] cefadroxil
1.3
10.5
846
6780
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
3.3
10.5
39
120
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.4
10.5
586
4449
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.1
10.4
101
497
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.7
10.2
53
198
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.5
10.1
354
2474
N03AX16
ATC
[U] pregabalin
1.4
10.1
511
3819
M25.5
ICD-10 Finland
Pain in joint
1.3
10.1
1139
9532
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.2
10.0
2120
19019
B19.9
ICD-10 Finland
Unspecified viral hepatitis without hepatic coma
8.4
10.0
21
25
M01AB05
ATC
diclofenac; systemic, rectal
1.2
10.0
2030
18134
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
1.5
9.8
326
2256
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
1.5
9.7
281
1888
L04AX01
ATC
azathioprine; systemic
1.8
9.7
140
787
A02BC01
ATC
omeprazole; systemic
1.3
9.7
694
5465
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.6
9.7
221
1408
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
55.1
9.6
11
*
N05AH04
ATC
quetiapine; oral
1.3
9.6
741
5901
X58
ICD-10 Finland
Exposure to other specified factors
1.3
9.5
598
4624
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
100.3
9.4
10
*
K76.9
ICD-10 Finland
Liver disease, unspecified
2.8
9.4
44
156
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.6
9.3
192
1195
R74
ICPC
Upper respiratory infection acute
1.2
9.1
1769
15670
ZXA10
NOMESCO Finland
Bilateral
1.4
9.1
415
3046
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.5
9.0
238
1568
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.7
9.0
149
873
F43.1
ICD-10 Finland
Post-traumatic stress disorder
1.7
9.0
175
1073
SPAT1283
SPAT
Restricted health certificate
1.3
8.8
1089
9180
J01MA14
ATC
moxifloxacin; systemic
1.6
8.8
196
1241
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
4.5
8.8
21
47
J01CA04
ATC
amoxicillin; systemic
1.3
8.7
3468
33083
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.4
8.7
358
2581
R06AX27
ATC
desloratadine; oral
1.2
8.7
1263
10843
Z01.8
ICD-10 Finland
Other specified special examinations
1.3
8.6
654
5188
GD1AA, ,
SPAT
1.3
8.6
669
5329
C10AC01
ATC
colestyramine; oral
2.1
8.3
76
367
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.3
8.3
536
4156
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.6
8.3
168
1041
J45.9
ICD-10 Finland
Asthma, unspecified
1.3
8.3
555
4326
R05
ICD-10 Finland
Cough
1.3
8.2
683
5480
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
1.7
8.2
140
828
B17.8
ICD-10 Finland
Other specified acute viral hepatitis
14.5
8.2
13
9
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.4
8.2
358
2610
9981A
ICD-9 Finland
Other complications of procedures, not elsewhere classified, Haemorrhage or haematoma complicating a procedure
4.4
8.1
20
46
B33.2
ICD-10 Finland
Viral carditis
33.4
8.1
10
*
127
Kela drug reimbursment
Transplant complication
2.5
8.1
47
187
R01BA52
ATC
pseudoephedrine, combinations; oral
1.3
8.0
668
5366
AA1AD
NOMESCO Finland
CT of head and brain
1.3
8.0
532
4144
J35.1
ICD-10 Finland
Hypertrophy of tonsils
1.7
7.9
134
792
ZX120
NOMESCO Finland
Intravenous
1.5
7.9
208
1372
N30
ICD-10 Finland
Cystitis
1.4
7.9
321
2311
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.3
7.9
545
4268
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.4
7.9
347
2533
J03.8
ICD-10 Finland
Acute tonsillitis due to other specified organisms
3.1
7.8
32
105
C01CA24
ATC
epinephrine; parenteral
1.5
7.8
263
1825
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
1.7
7.7
144
873
R05FB02
ATC
cough suppressants and expectorants; systemic
1.3
7.7
753
6165
M79.1
ICD-10 Finland
Myalgia
1.3
7.7
562
4433
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.2
7.7
1089
9300
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.4
7.7
300
2144
SPAT1254
SPAT
Administration of medicine
1.3
7.6
526
4117
A03FA01
ATC
metoclopramide; systemic, rectal
1.3
7.6
568
4496
46309
ICD-8 Finland
Acute tonsillitis, Unspecified
2.2
7.6
63
294
H02AB07
ATC
prednisone; oral
1.5
7.5
271
1906
R02AD02
ATC
lidocaine; local oral
2.0
7.5
73
361
A87.9
ICD-10 Finland
Viral meningitis, unspecified
2.8
7.5
37
135
R05FA02
ATC
opium derivatives and expectorants; systemic
1.2
7.5
1115
9563
ZXE00
NOMESCO Finland
One hour or less
1.2
7.5
1170
10091
M54.5
ICD-10 Finland
Low back pain
1.2
7.4
1278
11123
7806A
ICD-9 Finland
General symptoms, Pyrexia of unknown origin
3.1
7.4
29
93
0785A
ICD-9 Finland
Other diseases due to viruses and Chlamydiae, Cytomegaloviral disease[MONONUCLEOSIS INFECTIOSA CYTOMEGALICA]
+∞
7.3
7
*
T78.4
ICD-10 Finland
Allergy, unspecified
1.5
7.3
195
1292
0340A
ICD-9 Finland
Streptococcal sore throat and scarlatina, Streptococcal sore throat[TONSILLITIS STREPTOCOCCICA,STREPTOC BETAHAEMOLYT-A]
3.4
7.2
25
74
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.4
7.2
318
2322
O47.0
ICD-10 Finland
False labour before 37 completed weeks of gestation
1.3
7.2
452
3489
K50.9
ICD-10 Finland
Crohn disease, unspecified
2.2
7.2
57
261
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
1.5
7.2
195
1296
E000001, ,
ATC
1.3
7.2
722
5929
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.3
7.2
678
5526
R02
ICPC
Shortness of breath/dyspnoea
1.4
7.1
363
2718
F51.0
ICD-10 Finland
Nonorganic insomnia
1.3
7.0
751
6213
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.2
7.0
925
7831
R03BA02
ATC
budesonide; inhalant
1.3
7.0
560
4470
K50.0
ICD-10 Finland
Crohn disease of small intestine
2.1
7.0
60
284
Z71.8
ICD-10 Finland
Other specified counselling
1.2
7.0
1369
12052
TAB00
NOMESCO Finland
Lumbar puncture
1.6
7.0
142
883
A02BC05
ATC
esomeprazole; systemic
1.2
6.9
1026
8789
50099
ICD-8 Finland
Hypertrophy of tonsils and adenoids
1.4
6.9
248
1745
S01GX01
ATC
cromoglicic acid; ophthalmic
1.2
6.8
774
6440
WYA10
NOMESCO Finland
Emergency care or similar visit
1.4
6.8
286
2071
G35
ICD-10 Finland
Multiple sclerosis
2.1
6.8
64
314
UJF32
NOMESCO Finland
Coloscopy
1.3
6.8
486
3823
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
1.7
6.7
117
699
4740A
ICD-9 Finland
Chronic disease of tonsils and adenoids, Chronic tonsillitis
1.8
6.7
92
514
K50.8
ICD-10 Finland
Other Crohn disease
2.1
6.6
62
303
R06.0
ICD-10 Finland
Dyspnoea
1.3
6.6
641
5238
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.5
6.6
204
1395
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.3
6.6
427
3311
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
2.3
6.6
49
219
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.2
6.6
757
6310
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.3
6.5
475
3742
N06AX12
ATC
bupropion; oral
1.3
6.5
369
2805
X59
ICD-10 Finland
Exposure to unspecified factor
1.3
6.5
640
5238
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.2
6.5
1171
10216
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.2
6.5
737
6134
NH1BG, ,
SPAT
1.8
6.5
85
468
A07EA06
ATC
budesonide; oral, local oral
1.7
6.4
122
745
OAB91, ,
SPAT
1.3
6.4
393
3024
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.2
6.4
771
6458
J04.0
ICD-10 Finland
Acute laryngitis
1.5
6.4
190
1290
S93.4
ICD-10 Finland
Sprain and strain of ankle
1.3
6.4
572
4631
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.6
6.3
151
976
R52.9
ICD-10 Finland
Pain, unspecified
1.4
6.3
309
2297
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.3
6.3
627
5140
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
2.2
6.2
48
218
SPAT1260
SPAT
Consultation of another employee
1.3
6.2
522
4191
W19
ICD-10 Finland
Unspecified fall
1.4
6.2
280
2054
TPH04
NOMESCO Finland
Cathetrisation of vein
1.3
6.2
525
4219
S18
ICPC
Laceration/cut
1.2
6.1
1302
11513
D07AB02
ATC
hydrocortisone butyrate; topical
1.2
6.1
923
7908
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.6
6.1
127
796
A98.5
ICD-10 Finland
Haemorrhagic fever with renal syndrome
2.1
6.1
54
260
K50.1
ICD-10 Finland
Crohn disease of large intestine
2.3
6.0
44
195
S06.0
ICD-10 Finland
Concussion
1.3
6.0
384
2970
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Otolaryngology
4 [38004449]
4 [38004449]
2.6e-02
4.7e-01
2.5e+00
7.9e+00
3.7e+00
1.6e+00
7.6e-01
cases:8.07%
controls:7.88%
cases:4.05%
controls:2.58%
cases:4.34%
controls:0.38%
cases:30.14%
controls:0.02%
cases:13.60%
controls:0.39%
cases:11.02%
controls:2.45%
cases:14.45%
controls:7.33%
249
2409
2837
28168
125
789
2964
29805
134
115
2955
30479
931
5
2158
30589
420
120
2669
30447
336
740
2713
29506
416
2082
2462
26340
Emergency Room Visit
ER [9203]
ER [9203]
1.7e-01
4.7e-01
2.4e+00
7.1e+00
2.5e+00
6.3e-01
4.5e-01
cases:27.74%
controls:24.43%
cases:14.24%
controls:9.40%
cases:12.59%
controls:1.26%
cases:41.86%
controls:0.06%
cases:12.66%
controls:1.21%
cases:16.63%
controls:9.64%
cases:39.30%
controls:29.13%
856
7470
2230
23107
440
2876
2649
27718
389
385
2700
30209
1293
18
1796
30576
391
370
2698
30197
507
2917
2542
27329
1131
8278
1747
20144
phenoxymethylpenicillin; oral
J01CE02 [21602842]
J01CE02 [21602842]
2.3e-01
6.5e-01
3.6e+00
5.2e+00
3.2e+00
5.8e-01
2.9e-01
cases:17.21%
controls:14.18%
cases:8.22%
controls:4.46%
cases:12.04%
controls:0.39%
cases:3.50%
controls:0.02%
cases:10.26%
controls:0.47%
cases:7.94%
controls:4.61%
cases:22.83%
controls:18.15%
531
4337
2555
26240
254
1365
2835
29229
372
119
2717
30475
108
6
2981
30588
317
145
2772
30422
242
1395
2807
28851
657
5158
2221
23264
benzathine phenoxymethylpenicillin; oral
J01CE10 [21602850]
J01CE10 [21602850]
2.3e-01
6.5e-01
3.6e+00
5.2e+00
3.2e+00
5.8e-01
2.9e-01
cases:17.21%
controls:14.18%
cases:8.22%
controls:4.46%
cases:12.04%
controls:0.39%
cases:3.50%
controls:0.02%
cases:10.26%
controls:0.47%
cases:7.94%
controls:4.61%
cases:22.83%
controls:18.15%
531
4337
2555
26240
254
1365
2835
29229
372
119
2717
30475
108
6
2981
30588
317
145
2772
30422
242
1395
2807
28851
657
5158
2221
23264
Acute tonsillitis, unspecified
J03.9 [45576942]
J03.9 [45576942]
4.7e-01
1.1e+00
5.4e+00
—
4.3e+00
2.0e+00
9.7e-01
cases:1.59%
controls:1.00%
cases:0.91%
controls:0.31%
cases:4.69%
controls:0.02%
—
—
cases:2.53%
controls:0.04%
cases:1.94%
controls:0.27%
cases:2.95%
controls:1.14%
49
306
3037
30271
28
96
3061
30498
145
7
2944
30587
—
78
11
3011
30556
59
83
2990
30163
85
325
2793
28097
Fever, unspecified
R50.9 [45582716]
R50.9 [45582716]
6.2e-01
1.4e+00
4.7e+00
1.0e+50
4.2e+00
1.5e+00
7.7e-01
cases:2.11%
controls:1.14%
cases:1.46%
controls:0.38%
cases:4.66%
controls:0.04%
cases:2.85%
controls:0.00%
cases:1.04%
controls:0.02%
cases:1.74%
controls:0.39%
cases:2.92%
controls:1.37%
65
349
3021
30228
45
116
3044
30478
144
13
2945
30581
88
0
3001
30594
32
5
3057
30562
53
118
2996
30128
84
389
2794
28033
Acute pharyngitis, unspecified
J02.9 [45538472]
J02.9 [45538472]
4.8e-01
1.5e+00
4.7e+00
—
4.3e+00
1.7e+00
9.0e-01
cases:1.23%
controls:0.76%
cases:0.84%
controls:0.20%
cases:3.11%
controls:0.03%
—
—
cases:1.20%
controls:0.02%
cases:1.44%
controls:0.25%
cases:2.50%
controls:1.03%
38
233
3048
30344
26
60
3063
30534
96
9
2993
30585
—
37
5
3052
30562
44
77
3005
30169
72
293
2806
28129
ciclosporin; oral, parenteral
L04AD01 [21603924]
L04AD01 [21603924]
1.6e+00
1.9e+00
2.4e+00
—
2.6e+00
2.4e+00
1.9e+00
cases:0.49%
controls:0.09%
cases:0.49%
controls:0.07%
cases:0.29%
controls:0.03%
—
—
cases:0.26%
controls:0.02%
cases:0.49%
controls:0.04%
cases:0.63%
controls:0.09%
15
29
3071
30548
15
22
3074
30572
9
8
3080
30586
—
8
6
3081
30561
15
13
3034
30233
18
27
2860
28395
Kidney transplant status
Z94.0 [45566477]
Z94.0 [45566477]
2.0e+00
2.1e+00
2.2e+00
1.0e+50
2.9e+00
2.1e+00
1.5e+00
cases:0.29%
controls:0.04%
cases:0.32%
controls:0.04%
cases:0.23%
controls:0.03%
cases:0.23%
controls:0.00%
cases:0.29%
controls:0.02%
cases:0.30%
controls:0.04%
cases:0.31%
controls:0.07%
9
12
3077
30565
10
12
3079
30582
7
8
3082
30586
7
0
3082
30594
9
5
3080
30562
9
11
3040
30235
9
19
2869
28403
General Practice
1 [38004446]
1 [38004446]
2.7e-01
5.3e-01
2.3e+00
5.9e+00
1.8e+00
6.2e-01
3.8e-01
cases:9.69%
controls:7.55%
cases:5.08%
controls:3.06%
cases:3.98%
controls:0.41%
cases:6.57%
controls:0.02%
cases:2.33%
controls:0.38%
cases:6.23%
controls:3.46%
cases:14.38%
controls:10.27%
299
2310
2787
28267
157
935
2932
29659
123
126
2966
30468
203
6
2886
30588
72
116
3017
30451
190
1046
2859
29200
414
2920
2464
25502
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1988-5 [3020460]
1.2e-01
3.7e-01
2.5e+00
5.3e+00
2.4e+00
5.9e-01
3.1e-01
cases:13.51%
controls:12.22%
cases:10.97%
controls:7.84%
cases:14.57%
controls:1.32%
cases:13.08%
controls:0.07%
cases:11.85%
controls:1.21%
cases:13.51%
controls:7.98%
cases:28.42%
controls:22.57%
417
3736
2669
26841
339
2398
2750
28196
450
403
2639
30191
404
22
2685
30572
366
370
2723
30197
412
2415
2637
27831
818
6416
2060
22006
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
6768-6 [3035995]
8.7e-02
2.2e-01
2.0e+00
5.7e+00
2.6e+00
8.1e-01
3.6e-01
cases:6.55%
controls:6.03%
cases:4.76%
controls:3.87%
cases:4.86%
controls:0.67%
cases:4.63%
controls:0.02%
cases:8.16%
controls:0.64%
cases:8.27%
controls:3.87%
cases:14.28%
controls:10.40%
202
1845
2884
28732
147
1185
2942
29409
150
206
2939
30388
143
5
2946
30589
252
197
2837
30370
252
1170
2797
29076
411
2957
2467
25465
Differential panel, method unspecified - Blood
69738-3 [42870588]
69738-3 [42870588]
2.3e-01
4.5e-01
2.2e+00
4.7e+00
2.5e+00
6.6e-01
4.7e-01
cases:3.89%
controls:3.10%
cases:2.78%
controls:1.79%
cases:3.50%
controls:0.42%
cases:2.85%
controls:0.03%
cases:4.44%
controls:0.37%
cases:3.77%
controls:1.99%
cases:7.02%
controls:4.50%
120
948
2966
29629
86
549
3003
30045
108
128
2981
30466
88
8
3001
30586
137
114
2952
30453
115
601
2934
29645
202
1278
2676
27144
Streptococcal tonsillitis
J03.0 [45601114]
J03.0 [45601114]
2.7e-01
1.1e+00
3.9e+00
1.0e+50
3.2e+00
1.8e+00
8.4e-01
cases:0.71%
controls:0.54%
cases:0.49%
controls:0.17%
cases:1.17%
controls:0.02%
cases:2.10%
controls:0.00%
cases:0.58%
controls:0.02%
cases:0.89%
controls:0.15%
cases:1.49%
controls:0.65%
22
166
3064
30411
15
51
3074
30543
36
7
3053
30587
65
0
3024
30594
18
7
3071
30560
27
45
3022
30201
43
184
2835
28238
cefalexin; oral
J01DB01 [21602870]
J01DB01 [21602870]
1.3e-01
4.3e-01
2.7e+00
4.4e+00
2.3e+00
5.6e-01
3.7e-01
cases:25.92%
controls:23.58%
cases:11.17%
controls:7.56%
cases:11.46%
controls:0.85%
cases:2.17%
controls:0.03%
cases:8.64%
controls:0.96%
cases:13.12%
controls:7.91%
cases:34.19%
controls:26.43%
800
7209
2286
23368
345
2313
2744
28281
354
259
2735
30335
67
8
3022
30586
267
293
2822
30274
400
2393
2649
27853
984
7511
1894
20911
ibuprofen
R02AX02 [1588667]
R02AX02 [1588667]
2.5e-01
3.1e-01
2.3e+00
5.0e+00
2.1e+00
4.7e-01
3.9e-01
cases:25.11%
controls:20.71%
cases:12.85%
controls:9.76%
cases:10.07%
controls:1.16%
cases:4.47%
controls:0.03%
cases:8.45%
controls:1.13%
cases:15.55%
controls:10.32%
cases:41.45%
controls:32.31%
775
6333
2311
24244
397
2987
2692
27607
311
355
2778
30239
138
10
2951
30584
261
344
2828
30223
474
3122
2575
27124
1193
9182
1685
19240
ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]
M01AE01 [21603967]
2.5e-01
3.1e-01
2.3e+00
5.0e+00
2.1e+00
4.7e-01
3.9e-01
cases:25.11%
controls:20.71%
cases:12.85%
controls:9.76%
cases:10.07%
controls:1.16%
cases:4.47%
controls:0.03%
cases:8.45%
controls:1.13%
cases:15.55%
controls:10.32%
cases:41.45%
controls:32.31%
775
6333
2311
24244
397
2987
2692
27607
311
355
2778
30239
138
10
2951
30584
261
344
2828
30223
474
3122
2575
27124
1193
9182
1685
19240
Acute upper respiratory infection, unspecified
J06.9 [45562437]
J06.9 [45562437]
3.9e-01
6.6e-01
3.0e+00
4.1e+00
1.3e+00
6.6e-01
5.5e-01
cases:10.21%
controls:7.13%
cases:5.89%
controls:3.14%
cases:7.02%
controls:0.36%
cases:1.00%
controls:0.02%
cases:1.20%
controls:0.33%
cases:6.43%
controls:3.44%
cases:19.25%
controls:12.14%
315
2179
2771
28398
182
960
2907
29634
217
111
2872
30483
31
5
3058
30589
37
101
3052
30466
196
1041
2853
29205
554
3450
2324
24972
Monocytes/Leukocytes in Blood
26485-3 [3019069]
26485-3 [3019069]
2.5e-01
3.7e-01
2.2e+00
4.5e+00
2.4e+00
7.5e-01
4.5e-01
cases:5.96%
controls:4.70%
cases:4.05%
controls:2.84%
cases:5.11%
controls:0.61%
cases:3.40%
controls:0.04%
cases:5.54%
controls:0.55%
cases:5.64%
controls:2.76%
cases:10.32%
controls:6.86%
184
1438
2902
29139
125
870
2964
29724
158
188
2931
30406
105
12
2984
30582
171
167
2918
30400
172
834
2877
29412
297
1950
2581
26472
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
26478-8 [3002030]
1.8e-01
3.4e-01
2.2e+00
4.5e+00
2.4e+00
7.4e-01
4.2e-01
cases:5.99%
controls:5.07%
cases:4.18%
controls:3.00%
cases:5.50%
controls:0.63%
cases:3.46%
controls:0.04%
cases:5.60%
controls:0.56%
cases:5.84%
controls:2.88%
cases:10.88%
controls:7.46%
185
1549
2901
29028
129
918
2960
29676
170
194
2919
30400
107
12
2982
30582
173
170
2916
30397
178
872
2871
29374
313
2119
2565
26303
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
26450-7 [3006504]
2.3e-01
3.7e-01
2.1e+00
4.5e+00
2.4e+00
7.5e-01
4.5e-01
cases:5.83%
controls:4.70%
cases:4.05%
controls:2.84%
cases:4.95%
controls:0.60%
cases:3.30%
controls:0.04%
cases:5.41%
controls:0.54%
cases:5.67%
controls:2.76%
cases:10.28%
controls:6.80%
180
1438
2906
29139
125
868
2964
29726
153
185
2936
30409
102
12
2987
30582
167
165
2922
30402
173
836
2876
29410
296
1934
2582
26488
Inpatient Hospital
21 [8717]
21 [8717]
-3.0e-01
-2.5e-02
1.3e+00
6.8e+00
2.3e+00
3.2e-01
1.7e-01
cases:18.50%
controls:23.51%
cases:8.03%
controls:8.22%
cases:3.66%
controls:1.03%
cases:33.47%
controls:0.06%
cases:9.32%
controls:1.06%
cases:10.46%
controls:7.80%
cases:26.34%
controls:23.22%
571
7189
2515
23388
248
2514
2841
28080
113
315
2976
30279
1034
18
2055
30576
288
323
2801
30244
319
2359
2730
27887
758
6599
2120
21823
Basophils/Leukocytes in Blood
30180-4 [3022096]
30180-4 [3022096]
2.3e-01
3.6e-01
2.1e+00
4.4e+00
2.4e+00
7.5e-01
4.5e-01
cases:5.83%
controls:4.69%
cases:4.01%
controls:2.83%
cases:4.82%
controls:0.61%
cases:3.14%
controls:0.04%
cases:5.44%
controls:0.54%
cases:5.67%
controls:2.76%
cases:10.25%
controls:6.81%
180
1433
2906
29144
124
866
2965
29728
149
187
2940
30407
97
12
2992
30582
168
164
2921
30403
173
834
2876
29412
295
1935
2583
26487
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
34487-9 [3044938]
6.5e-01
1.2e+00
3.7e+00
1.0e+50
3.8e+00
8.7e-01
9.3e-01
cases:1.04%
controls:0.55%
cases:0.78%
controls:0.24%
cases:1.17%
controls:0.03%
cases:1.55%
controls:0.00%
cases:0.97%
controls:0.02%
cases:0.69%
controls:0.29%
cases:2.50%
controls:1.00%
32
167
3054
30410
24
72
3065
30522
36
9
3053
30585
48
0
3041
30594
30
7
3059
30560
21
88
3028
30158
72
285
2806
28137
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
26511-6 [3018010]
1.8e-01
3.5e-01
2.2e+00
4.3e+00
2.3e+00
7.6e-01
4.2e-01
cases:5.77%
controls:4.88%
cases:4.05%
controls:2.89%
cases:5.21%
controls:0.61%
cases:2.69%
controls:0.04%
cases:5.05%
controls:0.54%
cases:5.81%
controls:2.79%
cases:10.53%
controls:7.15%
178
1492
2908
29085
125
883
2964
29711
161
188
2928
30406
83
11
3006
30583
156
166
2933
30401
177
844
2872
29402
303
2032
2575
26390
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
14804-9 [3022250]
6.2e-01
8.9e-01
3.1e+00
1.0e+50
3.8e+00
1.6e+00
8.9e-01
cases:0.75%
controls:0.40%
cases:0.68%
controls:0.28%
cases:0.74%
controls:0.03%
cases:0.32%
controls:0.00%
cases:1.55%
controls:0.04%
cases:1.12%
controls:0.22%
cases:1.77%
controls:0.74%
23
123
3063
30454
21
86
3068
30508
23
10
3066
30584
10
0
3079
30594
48
11
3041
30556
34
66
3015
30180
51
210
2827
28212
Bacteria identified in Blood by Culture
600-7 [3023368]
600-7 [3023368]
1.4e-01
8.3e-01
3.5e+00
—
4.2e+00
1.1e+00
6.6e-01
cases:1.26%
controls:1.10%
cases:1.13%
controls:0.50%
cases:2.04%
controls:0.06%
—
—
cases:2.14%
controls:0.03%
cases:1.54%
controls:0.51%
cases:3.58%
controls:1.89%
39
336
3047
30241
35
152
3054
30442
63
19
3026
30575
—
66
10
3023
30557
47
154
3002
30092
103
536
2775
27886
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
40987-0 [3043924]
6.4e-01
1.2e+00
3.8e+00
1.0e+50
3.4e+00
9.9e-01
8.4e-01
cases:0.71%
controls:0.38%
cases:0.49%
controls:0.15%
cases:0.87%
controls:0.02%
cases:0.97%
controls:0.00%
cases:0.71%
controls:0.02%
cases:0.52%
controls:0.20%
cases:1.70%
controls:0.74%
22
115
3064
30462
15
46
3074
30548
27
6
3062
30588
30
0
3059
30594
22
7
3067
30560
16
59
3033
30187
49
210
2829
28212
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
4537-7 [3013707]
2.3e-01
3.2e-01
2.3e+00
4.3e+00
2.0e+00
6.5e-01
4.2e-01
cases:8.10%
controls:6.54%
cases:4.82%
controls:3.54%
cases:4.56%
controls:0.47%
cases:1.59%
controls:0.02%
cases:3.24%
controls:0.44%
cases:6.36%
controls:3.43%
cases:15.95%
controls:11.06%
250
2001
2836
28576
149
1082
2940
29512
141
144
2948
30450
49
7
3040
30587
100
133
2989
30434
194
1037
2855
29209
459
3144
2419
25278
Eosinophils [#/volume] in Blood
26449-9 [3013115]
26449-9 [3013115]
2.3e-01
4.0e-01
2.0e+00
4.2e+00
2.2e+00
7.7e-01
4.3e-01
cases:6.45%
controls:5.20%
cases:4.60%
controls:3.14%
cases:4.86%
controls:0.71%
cases:2.98%
controls:0.05%
cases:5.18%
controls:0.61%
cases:6.49%
controls:3.11%
cases:11.47%
controls:7.79%
199
1589
2887
28988
142
961
2947
29633
150
216
2939
30378
92
14
2997
30580
160
187
2929
30380
198
941
2851
29305
330
2215
2548
26207
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
26474-7 [3019198]
1.9e-01
3.6e-01
2.0e+00
4.2e+00
2.2e+00
7.8e-01
4.5e-01
cases:6.38%
controls:5.35%
cases:4.50%
controls:3.19%
cases:4.86%
controls:0.68%
cases:2.49%
controls:0.04%
cases:4.92%
controls:0.59%
cases:6.53%
controls:3.10%
cases:11.81%
controls:7.89%
197
1636
2889
28941
139
976
2950
29618
150
207
2939
30387
77
12
3012
30582
152
180
2937
30387
199
937
2850
29309
340
2243
2538
26179
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1742-6 [3006923]
6.3e-02
1.3e-01
1.9e+00
5.1e+00
2.2e+00
4.6e-01
1.9e-01
cases:12.02%
controls:11.37%
cases:8.84%
controls:7.83%
cases:8.61%
controls:1.41%
cases:7.74%
controls:0.05%
cases:11.49%
controls:1.38%
cases:12.79%
controls:8.45%
cases:25.47%
controls:22.01%
371
3478
2715
27099
273
2397
2816
28197
266
430
2823
30164
239
16
2850
30578
355
423
2734
30144
390
2556
2659
27690
733
6255
2145
22167
Basophils [#/volume] in Blood
26444-0 [3006315]
26444-0 [3006315]
2.2e-01
3.6e-01
1.9e+00
4.1e+00
2.2e+00
7.6e-01
4.6e-01
cases:6.16%
controls:5.02%
cases:4.31%
controls:3.04%
cases:4.24%
controls:0.66%
cases:2.27%
controls:0.04%
cases:4.76%
controls:0.57%
cases:6.23%
controls:3.02%
cases:11.19%
controls:7.38%
190
1535
2896
29042
133
930
2956
29664
131
202
2958
30392
70
12
3019
30582
147
173
2942
30394
190
914
2859
29332
322
2098
2556
26324
Monocytes [#/volume] in Blood
26484-6 [3001604]
26484-6 [3001604]
2.3e-01
3.6e-01
1.9e+00
4.1e+00
2.2e+00
7.7e-01
4.5e-01
cases:6.25%
controls:5.01%
cases:4.31%
controls:3.04%
cases:4.27%
controls:0.66%
cases:2.23%
controls:0.04%
cases:4.79%
controls:0.57%
cases:6.26%
controls:3.01%
cases:11.15%
controls:7.39%
193
1533
2893
29044
133
929
2956
29665
132
203
2957
30391
69
12
3020
30582
148
175
2941
30392
191
911
2858
29335
321
2101
2557
26321
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
751-8 [3013650]
1.6e-01
3.1e-01
1.9e+00
4.3e+00
2.1e+00
6.9e-01
4.1e-01
cases:6.68%
controls:5.76%
cases:4.79%
controls:3.57%
cases:5.60%
controls:0.91%
cases:3.98%
controls:0.06%
cases:5.54%
controls:0.74%
cases:6.59%
controls:3.42%
cases:12.47%
controls:8.65%
206
1761
2880
28816
148
1093
2941
29501
173
277
2916
30317
123
17
2966
30577
171
225
2918
30342
201
1035
2848
29211
359
2458
2519
25964
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2951-2 [3019550]
6.0e-02
1.4e-01
1.9e+00
5.1e+00
2.0e+00
3.3e-01
2.1e-01
cases:10.82%
controls:10.26%
cases:7.67%
controls:6.72%
cases:7.38%
controls:1.18%
cases:7.51%
controls:0.05%
cases:7.54%
controls:1.05%
cases:9.51%
controls:7.00%
cases:23.00%
controls:19.44%
334
3136
2752
27441
237
2056
2852
28538
228
360
2861
30234
232
15
2857
30579
233
320
2856
30247
290
2118
2759
28128
662
5526
2216
22896
Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
546-2 [3024135]
546-2 [3024135]
3.2e-01
8.4e-01
4.2e+00
—
2.5e+00
9.6e-01
6.4e-01
cases:5.70%
controls:4.20%
cases:4.01%
controls:1.77%
cases:9.91%
controls:0.16%
—
—
cases:1.85%
controls:0.15%
cases:4.33%
controls:1.70%
cases:12.47%
controls:7.02%
176
1283
2910
29294
124
540
2965
30054
306
48
2783
30546
—
57
45
3032
30522
132
515
2917
29731
359
1995
2519
26427
Hematology
82 [38004501]
82 [38004501]
4.2e-01
1.3e+00
2.8e+00
—
3.1e+00
1.5e+00
9.1e-01
cases:0.45%
controls:0.30%
cases:0.81%
controls:0.23%
cases:0.78%
controls:0.05%
—
—
cases:1.04%
controls:0.05%
cases:1.02%
controls:0.23%
cases:1.22%
controls:0.49%
14
91
3072
30486
25
70
3064
30524
24
14
3065
30580
—
32
15
3057
30552
31
71
3018
30175
35
140
2843
28282
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2823-3 [3023103]
6.3e-02
1.5e-01
1.9e+00
5.0e+00
2.0e+00
3.3e-01
2.1e-01
cases:10.89%
controls:10.29%
cases:7.74%
controls:6.75%
cases:7.35%
controls:1.18%
cases:7.51%
controls:0.06%
cases:7.51%
controls:1.04%
cases:9.45%
controls:6.99%
cases:23.04%
controls:19.46%
336
3146
2750
27431
239
2065
2850
28529
227
361
2862
30233
232
17
2857
30577
232
319
2857
30248
288
2114
2761
28132
663
5531
2215
22891
Normoblasts [#/volume] in Blood
715-3 [3021589]
715-3 [3021589]
1.7e-01
2.4e-01
2.0e+00
4.6e+00
2.1e+00
4.7e-01
2.5e-01
cases:5.09%
controls:4.33%
cases:3.69%
controls:2.92%
cases:3.98%
controls:0.58%
cases:3.56%
controls:0.04%
cases:4.50%
controls:0.56%
cases:4.69%
controls:2.99%
cases:8.62%
controls:6.87%
157
1324
2929
29253
114
893
2975
29701
123
178
2966
30416
110
11
2979
30583
139
171
2950
30396
143
904
2906
29342
248
1952
2630
26470
Sampling
SPAT1263 [2001700364]
SPAT1263 [2001700364]
2.2e-01
4.8e-01
2.4e+00
4.5e+00
1.2e+00
4.8e-01
2.4e-01
cases:6.84%
controls:5.56%
cases:4.08%
controls:2.57%
cases:3.30%
controls:0.29%
cases:1.72%
controls:0.02%
cases:0.94%
controls:0.27%
cases:4.17%
controls:2.63%
cases:11.15%
controls:8.97%
211
1700
2875
28877
126
785
2963
29809
102
90
2987
30504
53
6
3036
30588
29
84
3060
30483
127
796
2922
29450
321
2550
2557
25872
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
N02BE01 [21604344]
2.1e-01
2.0e-01
1.7e+00
5.0e+00
1.8e+00
3.3e-01
4.0e-01
cases:15.59%
controls:12.97%
cases:7.28%
controls:6.02%
cases:4.56%
controls:0.88%
cases:2.72%
controls:0.02%
cases:4.69%
controls:0.82%
cases:9.02%
controls:6.67%
cases:27.38%
controls:20.21%
481
3966
2605
26611
225
1841
2864
28753
141
270
2948
30324
84
6
3005
30588
145
252
2944
30315
275
2017
2774
28229
788
5745
2090
22677
Throat symptom/complaint
R21 [2002000891]
R21 [2002000891]
3.8e-01
7.6e-01
3.9e+00
—
2.6e+00
1.0e+00
5.9e-01
cases:7.36%
controls:5.13%
cases:4.08%
controls:1.95%
cases:7.87%
controls:0.18%
—
—
cases:2.43%
controls:0.18%
cases:4.66%
controls:1.77%
cases:11.15%
controls:6.52%
227
1568
2859
29009
126
597
2963
29997
243
55
2846
30539
—
75
55
3014
30512
142
534
2907
29712
321
1854
2557
26568
Epstein Barr virus Ab [Presence] in Serum
49178-7 [3048929]
49178-7 [3048929]
3.1e-01
1.6e+00
5.8e+00
1.0e+50
—
1.8e+00
3.8e-01
cases:1.10%
controls:0.81%
cases:1.26%
controls:0.26%
cases:7.96%
controls:0.03%
cases:10.04%
controls:0.00%
—
—
cases:1.38%
controls:0.24%
cases:1.88%
controls:1.29%
34
248
3052
30329
39
80
3050
30514
246
8
2843
30586
310
0
2779
30594
—
42
73
3007
30173
54
368
2824
28054
CBC panel - Blood by Automated count
58410-2 [40761511]
58410-2 [40761511]
7.2e-02
1.8e-01
1.8e+00
4.9e+00
1.9e+00
3.6e-01
2.1e-01
cases:13.55%
controls:12.73%
cases:9.84%
controls:8.39%
cases:7.74%
controls:1.40%
cases:7.09%
controls:0.06%
cases:8.16%
controls:1.28%
cases:11.64%
controls:8.40%
cases:28.25%
controls:24.14%
418
3891
2668
26686
304
2567
2785
28027
239
427
2850
30167
219
18
2870
30576
252
390
2837
30177
355
2541
2694
27705
813
6862
2065
21560
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
2465-3 [3005719]
-1.9e-02
9.3e-01
2.7e+00
1.0e+50
3.3e+00
1.4e+00
8.4e-01
cases:0.68%
controls:0.69%
cases:0.71%
controls:0.28%
cases:0.65%
controls:0.05%
cases:0.23%
controls:0.00%
cases:1.23%
controls:0.05%
cases:0.95%
controls:0.23%
cases:1.81%
controls:0.79%
21
212
3065
30365
22
86
3067
30508
20
14
3069
30580
7
0
3082
30594
38
14
3051
30553
29
71
3020
30175
52
225
2826
28197
Blasts/Leukocytes in Blood
26446-5 [3025159]
26446-5 [3025159]
8.7e-01
7.0e-01
3.4e+00
—
3.5e+00
1.4e+00
3.9e-01
cases:0.78%
controls:0.33%
cases:0.55%
controls:0.27%
cases:0.94%
controls:0.03%
—
—
cases:1.04%
controls:0.03%
cases:1.02%
controls:0.25%
cases:1.11%
controls:0.75%
24
100
3062
30477
17
84
3072
30510
29
10
3060
30584
—
32
10
3057
30557
31
77
3018
30169
32
214
2846
28208
Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
43730-1 [3043849]
43730-1 [3043849]
—
1.5e+00
3.2e+00
1.0e+50
—
2.7e+00
1.7e+00
—
—
cases:0.36%
controls:0.08%
cases:0.62%
controls:0.03%
cases:0.36%
controls:0.00%
—
—
cases:0.69%
controls:0.05%
cases:0.69%
controls:0.13%
—
11
24
3078
30570
19
8
3070
30586
11
0
3078
30594
—
21
14
3028
30232
20
37
2858
28385
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
62238-1 [40764999]
6.1e-02
2.0e-01
1.7e+00
5.0e+00
1.8e+00
2.5e-01
2.5e-01
cases:7.00%
controls:6.61%
cases:6.44%
controls:5.35%
cases:5.24%
controls:0.96%
cases:4.69%
controls:0.03%
cases:5.15%
controls:0.89%
cases:7.58%
controls:6.03%
cases:18.76%
controls:15.29%
216
2022
2870
28555
199
1637
2890
28957
162
294
2927
30300
145
10
2944
30584
159
271
2930
30296
231
1823
2818
28423
540
4346
2338
24076
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
40982-1 [3038288]
5.8e-01
1.1e+00
3.4e+00
1.0e+50
3.7e+00
1.0e+00
8.4e-01
cases:0.68%
controls:0.38%
cases:0.42%
controls:0.15%
cases:0.78%
controls:0.03%
cases:0.91%
controls:0.00%
cases:0.78%
controls:0.02%
cases:0.52%
controls:0.19%
cases:1.67%
controls:0.72%
21
117
3065
30460
13
45
3076
30549
24
8
3065
30586
28
0
3061
30594
24
6
3065
30561
16
56
3033
30190
48
206
2830
28216
Peritonsillar abscess
J36 [45581858]
J36 [45581858]
-5.0e-01
1.2e+00
3.9e+00
1.0e+50
—
2.7e+00
1.1e+00
cases:0.29%
controls:0.48%
cases:0.45%
controls:0.13%
cases:1.00%
controls:0.02%
cases:2.85%
controls:0.00%
—
—
cases:1.34%
controls:0.10%
cases:1.18%
controls:0.38%
9
147
3077
30430
14
41
3075
30553
31
6
3058
30588
88
0
3001
30594
—
41
29
3008
30217
34
108
2844
28314
Platelets [#/volume] in Blood
26515-7 [3007461]
26515-7 [3007461]
2.4e-02
1.3e-01
1.8e+00
4.8e+00
1.8e+00
3.2e-01
1.9e-01
cases:16.07%
controls:15.76%
cases:13.92%
controls:12.47%
cases:13.86%
controls:2.50%
cases:12.85%
controls:0.12%
cases:13.37%
controls:2.37%
cases:17.25%
controls:13.19%
cases:34.40%
controls:30.35%
496
4818
2590
25759
430
3814
2659
26780
428
766
2661
29828
397
38
2692
30556
413
725
2676
29842
526
3990
2523
26256
990
8626
1888
19796
Leukocytes [#/volume] in Blood
26464-8 [3010813]
26464-8 [3010813]
2.1e-02
1.3e-01
1.8e+00
4.8e+00
1.8e+00
3.1e-01
1.9e-01
cases:16.14%
controls:15.86%
cases:13.99%
controls:12.53%
cases:14.05%
controls:2.54%
cases:13.08%
controls:0.13%
cases:13.37%
controls:2.40%
cases:17.32%
controls:13.28%
cases:34.61%
controls:30.55%
498
4848
2588
25729
432
3832
2657
26762
434
777
2655
29817
404
39
2685
30555
413
734
2676
29833
528
4018
2521
26228
996
8682
1882
19740
Internal Medicine
11 [38004456]
11 [38004456]
-2.4e-01
-2.5e-01
1.3e+00
6.2e+00
1.9e+00
6.7e-03
-2.1e-01
cases:9.27%
controls:11.46%
cases:5.73%
controls:7.24%
cases:5.28%
controls:1.43%
cases:20.01%
controls:0.05%
cases:8.55%
controls:1.43%
cases:8.13%
controls:8.08%
cases:15.84%
controls:18.78%
286
3504
2800
27073
177
2216
2912
28378
163
437
2926
30157
618
16
2471
30578
264
437
2825
30130
248
2445
2801
27801
456
5339
2422
23083
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
718-7 [3000963]
2.3e-02
1.2e-01
1.8e+00
4.8e+00
1.8e+00
3.1e-01
1.8e-01
cases:16.17%
controls:15.86%
cases:13.95%
controls:12.54%
cases:13.89%
controls:2.52%
cases:12.88%
controls:0.13%
cases:13.37%
controls:2.39%
cases:17.28%
controls:13.30%
cases:34.54%
controls:30.56%
499
4851
2587
25726
431
3838
2658
26756
429
771
2660
29823
398
39
2691
30555
413
730
2676
29837
527
4023
2522
26223
994
8685
1884
19737
MCH [Entitic mass]
28539-5 [3035941]
28539-5 [3035941]
2.3e-02
1.3e-01
1.8e+00
4.7e+00
1.8e+00
3.1e-01
1.8e-01
cases:16.10%
controls:15.79%
cases:13.95%
controls:12.48%
cases:13.82%
controls:2.51%
cases:12.85%
controls:0.13%
cases:13.34%
controls:2.38%
cases:17.19%
controls:13.23%
cases:34.50%
controls:30.46%
497
4829
2589
25748
431
3818
2658
26776
427
767
2662
29827
397
39
2692
30555
412
728
2677
29839
524
4001
2525
26245
993
8656
1885
19766
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
26453-1 [3026361]
2.3e-02
1.3e-01
1.8e+00
4.7e+00
1.8e+00
3.1e-01
1.8e-01
cases:16.10%
controls:15.80%
cases:13.95%
controls:12.51%
cases:13.86%
controls:2.51%
cases:12.85%
controls:0.13%
cases:13.34%
controls:2.38%
cases:17.22%
controls:13.25%
cases:34.50%
controls:30.49%
497
4832
2589
25745
431
3827
2658
26767
428
768
2661
29826
397
39
2692
30555
412
729
2677
29838
525
4008
2524
26238
993
8665
1885
19757
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
30428-7 [3024731]
2.3e-02
1.3e-01
1.8e+00
4.7e+00
1.8e+00
3.1e-01
1.8e-01
cases:16.10%
controls:15.80%
cases:13.92%
controls:12.48%
cases:13.79%
controls:2.50%
cases:12.82%
controls:0.13%
cases:13.34%
controls:2.38%
cases:17.19%
controls:13.23%
cases:34.50%
controls:30.48%
497
4830
2589
25747
430
3818
2659
26776
426
766
2663
29828
396
39
2693
30555
412
726
2677
29841
524
4002
2525
26244
993
8662
1885
19760
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
20570-8 [3009542]
2.3e-02
1.3e-01
1.8e+00
4.7e+00
1.8e+00
3.1e-01
1.8e-01
cases:16.10%
controls:15.80%
cases:13.95%
controls:12.50%
cases:13.86%
controls:2.51%
cases:12.85%
controls:0.13%
cases:13.37%
controls:2.38%
cases:17.28%
controls:13.25%
cases:34.47%
controls:30.49%
497
4832
2589
25745
431
3825
2658
26769
428
769
2661
29825
397
40
2692
30554
413
729
2676
29838
527
4009
2522
26237
992
8666
1886
19756
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
2472-9 [3028026]
4.9e-02
1.0e+00
2.8e+00
1.0e+50
3.8e+00
1.4e+00
8.7e-01
cases:0.52%
controls:0.49%
cases:0.45%
controls:0.17%
cases:0.52%
controls:0.03%
cases:0.16%
controls:0.00%
cases:0.91%
controls:0.02%
cases:0.66%
controls:0.16%
cases:1.29%
controls:0.54%
16
151
3070
30426
14
51
3075
30543
16
10
3073
30584
5
0
3084
30594
28
6
3061
30561
20
49
3029
30197
37
154
2841
28268
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
14682-9 [3020564]
5.7e-02
1.1e-01
1.7e+00
4.8e+00
1.8e+00
2.9e-01
2.3e-01
cases:12.44%
controls:11.83%
cases:9.49%
controls:8.58%
cases:8.19%
controls:1.58%
cases:8.09%
controls:0.08%
cases:8.42%
controls:1.43%
cases:11.61%
controls:8.97%
cases:27.35%
controls:23.00%
384
3618
2702
26959
293
2624
2796
27970
253
483
2836
30111
250
23
2839
30571
260
436
2829
30131
354
2712
2695
27534
787
6538
2091
21884
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 [43055120]
72493-0 [43055120]
3.2e-01
1.4e+00
3.6e+00
1.0e+50
—
2.1e+00
1.6e+00
cases:0.19%
controls:0.14%
cases:0.42%
controls:0.11%
cases:0.84%
controls:0.02%
cases:0.42%
controls:0.00%
—
—
cases:0.56%
controls:0.07%
cases:0.87%
controls:0.18%
6
43
3080
30534
13
33
3076
30561
26
7
3063
30587
13
0
3076
30594
—
17
20
3032
30226
25
50
2853
28372
Promyelocytes/Leukocytes in Blood
26524-9 [3021440]
26524-9 [3021440]
7.6e-01
6.9e-01
3.1e+00
—
3.6e+00
1.4e+00
6.2e-01
cases:0.75%
controls:0.35%
cases:0.55%
controls:0.28%
cases:0.71%
controls:0.03%
—
—
cases:1.04%
controls:0.03%
cases:0.92%
controls:0.22%
cases:1.32%
controls:0.72%
23
107
3063
30470
17
85
3072
30509
22
10
3067
30584
—
32
9
3057
30558
28
68
3021
30178
38
204
2840
28218
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
29953-7 [3037522]
1.4e-01
9.0e-01
3.2e+00
1.0e+50
3.2e+00
8.6e-01
5.3e-01
cases:1.10%
controls:0.96%
cases:0.81%
controls:0.33%
cases:0.81%
controls:0.03%
cases:0.16%
controls:0.00%
cases:0.84%
controls:0.04%
cases:0.89%
controls:0.38%
cases:2.47%
controls:1.46%
34
293
3052
30284
25
101
3064
30493
25
10
3064
30584
5
0
3084
30594
26
11
3063
30556
27
114
3022
30132
71
415
2807
28007
Streptococcus pyogenes Ag [Presence] in Throat
18481-2 [3033319]
18481-2 [3033319]
5.1e-01
7.1e-01
4.2e+00
—
2.2e+00
6.0e-01
4.4e-01
cases:2.98%
controls:1.82%
cases:1.46%
controls:0.72%
cases:3.85%
controls:0.06%
—
—
cases:0.62%
controls:0.07%
cases:1.64%
controls:0.91%
cases:5.49%
controls:3.59%
92
556
2994
30021
45
221
3044
30373
119
19
2970
30575
—
19
20
3070
30547
50
275
2999
29971
158
1021
2720
27401
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
57782-5 [40760892]
5.5e-01
8.6e-01
2.8e+00
—
2.9e+00
1.1e+00
4.8e-01
cases:2.98%
controls:1.74%
cases:2.27%
controls:0.97%
cases:2.91%
controls:0.19%
—
—
cases:2.33%
controls:0.14%
cases:3.08%
controls:1.04%
cases:5.42%
controls:3.43%
92
531
2994
30046
70
296
3019
30298
90
58
2999
30536
—
72
42
3017
30525
94
316
2955
29930
156
976
2722
27446
Metamyelocytes/Leukocytes in Blood
28541-1 [3002179]
28541-1 [3002179]
7.7e-01
7.6e-01
3.3e+00
—
3.6e+00
1.5e+00
5.4e-01
cases:0.71%
controls:0.33%
cases:0.55%
controls:0.26%
cases:0.78%
controls:0.03%
—
—
cases:1.23%
controls:0.03%
cases:0.98%
controls:0.22%
cases:1.18%
controls:0.69%
22
101
3064
30476
17
79
3072
30515
24
9
3065
30585
—
38
10
3051
30557
30
66
3019
30180
34
196
2844
28226
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
28540-3 [3003338]
-5.3e-02
5.4e-02
1.8e+00
4.6e+00
1.7e+00
3.0e-01
1.1e-01
cases:11.76%
controls:12.33%
cases:9.61%
controls:9.15%
cases:9.74%
controls:1.79%
cases:8.22%
controls:0.09%
cases:8.77%
controls:1.69%
cases:12.27%
controls:9.42%
cases:25.92%
controls:23.86%
363
3769
2723
26808
297
2800
2792
27794
301
547
2788
30047
254
27
2835
30567
271
517
2818
30050
374
2850
2675
27396
746
6782
2132
21640
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
30385-9 [3002385]
-4.1e-02
1.4e-02
1.7e+00
4.7e+00
1.8e+00
2.2e-01
1.3e-01
cases:10.53%
controls:10.93%
cases:8.35%
controls:8.25%
cases:8.09%
controls:1.58%
cases:8.32%
controls:0.08%
cases:8.42%
controls:1.54%
cases:10.50%
controls:8.57%
cases:22.17%
controls:20.02%
325
3341
2761
27236
258
2523
2831
28071
250
482
2839
30112
257
26
2832
30568
260
472
2829
30095
320
2593
2729
27653
638
5689
2240
22733
Myelocytes/Leukocytes in Blood
26498-6 [3017181]
26498-6 [3017181]
7.3e-01
7.9e-01
3.3e+00
—
3.6e+00
1.5e+00
5.6e-01
cases:0.75%
controls:0.36%
cases:0.62%
controls:0.28%
cases:0.87%
controls:0.03%
—
—
cases:1.20%
controls:0.03%
cases:0.98%
controls:0.23%
cases:1.32%
controls:0.76%
23
110
3063
30467
19
86
3070
30508
27
10
3062
30584
—
37
10
3052
30557
30
70
3019
30176
38
215
2840
28207
Short blood count panel - Blood
55429-5 [40758558]
55429-5 [40758558]
-1.0e-01
-3.2e-01
1.4e+00
4.4e+00
1.9e+00
4.6e-01
2.8e-01
cases:2.53%
controls:2.79%
cases:1.17%
controls:1.60%
cases:1.26%
controls:0.30%
cases:1.62%
controls:0.02%
cases:2.01%
controls:0.31%
cases:2.07%
controls:1.32%
cases:4.41%
controls:3.38%
78
852
3008
29725
36
491
3053
30103
39
93
3050
30501
50
6
3039
30588
62
95
3027
30472
63
398
2986
29848
127
960
2751
27462
clindamycin; oral, parenteral
J01FF01 [21602985]
J01FF01 [21602985]
1.5e-01
6.2e-01
3.4e+00
1.0e+50
3.3e+00
9.5e-01
4.3e-01
cases:2.24%
controls:1.92%
cases:1.07%
controls:0.58%
cases:1.29%
controls:0.04%
cases:0.29%
controls:0.00%
cases:1.46%
controls:0.06%
cases:1.54%
controls:0.60%
cases:4.34%
controls:2.86%
69
588
3017
29989
33
176
3056
30418
40
13
3049
30581
9
0
3080
30594
45
17
3044
30550
47
182
3002
30064
125
812
2753
27610
pantoprazole; oral, parenteral
A02BC02 [21600097]
A02BC02 [21600097]
3.9e-01
4.9e-01
1.2e+00
3.1e+00
1.4e+00
7.6e-01
6.6e-01
cases:6.25%
controls:4.30%
cases:3.33%
controls:2.06%
cases:1.13%
controls:0.35%
cases:0.45%
controls:0.02%
cases:1.65%
controls:0.40%
cases:4.53%
controls:2.18%
cases:11.67%
controls:6.41%
193
1316
2893
29261
103
631
2986
29963
35
106
3054
30488
14
6
3075
30588
51
123
3038
30444
138
659
2911
29587
336
1822
2542
26600
Infectious Disease
44 [38004484]
44 [38004484]
4.0e-01
7.1e-01
2.7e+00
1.0e+50
3.7e+00
1.6e+00
4.6e-01
cases:1.20%
controls:0.81%
cases:0.78%
controls:0.38%
cases:0.87%
controls:0.06%
cases:2.85%
controls:0.00%
cases:1.97%
controls:0.05%
cases:1.84%
controls:0.37%
cases:2.08%
controls:1.33%
37
247
3049
30330
24
117
3065
30477
27
19
3062
30575
88
0
3001
30594
61
15
3028
30552
56
113
2993
30133
60
377
2818
28045
ketoprofen; oral, parenteral, rectal
M01AE03 [21603969]
M01AE03 [21603969]
1.4e-01
1.7e-01
2.3e+00
—
4.3e+00
9.6e-01
3.2e-01
cases:3.47%
controls:3.02%
cases:1.07%
controls:0.91%
cases:0.78%
controls:0.08%
—
—
cases:5.99%
controls:0.09%
cases:2.26%
controls:0.88%
cases:4.69%
controls:3.45%
107
922
2979
29655
33
277
3056
30317
24
23
3065
30571
—
185
27
2904
30540
69
266
2980
29980
135
980
2743
27442
Telehealth
OMOP5556618 [722455]
OMOP5556618 [722455]
8.8e-02
2.2e-01
1.4e+00
4.3e+00
1.3e+00
4.8e-01
2.1e-01
cases:16.98%
controls:15.77%
cases:9.65%
controls:7.87%
cases:4.53%
controls:1.16%
cases:3.46%
controls:0.05%
cases:4.21%
controls:1.18%
cases:11.87%
controls:7.72%
cases:24.39%
controls:20.80%
524
4823
2562
25754
298
2407
2791
28187
140
354
2949
30240
107
15
2982
30579
130
362
2959
30205
362
2335
2687
27911
702
5913
2176
22509
Tonsillectomy
EMB10 [2001302265]
EMB10 [2001302265]
-6.2e-01
3.3e-01
—
1.0e+50
3.3e+00
3.1e+00
1.5e+00
cases:0.52%
controls:0.95%
cases:0.32%
controls:0.23%
—
—
cases:1.13%
controls:0.00%
cases:0.84%
controls:0.03%
cases:3.35%
controls:0.16%
cases:4.07%
controls:0.89%
16
292
3070
30285
10
71
3079
30523
—
35
0
3054
30594
26
10
3063
30557
102
48
2947
30198
117
254
2761
28168
cefuroxime; oral, parenteral
J01DC02 [21602884]
J01DC02 [21602884]
5.9e-01
3.2e-01
2.9e+00
—
2.8e+00
9.6e-01
6.9e-01
cases:2.01%
controls:1.13%
cases:0.32%
controls:0.24%
cases:0.52%
controls:0.03%
—
—
cases:0.52%
controls:0.03%
cases:0.66%
controls:0.25%
cases:1.81%
controls:0.91%
62
344
3024
30233
10
72
3079
30522
16
9
3073
30585
—
16
10
3073
30557
20
76
3029
30170
52
260
2826
28162
Viral infection, unspecified
B34.9 [45605229]
B34.9 [45605229]
2.4e+00
2.7e+00
1.0e+50
1.0e+50
—
2.8e+00
6.6e-01
cases:0.58%
controls:0.06%
cases:0.39%
controls:0.03%
cases:1.04%
controls:0.00%
cases:0.26%
controls:0.00%
—
—
cases:0.36%
controls:0.02%
cases:0.31%
controls:0.16%
18
17
3068
30560
12
8
3077
30586
32
0
3057
30594
8
0
3081
30594
—
11
7
3038
30239
9
46
2869
28376
Thorax X-ray examination
GD1AA [2001303617]
GD1AA [2001303617]
3.6e-01
7.5e-01
3.1e+00
—
1.9e+00
1.1e+00
6.6e-01
cases:3.47%
controls:2.44%
cases:1.88%
controls:0.89%
cases:1.88%
controls:0.09%
—
—
cases:0.74%
controls:0.11%
cases:1.97%
controls:0.68%
cases:4.66%
controls:2.47%
107
745
2979
29832
58
273
3031
30321
58
27
3031
30567
—
23
35
3066
30532
60
206
2989
30040
134
702
2744
27720
Outpatient Hospital
22 [8756]
22 [8756]
-1.3e-01
7.2e-02
5.8e-01
5.3e+00
1.5e+00
6.4e-01
2.3e-01
cases:12.80%
controls:14.35%
cases:4.89%
controls:4.56%
cases:0.87%
controls:0.49%
cases:4.82%
controls:0.03%
cases:2.62%
controls:0.57%
cases:7.71%
controls:4.22%
cases:17.44%
controls:14.31%
395
4389
2691
26188
151
1396
2938
29198
27
151
3062
30443
149
8
2940
30586
81
175
3008
30392
235
1275
2814
28971
502
4068
2376
24354
Pain localized to upper abdomen
R10.1 [45568111]
R10.1 [45568111]
5.0e-01
9.0e-01
2.0e+00
1.0e+50
2.6e+00
1.2e+00
7.9e-01
cases:1.36%
controls:0.83%
cases:0.81%
controls:0.33%
cases:0.32%
controls:0.04%
cases:0.23%
controls:0.00%
cases:0.45%
controls:0.03%
cases:1.02%
controls:0.32%
cases:2.99%
controls:1.38%
42
255
3044
30322
25
101
3064
30493
10
13
3079
30581
7
0
3082
30594
14
10
3075
30557
31
96
3018
30150
86
391
2792
28031
Laboratory Visit
OMOP4822461 [32036]
OMOP4822461 [32036]
4.4e-02
1.2e-01
1.7e+00
4.3e+00
1.4e+00
2.3e-01
1.2e-01
cases:21.22%
controls:20.50%
cases:20.91%
controls:18.97%
cases:22.27%
controls:5.14%
cases:17.45%
controls:0.29%
cases:16.77%
controls:4.94%
cases:24.76%
controls:20.66%
cases:41.49%
controls:38.69%
655
6267
2431
24310
646
5805
2443
24789
688
1572
2401
29022
539
90
2550
30504
518
1511
2571
29056
755
6249
2294
23997
1194
10996
1684
17426
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
J01MA12 [21603019]
6.4e-01
9.9e-01
2.5e+00
—
2.5e+00
9.3e-01
5.3e-01
cases:1.00%
controls:0.53%
cases:0.62%
controls:0.23%
cases:0.32%
controls:0.03%
—
—
cases:0.49%
controls:0.04%
cases:0.56%
controls:0.22%
cases:1.98%
controls:1.18%
31
163
3055
30414
19
70
3070
30524
10
8
3079
30586
—
15
12
3074
30555
17
67
3032
30179
57
335
2821
28087
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
6598-7 [3019800]
2.7e-01
7.3e-01
3.0e+00
1.0e+50
2.3e+00
9.1e-01
4.8e-01
cases:1.65%
controls:1.27%
cases:1.39%
controls:0.68%
cases:0.91%
controls:0.05%
cases:0.78%
controls:0.00%
cases:0.74%
controls:0.08%
cases:1.57%
controls:0.64%
cases:4.03%
controls:2.53%
51
388
3035
30189
43
207
3046
30387
28
14
3061
30580
24
0
3065
30594
23
24
3066
30543
48
194
3001
30052
116
718
2762
27704
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
14631-6 [3006140]
1.9e-01
3.9e-01
2.6e+00
—
3.2e+00
1.1e+00
4.0e-01
cases:3.43%
controls:2.87%
cases:2.33%
controls:1.59%
cases:3.72%
controls:0.29%
—
—
cases:5.79%
controls:0.24%
cases:4.69%
controls:1.60%
cases:7.82%
controls:5.36%
106
877
2980
29700
72
487
3017
30107
115
88
2974
30506
—
179
73
2910
30494
143
485
2906
29761
225
1523
2653
26899
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
29760-6 [3005772]
2.6e-01
7.0e-01
2.4e+00
—
3.2e+00
1.1e+00
5.6e-01
cases:0.84%
controls:0.65%
cases:0.62%
controls:0.31%
cases:0.74%
controls:0.07%
—
—
cases:1.07%
controls:0.04%
cases:0.92%
controls:0.30%
cases:1.70%
controls:0.98%
26
199
3060
30378
19
94
3070
30500
23
21
3066
30573
—
33
13
3056
30554
28
91
3021
30155
49
278
2829
28144
Bone marrow biopsy
XW000 [2001310618]
XW000 [2001310618]
6.0e-01
2.6e+00
—
1.0e+50
—
2.8e+00
1.9e+00
cases:0.23%
controls:0.12%
cases:0.49%
controls:0.04%
—
—
cases:0.23%
controls:0.00%
—
—
cases:0.33%
controls:0.02%
cases:0.31%
controls:0.05%
7
38
3079
30539
15
11
3074
30583
—
7
0
3082
30594
—
10
6
3039
30240
9
14
2869
28408
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
1798-8 [3016771]
8.9e-02
4.1e-01
2.7e+00
1.0e+50
3.0e+00
1.1e+00
4.6e-01
cases:1.94%
controls:1.78%
cases:1.20%
controls:0.79%
cases:1.72%
controls:0.11%
cases:1.42%
controls:0.00%
cases:1.85%
controls:0.10%
cases:2.26%
controls:0.80%
cases:5.42%
controls:3.50%
60
545
3026
30032
37
243
3052
30351
53
35
3036
30559
44
0
3045
30594
57
30
3032
30537
69
243
2980
30003
156
996
2722
27426
SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
94500-6 [706163]
94500-6 [706163]
1.1e-01
3.0e-01
2.0e+00
4.0e+00
6.6e-01
2.9e-01
2.0e-01
cases:7.42%
controls:6.69%
cases:5.05%
controls:3.79%
cases:4.27%
controls:0.58%
cases:1.68%
controls:0.03%
cases:1.26%
controls:0.65%
cases:5.12%
controls:3.87%
cases:15.98%
controls:13.46%
229
2047
2857
28530
156
1160
2933
29434
132
177
2957
30417
52
10
3037
30584
39
200
3050
30367
156
1172
2893
29074
460
3827
2418
24595
methylprednisolone; oral, parenteral
H02AB04 [21602732]
H02AB04 [21602732]
1.0e+00
1.1e+00
2.3e+00
—
1.8e+00
1.2e+00
1.3e+00
cases:1.52%
controls:0.56%
cases:0.74%
controls:0.26%
cases:0.32%
controls:0.03%
—
—
cases:0.23%
controls:0.04%
cases:0.75%
controls:0.22%
cases:1.98%
controls:0.57%
47
170
3039
30407
23
79
3066
30515
10
10
3079
30584
—
7
12
3082
30555
23
66
3026
30180
57
163
2821
28259
Fever
A03 [2002000144]
A03 [2002000144]
4.3e-01
7.2e-01
3.6e+00
—
1.6e+00
4.0e-01
5.6e-01
cases:4.21%
controls:2.79%
cases:1.97%
controls:0.97%
cases:3.66%
controls:0.11%
—
—
cases:0.58%
controls:0.12%
cases:1.61%
controls:1.08%
cases:7.16%
controls:4.22%
130
852
2956
29725
61
296
3028
30298
113
33
2976
30561
—
18
36
3071
30531
49
326
3000
29920
206
1198
2672
27224
azathioprine; oral, parenteral
L04AX01 [21603927]
L04AX01 [21603927]
1.2e+00
1.4e+00
1.5e+00
—
—
1.4e+00
1.4e+00
cases:1.20%
controls:0.36%
cases:1.07%
controls:0.26%
cases:0.39%
controls:0.09%
—
—
—
—
cases:0.92%
controls:0.24%
cases:1.46%
controls:0.37%
37
109
3049
30468
33
80
3056
30514
12
27
3077
30567
—
—
28
72
3021
30174
42
105
2836
28317
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
1805-1 [3016417]
-3.5e-01
2.1e-01
2.9e+00
1.0e+50
2.9e+00
9.9e-01
2.5e-01
cases:0.42%
controls:0.60%
cases:0.29%
controls:0.24%
cases:0.68%
controls:0.04%
cases:0.65%
controls:0.00%
cases:0.45%
controls:0.03%
cases:0.66%
controls:0.24%
cases:1.11%
controls:0.87%
13
182
3073
30395
9
72
3080
30522
21
11
3068
30583
20
0
3069
30594
14
8
3075
30559
20
74
3029
30172
32
247
2846
28175
naproxcinod
M01AE18 [40254094]
M01AE18 [40254094]
1.9e-01
2.8e-01
1.5e+00
3.5e+00
1.1e+00
3.4e-01
3.0e-01
cases:11.15%
controls:9.40%
cases:4.69%
controls:3.58%
cases:1.94%
controls:0.42%
cases:0.52%
controls:0.02%
cases:1.36%
controls:0.44%
cases:4.85%
controls:3.51%
cases:13.52%
controls:10.40%
344
2875
2742
27702
145
1096
2944
29498
60
129
3029
30465
16
5
3073
30589
42
133
3047
30434
148
1062
2901
29184
389
2955
2489
25467
naproxen; oral, rectal
M01AE02 [21603968]
M01AE02 [21603968]
1.9e-01
2.8e-01
1.5e+00
3.5e+00
1.1e+00
3.4e-01
3.0e-01
cases:11.15%
controls:9.40%
cases:4.69%
controls:3.58%
cases:1.94%
controls:0.42%
cases:0.52%
controls:0.02%
cases:1.36%
controls:0.44%
cases:4.85%
controls:3.51%
cases:13.52%
controls:10.40%
344
2875
2742
27702
145
1096
2944
29498
60
129
3029
30465
16
5
3073
30589
42
133
3047
30434
148
1062
2901
29184
389
2955
2489
25467
prednisolone; oral, parenteral
H02AB06 [21602734]
H02AB06 [21602734]
5.8e-01
8.5e-01
1.4e+00
—
2.2e+00
9.2e-01
7.2e-01
cases:6.32%
controls:3.66%
cases:3.04%
controls:1.32%
cases:0.74%
controls:0.18%
—
—
cases:1.97%
controls:0.22%
cases:3.05%
controls:1.24%
cases:8.58%
controls:4.38%
195
1118
2891
29459
94
403
2995
30191
23
55
3066
30539
—
61
66
3028
30501
93
375
2956
29871
247
1244
2631
27178
prednisolone
A07EA01 [21600653]
A07EA01 [21600653]
5.7e-01
8.7e-01
1.4e+00
—
2.2e+00
9.1e-01
7.3e-01
cases:6.32%
controls:3.68%
cases:3.11%
controls:1.32%
cases:0.74%
controls:0.18%
—
—
cases:1.97%
controls:0.22%
cases:3.05%
controls:1.25%
cases:8.69%
controls:4.40%
195
1125
2891
29452
96
404
2993
30190
23
55
3066
30539
—
61
67
3028
30500
93
378
2956
29868
250
1251
2628
27171
Acute pharyngitis
J02 [45557615]
J02 [45557615]
7.6e-01
8.1e-01
4.2e+00
1.0e+50
—
1.6e+00
8.2e-01
cases:0.65%
controls:0.30%
cases:0.32%
controls:0.14%
cases:1.04%
controls:0.02%
cases:0.65%
controls:0.00%
—
—
cases:0.69%
controls:0.14%
cases:1.42%
controls:0.63%
20
93
3066
30484
10
44
3079
30550
32
5
3057
30589
20
0
3069
30594
—
21
42
3028
30204
41
179
2837
28243
Chronic tonsillitis
J35.0 [45548113]
J35.0 [45548113]
5.3e-02
5.5e-01
—
—
2.2e+00
2.8e+00
1.5e+00
cases:0.81%
controls:0.77%
cases:0.39%
controls:0.23%
—
—
—
—
cases:0.32%
controls:0.04%
cases:3.54%
controls:0.21%
cases:3.68%
controls:0.82%
25
235
3061
30342
12
69
3077
30525
—
—
10
11
3079
30556
108
65
2941
30181
106
232
2772
28190
Upper respiratory infection acute
R74 [2002000942]
R74 [2002000942]
2.7e-01
5.6e-01
2.3e+00
2.9e+00
5.9e-01
3.2e-01
4.7e-01
cases:6.84%
controls:5.29%
cases:4.08%
controls:2.37%
cases:2.69%
controls:0.27%
cases:0.36%
controls:0.02%
cases:0.45%
controls:0.25%
cases:3.64%
controls:2.68%
cases:13.97%
controls:9.18%
211
1617
2875
28960
126
726
2963
29868
83
84
3006
30510
11
6
3078
30588
14
77
3075
30490
111
810
2938
29436
402
2610
2476
25812
Pneumonia, unspecified
J18.9 [45601123]
J18.9 [45601123]
4.7e-01
7.9e-01
2.5e+00
1.0e+50
2.3e+00
8.9e-01
4.1e-01
cases:1.59%
controls:1.00%
cases:0.84%
controls:0.38%
cases:0.58%
controls:0.05%
cases:0.81%
controls:0.00%
cases:0.52%
controls:0.05%
cases:0.92%
controls:0.38%
cases:2.02%
controls:1.34%
49
305
3037
30272
26
117
3063
30477
18
15
3071
30579
25
0
3064
30594
16
16
3073
30551
28
115
3021
30131
58
381
2820
28041
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
5894-1 [3033658]
-6.0e-02
-9.7e-03
2.3e+00
—
2.8e+00
7.8e-01
5.1e-01
cases:1.59%
controls:1.68%
cases:0.91%
controls:0.92%
cases:1.23%
controls:0.13%
—
—
cases:1.88%
controls:0.11%
cases:1.41%
controls:0.65%
cases:3.41%
controls:2.07%
49
515
3037
30062
28
280
3061
30314
38
39
3051
30555
—
58
34
3031
30533
43
197
3006
30049
98
588
2780
27834
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
N02AX02 [21604298]
3.4e-01
5.1e-01
1.3e+00
—
3.2e+00
1.1e+00
7.2e-01
cases:2.72%
controls:1.95%
cases:1.36%
controls:0.82%
cases:0.71%
controls:0.19%
—
—
cases:3.20%
controls:0.14%
cases:2.36%
controls:0.82%
cases:5.73%
controls:2.87%
84
597
3002
29980
42
252
3047
30342
22
57
3067
30537
—
99
42
2990
30525
72
248
2977
29998
165
817
2713
27605
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
4679-7 [3027945]
2.9e-01
4.4e-01
2.1e+00
—
3.2e+00
1.0e+00
4.7e-01
cases:0.97%
controls:0.73%
cases:0.55%
controls:0.36%
cases:0.42%
controls:0.05%
—
—
cases:1.10%
controls:0.05%
cases:0.89%
controls:0.33%
cases:1.53%
controls:0.96%
30
223
3056
30354
17
109
3072
30485
13
16
3076
30578
—
34
14
3055
30553
27
99
3022
30147
44
274
2834
28148
metronidazole; oral, rectal
P01AB01 [21604857]
P01AB01 [21604857]
2.2e-01
6.4e-01
1.9e+00
1.0e+50
2.5e+00
7.1e-01
5.0e-01
cases:4.08%
controls:3.29%
cases:1.97%
controls:1.06%
cases:0.74%
controls:0.12%
cases:0.29%
controls:0.00%
cases:1.20%
controls:0.09%
cases:2.56%
controls:1.27%
cases:8.76%
controls:5.47%
126
1007
2960
29570
61
323
3028
30271
23
36
3066
30558
9
0
3080
30594
37
29
3052
30538
78
385
2971
29861
252
1556
2626
26866
Initiation, adjustment, discontinuation or repetition of medication
SPAT1253 [2001700354]
SPAT1253 [2001700354]
1.1e-01
4.1e-01
1.2e+00
3.6e+00
9.2e-01
3.3e-01
1.5e-01
cases:5.15%
controls:4.65%
cases:3.17%
controls:2.14%
cases:1.00%
controls:0.29%
cases:0.62%
controls:0.02%
cases:0.68%
controls:0.27%
cases:3.08%
controls:2.24%
cases:9.21%
controls:8.03%
159
1422
2927
29155
98
654
2991
29940
31
90
3058
30504
19
5
3070
30589
21
83
3068
30484
94
678
2955
29568
265
2283
2613
26139
ANTIHYPERTENSIVE_DRUG - yes
ANTIHYPERTENSIVE_DRUG-1 [2002330215]
ANTIHYPERTENSIVE_DRUG-1 [2002330215]
2.0e+00
2.4e+00
—
—
—
—
1.7e+00
cases:0.19%
controls:0.03%
cases:0.23%
controls:0.02%
—
—
—
—
—
—
—
—
cases:0.28%
controls:0.05%
6
8
3080
30569
7
6
3082
30588
—
—
—
—
8
14
2870
28408
Acute maxillary sinusitis
J01.0 [45601112]
J01.0 [45601112]
3.9e-01
6.3e-01
2.2e+00
—
1.5e+00
8.7e-01
5.8e-01
cases:3.79%
controls:2.60%
cases:1.75%
controls:0.94%
cases:1.00%
controls:0.11%
—
—
cases:0.52%
controls:0.12%
cases:2.36%
controls:1.01%
cases:5.91%
controls:3.41%
117
794
2969
29783
54
288
3035
30306
31
33
3058
30561
—
16
36
3073
30531
72
304
2977
29942
170
969
2708
27453
Gastroenterology
10 [38004455]
10 [38004455]
6.3e-01
8.0e-01
1.3e+00
—
1.9e+00
1.0e+00
5.5e-01
cases:2.98%
controls:1.61%
cases:2.04%
controls:0.93%
cases:0.81%
controls:0.22%
—
—
cases:1.62%
controls:0.26%
cases:2.72%
controls:1.00%
cases:4.93%
controls:2.91%
92
492
2994
30085
63
284
3026
30310
25
67
3064
30527
—
50
78
3039
30489
83
303
2966
29943
142
828
2736
27594
codeine and paracetamol
N02AJ06 [1123647]
N02AJ06 [1123647]
2.5e-01
5.0e-01
2.0e+00
—
2.3e+00
8.0e-01
5.7e-01
cases:6.42%
controls:5.05%
cases:3.27%
controls:2.01%
cases:1.88%
controls:0.26%
—
—
cases:2.59%
controls:0.26%
cases:4.30%
controls:1.97%
cases:12.68%
controls:7.57%
198
1544
2888
29033
101
614
2988
29980
58
81
3031
30513
—
80
80
3009
30487
131
596
2918
29650
365
2152
2513
26270
Intravenous
ZX120 [2001311495]
ZX120 [2001311495]
4.5e-01
1.1e+00
—
—
2.4e+00
1.3e+00
1.2e+00
cases:0.65%
controls:0.42%
cases:0.49%
controls:0.16%
—
—
—
—
cases:0.32%
controls:0.03%
cases:0.49%
controls:0.13%
cases:1.15%
controls:0.33%
20
127
3066
30450
15
49
3074
30545
—
—
10
9
3079
30558
15
39
3034
30207
33
95
2845
28327
Supplier / Service Provider
OMOP5117446 [33004]
OMOP5117446 [33004]
-9.5e-01
-1.2e+00
-1.1e+00
—
2.9e+00
2.7e+00
3.7e+00
cases:7.36%
controls:16.99%
cases:2.69%
controls:8.30%
cases:0.36%
controls:1.07%
—
—
cases:0.42%
controls:0.02%
cases:2.53%
controls:0.18%
cases:13.52%
controls:0.38%
227
5194
2859
25383
83
2540
3006
28054
11
327
3078
30267
—
13
7
3076
30560
77
53
2972
30193
389
108
2489
28314
roxithromycin; oral
J01FA06 [21602974]
J01FA06 [21602974]
3.4e-01
8.0e-01
1.9e+00
—
1.8e+00
6.4e-01
6.1e-01
cases:4.63%
controls:3.34%
cases:1.78%
controls:0.81%
cases:0.65%
controls:0.10%
—
—
cases:0.39%
controls:0.07%
cases:1.51%
controls:0.80%
cases:5.42%
controls:3.01%
143
1022
2943
29555
55
247
3034
30347
20
31
3069
30563
—
12
20
3077
30547
46
242
3003
30004
156
856
2722
27566
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
16128-1 [3017143]
-2.1e-01
1.9e-01
2.8e+00
—
2.5e+00
4.1e-01
6.7e-01
cases:1.23%
controls:1.51%
cases:0.94%
controls:0.77%
cases:1.23%
controls:0.08%
—
—
cases:0.78%
controls:0.06%
cases:1.08%
controls:0.72%
cases:4.76%
controls:2.48%
38
462
3048
30115
29
237
3060
30357
38
23
3051
30571
—
24
19
3065
30548
33
219
3016
30027
137
706
2741
27716
INR in Blood by Coagulation assay
34714-6 [3032080]
34714-6 [3032080]
2.5e-01
4.5e-01
2.0e+00
—
2.6e+00
8.4e-01
5.0e-01
cases:2.30%
controls:1.79%
cases:1.59%
controls:1.02%
cases:1.26%
controls:0.18%
—
—
cases:2.33%
controls:0.17%
cases:2.23%
controls:0.97%
cases:4.86%
controls:3.00%
71
548
3015
30029
49
311
3040
30283
39
55
3050
30539
—
72
52
3017
30515
68
294
2981
29952
140
853
2738
27569
mycophenolic acid; oral, parenteral
L04AA06 [21603896]
L04AA06 [21603896]
1.3e+00
2.1e+00
—
—
—
2.0e+00
1.8e+00
cases:0.26%
controls:0.07%
cases:0.36%
controls:0.04%
—
—
—
—
—
—
cases:0.30%
controls:0.04%
cases:0.38%
controls:0.06%
8
21
3078
30556
11
13
3078
30581
—
—
—
9
12
3040
30234
11
18
2867
28404
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
1920-8 [3013721]
1.0e-01
1.6e-01
2.3e+00
1.0e+50
2.8e+00
7.3e-01
2.0e-01
cases:2.72%
controls:2.46%
cases:1.49%
controls:1.27%
cases:1.75%
controls:0.18%
cases:1.00%
controls:0.00%
cases:2.91%
controls:0.18%
cases:2.66%
controls:1.29%
cases:5.46%
controls:4.50%
84
753
3002
29824
46
389
3043
30205
54
55
3035
30539
31
0
3058
30594
90
54
2999
30513
81
391
2968
29855
157
1279
2721
27143
Case Management Agency
251B00000X [38004193]
251B00000X [38004193]
-9.2e-02
6.7e-02
1.1e+00
4.0e+00
6.7e-01
9.6e-02
5.2e-02
cases:42.87%
controls:45.13%
cases:41.53%
controls:39.92%
cases:33.31%
controls:14.71%
cases:30.56%
controls:0.84%
cases:25.38%
controls:14.86%
cases:44.15%
controls:41.80%
cases:57.75%
controls:56.47%
1323
13798
1763
16779
1283
12214
1806
18380
1029
4500
2060
26094
944
257
2145
30337
784
4542
2305
26025
1346
12643
1703
17603
1662
16050
1216
12372
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
14196-0 [3023520]
2.8e-01
6.7e-01
2.1e+00
—
3.5e+00
8.4e-01
5.1e-01
cases:0.49%
controls:0.37%
cases:0.39%
controls:0.20%
cases:0.19%
controls:0.02%
—
—
cases:0.78%
controls:0.02%
cases:0.46%
controls:0.20%
cases:1.01%
controls:0.61%
15
113
3071
30464
12
61
3077
30533
6
7
3083
30587
—
24
7
3065
30560
14
60
3035
30186
29
172
2849
28250
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1751-7 [3024561]
2.1e-01
3.8e-01
1.7e+00
—
2.6e+00
8.2e-01
4.7e-01
cases:2.95%
controls:2.41%
cases:2.14%
controls:1.47%
cases:1.26%
controls:0.23%
—
—
cases:2.59%
controls:0.19%
cases:3.12%
controls:1.40%
cases:5.98%
controls:3.80%
91
737
2995
29840
66
450
3023
30144
39
69
3050
30525
—
80
58
3009
30509
95
424
2954
29822
172
1081
2706
27341
Counselling related to known health issue
SPAT1310 [2001700411]
SPAT1310 [2001700411]
1.4e-01
2.4e-01
1.5e+00
3.3e+00
8.1e-01
6.0e-01
2.9e-01
cases:5.48%
controls:4.79%
cases:2.33%
controls:1.84%
cases:1.26%
controls:0.28%
cases:0.42%
controls:0.02%
cases:0.45%
controls:0.20%
cases:3.28%
controls:1.83%
cases:8.06%
controls:6.16%
169
1465
2917
29112
72
563
3017
30031
39
85
3050
30509
13
5
3076
30589
14
62
3075
30505
100
555
2949
29691
232
1750
2646
26672
Extensive body CT
JN4BD [2001310899]
JN4BD [2001310899]
1.1e+00
1.2e+00
—
1.0e+50
—
2.7e+00
1.8e+00
cases:0.55%
controls:0.18%
cases:0.29%
controls:0.08%
—
—
cases:0.29%
controls:0.00%
—
—
cases:0.62%
controls:0.04%
cases:0.42%
controls:0.07%
17
55
3069
30522
9
26
3080
30568
—
9
0
3080
30594
—
19
13
3030
30233
12
20
2866
28402
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
50554-5 [3029287]
2.5e-01
4.0e-01
2.2e+00
—
2.1e+00
7.3e-01
5.7e-01
cases:3.14%
controls:2.47%
cases:1.75%
controls:1.18%
cases:1.46%
controls:0.16%
—
—
cases:1.10%
controls:0.14%
cases:2.23%
controls:1.09%
cases:6.43%
controls:3.76%
97
755
2989
29822
54
361
3035
30233
45
50
3044
30544
—
34
43
3055
30524
68
329
2981
29917
185
1068
2693
27354
Hepatitis B virus core Ab [Presence] in Serum
16933-4 [3021879]
16933-4 [3021879]
-1.5e-01
2.1e-01
2.8e+00
—
2.2e+00
3.4e-01
5.2e-01
cases:0.71%
controls:0.82%
cases:0.58%
controls:0.47%
cases:0.65%
controls:0.04%
—
—
cases:0.42%
controls:0.05%
cases:0.62%
controls:0.44%
cases:2.36%
controls:1.42%
22
252
3064
30325
18
144
3071
30450
20
12
3069
30582
—
13
14
3076
30553
19
134
3030
30112
68
404
2810
28018
Pharmacy visit
OMOP4822462 [581458]
OMOP4822462 [581458]
1.1e-02
5.9e-02
1.3e+00
2.7e+00
9.6e-01
2.2e-01
3.5e-01
cases:81.37%
controls:81.20%
cases:66.82%
controls:65.49%
cases:52.83%
controls:23.85%
cases:14.60%
controls:1.09%
cases:45.58%
controls:24.26%
cases:72.06%
controls:67.46%
cases:93.33%
controls:90.77%
2511
24829
575
5748
2064
20037
1025
10557
1632
7296
1457
23298
451
334
2638
30260
1408
7415
1681
23152
2197
20405
852
9841
2686
25800
192
2622
Emergency Medicine
93 [38004510]
93 [38004510]
2.1e-01
5.1e-01
2.2e+00
—
1.8e+00
5.6e-01
3.6e-01
cases:7.55%
controls:6.18%
cases:5.54%
controls:3.39%
cases:4.44%
controls:0.49%
—
—
cases:2.82%
controls:0.48%
cases:6.43%
controls:3.77%
cases:16.89%
controls:12.44%
233
1891
2853
28686
171
1038
2918
29556
137
151
2952
30443
—
87
148
3002
30419
196
1139
2853
29107
486
3537
2392
24885
Hypertrophy of tonsils with hypertrophy of adenoids
J35.3 [45538480]
J35.3 [45538480]
—
—
—
—
—
3.3e+00
2.1e+00
—
—
—
—
—
—
—
—
—
—
cases:0.46%
controls:0.02%
cases:0.35%
controls:0.04%
—
—
—
—
—
14
5
3035
30241
10
12
2868
28410
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
30391-7 [3002582]
2.3e-01
4.0e-01
2.1e+00
—
2.0e+00
6.6e-01
5.7e-01
cases:2.79%
controls:2.23%
cases:1.65%
controls:1.12%
cases:1.29%
controls:0.15%
—
—
cases:1.04%
controls:0.14%
cases:1.90%
controls:0.99%
cases:5.94%
controls:3.46%
86
683
3000
29894
51
342
3038
30252
40
47
3049
30547
—
32
43
3057
30524
58
299
2991
29947
171
984
2707
27438
IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]
2458-8 [3007164]
9.4e-02
3.9e-01
1.8e+00
—
2.6e+00
5.8e-01
3.1e-01
cases:2.98%
controls:2.72%
cases:1.49%
controls:1.02%
cases:0.68%
controls:0.11%
—
—
cases:1.04%
controls:0.08%
cases:1.87%
controls:1.05%
cases:5.59%
controls:4.15%
92
832
2994
29745
46
311
3043
30283
21
35
3068
30559
—
32
23
3057
30544
57
318
2992
29928
161
1180
2717
27242
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
51483-6 [3030467]
1.9e-01
3.9e-01
2.0e+00
—
2.0e+00
6.5e-01
6.2e-01
cases:2.33%
controls:1.93%
cases:1.39%
controls:0.94%
cases:0.97%
controls:0.13%
—
—
cases:0.78%
controls:0.10%
cases:1.57%
controls:0.83%
cases:4.97%
controls:2.74%
72
590
3014
29987
43
289
3046
30305
30
41
3059
30553
—
24
31
3065
30536
48
250
3001
29996
143
778
2735
27644
Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 [3020059]
29265-6 [3020059]
6.2e-02
2.4e-01
2.1e+00
—
2.6e+00
8.1e-01
5.6e-01
cases:0.71%
controls:0.67%
cases:0.42%
controls:0.33%
cases:0.29%
controls:0.04%
—
—
cases:0.26%
controls:0.02%
cases:0.66%
controls:0.29%
cases:1.91%
controls:1.10%
22
205
3064
30372
13
101
3076
30493
9
11
3080
30583
—
8
6
3081
30561
20
89
3029
30157
55
314
2823
28108
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
2324-2 [3026910]
3.1e-02
1.2e-01
1.9e+00
—
2.4e+00
6.1e-01
3.2e-01
cases:5.28%
controls:5.13%
cases:3.04%
controls:2.70%
cases:2.69%
controls:0.41%
—
—
cases:4.08%
controls:0.38%
cases:5.15%
controls:2.88%
cases:14.11%
controls:10.70%
163
1568
2923
29009
94
827
2995
29767
83
126
3006
30468
—
126
116
2963
30451
157
870
2892
29376
406
3041
2472
25381
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
30383-4 [3000850]
2.1e-01
5.5e-01
1.8e+00
—
2.1e+00
7.5e-01
6.6e-01
cases:1.88%
controls:1.52%
cases:1.26%
controls:0.73%
cases:0.58%
controls:0.10%
—
—
cases:0.62%
controls:0.08%
cases:1.25%
controls:0.60%
cases:3.65%
controls:1.92%
58
466
3028
30111
39
224
3050
30370
18
31
3071
30563
—
19
24
3070
30543
38
180
3011
30066
105
546
2773
27876
Osmolality of Urine
2695-5 [3026782]
2695-5 [3026782]
2.7e-01
5.6e-01
1.7e+00
—
2.1e+00
8.4e-01
6.1e-01
cases:2.01%
controls:1.54%
cases:1.17%
controls:0.67%
cases:0.52%
controls:0.10%
—
—
cases:0.55%
controls:0.07%
cases:1.18%
controls:0.51%
cases:3.23%
controls:1.79%
62
472
3024
30105
36
204
3053
30390
16
30
3073
30564
—
17
21
3072
30546
36
155
3013
30091
93
508
2785
27914
Bacteria [Presence] in Urine
87829-8 [36304419]
87829-8 [36304419]
1.9e-01
4.6e-01
1.9e+00
—
1.9e+00
6.7e-01
6.4e-01
cases:2.33%
controls:1.93%
cases:1.46%
controls:0.92%
cases:0.87%
controls:0.13%
—
—
cases:0.74%
controls:0.11%
cases:1.54%
controls:0.79%
cases:5.00%
controls:2.70%
72
591
3014
29986
45
282
3044
30312
27
40
3062
30554
—
23
33
3066
30534
47
240
3002
30006
144
766
2734
27656
Acute bronchitis, unspecified
J20.9 [45562445]
J20.9 [45562445]
8.1e-01
9.3e-01
2.4e+00
—
—
6.8e-01
9.7e-01
cases:2.17%
controls:0.98%
cases:0.84%
controls:0.33%
cases:0.36%
controls:0.03%
—
—
—
—
cases:0.75%
controls:0.38%
cases:3.68%
controls:1.44%
67
300
3019
30277
26
102
3063
30492
11
10
3078
30584
—
—
23
116
3026
30130
106
408
2772
28014
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 [3051714]
48065-7 [3051714]
3.5e-01
4.8e-01
2.3e+00
1.0e+50
2.2e+00
5.9e-01
5.6e-01
cases:1.59%
controls:1.12%
cases:0.91%
controls:0.56%
cases:0.42%
controls:0.04%
cases:0.26%
controls:0.00%
cases:0.49%
controls:0.05%
cases:0.85%
controls:0.47%
cases:3.37%
controls:1.96%
49
343
3037
30234
28
172
3061
30422
13
13
3076
30581
8
0
3081
30594
15
16
3074
30551
26
143
3023
30103
97
557
2781
27865
filgrastim; parenteral
L03AA02 [21603851]
L03AA02 [21603851]
1.4e+00
—
—
—
—
2.6e+00
2.4e+00
cases:0.19%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.23%
controls:0.02%
cases:0.24%
controls:0.02%
6
15
3080
30562
—
—
—
—
7
5
3042
30241
7
6
2871
28416
Bacteria identified in Skin by Aerobe culture
620-5 [3007853]
620-5 [3007853]
-9.4e-02
5.1e-01
2.2e+00
1.0e+50
1.8e+00
1.1e+00
4.2e-01
cases:0.81%
controls:0.89%
cases:0.52%
controls:0.31%
cases:0.23%
controls:0.03%
cases:0.36%
controls:0.00%
cases:0.29%
controls:0.05%
cases:0.85%
controls:0.28%
cases:2.33%
controls:1.54%
25
272
3061
30305
16
95
3073
30499
7
8
3082
30586
11
0
3078
30594
9
15
3080
30552
26
85
3023
30161
67
438
2811
27984
Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5257-1 [3010521]
5257-1 [3010521]
3.6e-01
1.7e+00
2.3e+00
—
—
9.5e-01
1.1e+00
cases:0.62%
controls:0.43%
cases:0.42%
controls:0.08%
cases:0.26%
controls:0.03%
—
—
—
—
cases:0.20%
controls:0.08%
cases:0.87%
controls:0.30%
19
132
3067
30445
13
24
3076
30570
8
8
3081
30586
—
—
6
23
3043
30223
25
86
2853
28336
Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5253-0 [3027545]
5253-0 [3027545]
4.4e-01
1.6e+00
2.7e+00
—
—
9.4e-01
8.2e-01
cases:0.68%
controls:0.44%
cases:0.42%
controls:0.09%
cases:0.32%
controls:0.02%
—
—
—
—
cases:0.26%
controls:0.10%
cases:0.94%
controls:0.42%
21
134
3065
30443
13
27
3076
30567
10
7
3079
30587
—
—
8
31
3041
30215
27
118
2851
28304
HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]
75622-1 [46235355]
5.5e-02
3.7e-01
1.9e+00
—
1.9e+00
6.9e-01
5.5e-01
cases:4.05%
controls:3.84%
cases:3.04%
controls:2.12%
cases:1.55%
controls:0.24%
—
—
cases:1.55%
controls:0.24%
cases:4.03%
controls:2.06%
cases:13.41%
controls:8.23%
125
1175
2961
29402
94
648
2995
29946
48
73
3041
30521
—
48
73
3041
30494
123
622
2926
29624
386
2339
2492
26083
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
A03FA01 [21600484]
9.3e-02
3.0e-01
1.6e+00
—
2.3e+00
6.9e-01
3.5e-01
cases:2.17%
controls:1.98%
cases:1.00%
controls:0.75%
cases:0.39%
controls:0.08%
—
—
cases:0.81%
controls:0.08%
cases:1.57%
controls:0.79%
cases:4.10%
controls:2.93%
67
606
3019
29971
31
228
3058
30366
12
23
3077
30571
—
25
25
3064
30542
48
240
3001
30006
118
833
2760
27589
Other and unspecified abdominal pain
R10.4 [45568113]
R10.4 [45568113]
3.8e-01
3.4e-01
1.8e+00
—
1.2e+00
8.2e-01
7.9e-01
cases:6.35%
controls:4.43%
cases:2.17%
controls:1.56%
cases:1.20%
controls:0.20%
—
—
cases:0.55%
controls:0.17%
cases:3.21%
controls:1.44%
cases:11.67%
controls:5.65%
196
1354
2890
29223
67
476
3022
30118
37
61
3052
30533
—
17
53
3072
30514
98
435
2951
29811
336
1607
2542
26815
Clarification/discussion RFE/demand
-48 [2002000119]
-48 [2002000119]
3.0e-01
3.7e-01
2.5e+00
—
—
1.6e+00
9.0e-01
cases:0.71%
controls:0.53%
cases:0.23%
controls:0.16%
cases:0.19%
controls:0.02%
—
—
—
—
cases:0.39%
controls:0.08%
cases:0.73%
controls:0.30%
22
161
3064
30416
7
48
3082
30546
6
5
3083
30589
—
—
12
25
3037
30221
21
85
2857
28337
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]
5195-3 [3019284]
-3.5e-02
-2.0e-01
2.5e+00
—
2.0e+00
4.4e-01
5.0e-01
cases:2.40%
controls:2.48%
cases:1.04%
controls:1.26%
cases:1.26%
controls:0.11%
—
—
cases:0.91%
controls:0.13%
cases:1.71%
controls:1.11%
cases:7.47%
controls:4.69%
74
759
3012
29818
32
385
3057
30209
39
33
3050
30561
—
28
39
3061
30528
52
335
2997
29911
215
1333
2663
27089
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
51486-9 [3029879]
7.9e-02
-1.2e-01
2.3e+00
—
2.1e+00
4.3e-01
5.0e-01
cases:1.00%
controls:0.93%
cases:0.39%
controls:0.44%
cases:0.58%
controls:0.06%
—
—
cases:0.49%
controls:0.06%
cases:0.72%
controls:0.47%
cases:2.74%
controls:1.69%
31
284
3055
30293
12
134
3077
30460
18
18
3071
30576
—
15
19
3074
30548
22
142
3027
30104
79
479
2799
27943
mesalazine; oral, rectal
A07EC02 [21600664]
A07EC02 [21600664]
9.0e-01
8.7e-01
1.1e+00
—
2.3e-01
9.1e-01
1.1e+00
cases:1.33%
controls:0.55%
cases:1.00%
controls:0.42%
cases:0.45%
controls:0.16%
—
—
cases:0.23%
controls:0.18%
cases:1.02%
controls:0.41%
cases:1.74%
controls:0.59%
41
167
3045
30410
31
130
3058
30464
14
48
3075
30546
—
7
55
3082
30512
31
124
3018
30122
50
169
2828
28253
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
2075-0 [3014576]
-1.2e-01
6.3e-01
1.7e+00
1.0e+50
2.6e+00
8.8e-01
5.7e-01
cases:0.42%
controls:0.47%
cases:0.42%
controls:0.23%
cases:0.26%
controls:0.05%
cases:0.16%
controls:0.00%
cases:0.39%
controls:0.03%
cases:0.49%
controls:0.20%
cases:1.60%
controls:0.91%
13
145
3073
30432
13
69
3076
30525
8
15
3081
30579
5
0
3084
30594
12
9
3077
30558
15
62
3034
30184
46
259
2832
28163
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
14338-8 [3013742]
-1.9e-02
-3.8e-01
2.1e+00
1.0e+50
2.7e+00
3.9e-01
4.9e-01
cases:0.68%
controls:0.69%
cases:0.23%
controls:0.33%
cases:0.45%
controls:0.06%
cases:0.19%
controls:0.00%
cases:0.68%
controls:0.05%
cases:0.52%
controls:0.36%
cases:1.15%
controls:0.70%
21
212
3065
30365
7
101
3082
30493
14
17
3075
30577
6
0
3083
30594
21
14
3068
30553
16
108
3033
30138
33
200
2845
28222
Leukocytes [#/volume] in Urine
30405-5 [3018095]
30405-5 [3018095]
1.5e-01
4.4e-01
2.0e+00
—
1.8e+00
5.4e-01
4.7e-01
cases:3.05%
controls:2.63%
cases:2.14%
controls:1.38%
cases:1.46%
controls:0.20%
—
—
cases:1.10%
controls:0.19%
cases:2.30%
controls:1.35%
cases:7.30%
controls:4.70%
94
804
2992
29773
66
423
3023
30171
45
62
3044
30532
—
34
57
3055
30510
70
408
2979
29838
210
1337
2668
27085
Restricted health certificate
SPAT1283 [2001700384]
SPAT1283 [2001700384]
2.5e-01
3.6e-01
2.1e+00
—
1.5e+00
6.1e-01
5.3e-01
cases:5.31%
controls:4.20%
cases:2.46%
controls:1.72%
cases:1.68%
controls:0.21%
—
—
cases:0.81%
controls:0.18%
cases:3.28%
controls:1.82%
cases:9.73%
controls:5.96%
164
1283
2922
29294
76
527
3013
30067
52
64
3037
30530
—
25
55
3064
30512
100
549
2949
29697
280
1693
2598
26729
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
14979-9 [3018677]
3.8e-02
-1.9e-03
2.0e+00
—
2.7e+00
7.8e-01
4.7e-01
cases:0.84%
controls:0.81%
cases:0.42%
controls:0.42%
cases:0.23%
controls:0.03%
—
—
cases:0.58%
controls:0.04%
cases:0.66%
controls:0.30%
cases:1.53%
controls:0.96%
26
248
3060
30329
13
129
3076
30465
7
9
3082
30585
—
18
12
3071
30555
20
91
3029
30155
44
273
2834
28149
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
51485-1 [3030306]
-5.0e-02
-1.6e-01
2.2e+00
—
2.0e+00
4.4e-01
5.1e-01
cases:0.78%
controls:0.82%
cases:0.36%
controls:0.42%
cases:0.49%
controls:0.05%
—
—
cases:0.39%
controls:0.05%
cases:0.69%
controls:0.44%
cases:2.74%
controls:1.67%
24
250
3062
30327
11
128
3078
30466
15
16
3074
30578
—
12
16
3077
30551
21
134
3028
30112
79
476
2799
27946
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1995-0 [3021347]
6.5e-02
3.8e-01
1.6e+00
—
2.1e+00
6.3e-01
4.3e-01
cases:3.08%
controls:2.89%
cases:1.97%
controls:1.36%
cases:0.97%
controls:0.20%
—
—
cases:1.42%
controls:0.18%
cases:2.43%
controls:1.30%
cases:6.29%
controls:4.20%
95
884
2991
29693
61
416
3028
30178
30
62
3059
30532
—
44
54
3045
30513
74
394
2975
29852
181
1193
2697
27229
Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
62424-7 [40765161]
62424-7 [40765161]
1.2e+00
—
—
—
1.0e+50
2.6e+00
2.1e+00
cases:0.26%
controls:0.08%
—
—
—
—
—
—
cases:0.32%
controls:0.00%
cases:0.23%
controls:0.02%
cases:0.49%
controls:0.06%
8
24
3078
30553
—
—
—
10
0
3079
30567
7
5
3042
30241
14
17
2864
28405
amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 [21602863]
J01CR02 [21602863]
2.5e-01
3.6e-01
2.2e+00
—
1.2e+00
6.6e-01
3.6e-01
cases:7.32%
controls:5.81%
cases:2.43%
controls:1.71%
cases:1.39%
controls:0.16%
—
—
cases:0.49%
controls:0.14%
cases:3.44%
controls:1.81%
cases:9.90%
controls:7.15%
226
1777
2860
28800
75
524
3014
30070
43
48
3046
30546
—
15
43
3074
30524
105
546
2944
29700
285
2032
2593
26390
pH of Serum or Plasma
2753-2 [3018418]
2753-2 [3018418]
3.2e-03
4.8e-01
1.5e+00
—
2.1e+00
6.4e-01
3.7e-01
cases:1.59%
controls:1.58%
cases:1.36%
controls:0.85%
cases:0.49%
controls:0.11%
—
—
cases:0.94%
controls:0.11%
cases:1.67%
controls:0.89%
cases:3.79%
controls:2.66%
49
484
3037
30093
42
260
3047
30334
15
33
3074
30561
—
29
34
3060
30533
51
268
2998
29978
109
755
2769
27667
FEV1
20150-9 [3024653]
20150-9 [3024653]
7.8e-01
1.3e+00
—
—
—
1.1e+00
1.4e+00
cases:1.39%
controls:0.64%
cases:0.78%
controls:0.21%
—
—
—
—
—
—
cases:0.52%
controls:0.18%
cases:1.60%
controls:0.38%
43
196
3043
30381
24
65
3065
30529
—
—
—
16
53
3033
30193
46
108
2832
28314
FEV1/FVC
19926-5 [3011505]
19926-5 [3011505]
7.8e-01
1.3e+00
—
—
—
1.1e+00
1.4e+00
cases:1.39%
controls:0.64%
cases:0.78%
controls:0.21%
—
—
—
—
—
—
cases:0.52%
controls:0.18%
cases:1.60%
controls:0.38%
43
196
3043
30381
24
65
3065
30529
—
—
—
16
53
3033
30193
46
108
2832
28314
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
19870-5 [3020158]
7.8e-01
1.3e+00
—
—
—
1.1e+00
1.4e+00
cases:1.39%
controls:0.64%
cases:0.78%
controls:0.21%
—
—
—
—
—
—
cases:0.52%
controls:0.18%
cases:1.60%
controls:0.38%
43
196
3043
30381
24
65
3065
30529
—
—
—
16
53
3033
30193
46
108
2832
28314
doxycycline; oral, parenteral
J01AA02 [21602800]
J01AA02 [21602800]
3.4e-01
4.8e-01
1.7e+00
—
1.0e+00
5.1e-01
4.9e-01
cases:12.28%
controls:9.05%
cases:5.15%
controls:3.24%
cases:1.88%
controls:0.34%
—
—
cases:0.87%
controls:0.31%
cases:5.25%
controls:3.22%
cases:18.38%
controls:12.09%
379
2766
2707
27811
159
990
2930
29604
58
103
3031
30491
—
27
95
3062
30472
160
973
2889
29273
529
3437
2349
24985
Adenotonsillectomy
EMB20 [2001302267]
EMB20 [2001302267]
-2.3e-01
—
—
—
—
3.0e+00
1.6e+00
cases:0.26%
controls:0.33%
—
—
—
—
—
—
—
—
cases:1.05%
controls:0.05%
cases:0.59%
controls:0.12%
8
100
3078
30477
—
—
—
—
32
16
3017
30230
17
34
2861
28388
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
2157-6 [3007220]
3.6e-01
3.4e-01
1.8e+00
—
1.7e+00
6.8e-01
3.9e-01
cases:1.72%
controls:1.20%
cases:0.91%
controls:0.65%
cases:0.39%
controls:0.07%
—
—
cases:0.45%
controls:0.08%
cases:1.08%
controls:0.55%
cases:3.09%
controls:2.11%
53
367
3033
30210
28
198
3061
30396
12
20
3077
30574
—
14
25
3075
30542
33
167
3016
30079
89
599
2789
27823
Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5159-9 [3007844]
5159-9 [3007844]
-1.8e-02
1.7e+00
—
1.0e+50
—
1.9e+00
9.6e-01
cases:0.36%
controls:0.36%
cases:0.52%
controls:0.10%
—
—
cases:1.78%
controls:0.00%
—
—
cases:0.59%
controls:0.09%
cases:0.83%
controls:0.32%
11
111
3075
30466
16
30
3073
30564
—
55
0
3034
30594
—
18
26
3031
30220
24
91
2854
28331
Office Visit
OMOP4822458 [581477]
OMOP4822458 [581477]
-5.7e-01
-3.3e-01
4.7e-02
3.7e+00
1.5e+00
-3.9e-02
-1.7e-02
cases:6.12%
controls:10.38%
cases:2.88%
controls:3.96%
cases:0.65%
controls:0.62%
cases:1.26%
controls:0.03%
cases:2.43%
controls:0.57%
cases:3.51%
controls:3.64%
cases:8.65%
controls:8.79%
189
3175
2897
27402
89
1210
3000
29384
20
189
3069
30405
39
10
3050
30584
75
174
3014
30393
107
1102
2942
29144
249
2498
2629
25924
Choriogonadotropin [Units/volume] in Urine
25372-4 [3023511]
25372-4 [3023511]
2.0e-01
9.5e-01
1.9e+00
—
—
1.1e+00
5.8e-01
cases:0.91%
controls:0.75%
cases:0.71%
controls:0.28%
cases:0.26%
controls:0.04%
—
—
—
—
cases:0.85%
controls:0.27%
cases:2.33%
controls:1.32%
28
228
3058
30349
22
85
3067
30509
8
12
3081
30582
—
—
26
83
3023
30163
67
376
2811
28046
Localized enlarged lymph nodes
R59.0 [45534459]
R59.0 [45534459]
8.4e-02
1.5e+00
—
1.0e+50
—
2.1e+00
9.6e-01
cases:0.29%
controls:0.27%
cases:0.36%
controls:0.08%
—
—
cases:0.26%
controls:0.00%
—
—
cases:0.36%
controls:0.05%
cases:0.66%
controls:0.25%
9
82
3077
30495
11
24
3078
30570
—
8
0
3081
30594
—
11
14
3038
30232
19
72
2859
28350
valaciclovir; oral
J05AB11 [21603137]
J05AB11 [21603137]
-2.2e-02
3.6e-01
1.4e+00
—
1.5e+00
1.1e+00
5.5e-01
cases:0.78%
controls:0.79%
cases:0.58%
controls:0.41%
cases:0.32%
controls:0.08%
—
—
cases:0.39%
controls:0.09%
cases:1.31%
controls:0.45%
cases:2.54%
controls:1.48%
24
243
3062
30334
18
125
3071
30469
10
24
3079
30570
—
12
27
3077
30540
40
137
3009
30109
73
421
2805
28001
Person consulting for explanation of investigation findings
Z71.2 [45552100]
Z71.2 [45552100]
-5.8e-02
-1.3e-02
1.5e+00
—
2.4e+00
6.9e-01
2.8e-01
cases:2.20%
controls:2.33%
cases:1.00%
controls:1.02%
cases:0.45%
controls:0.10%
—
—
cases:1.10%
controls:0.10%
cases:1.74%
controls:0.88%
cases:4.86%
controls:3.72%
68
713
3018
29864
31
311
3058
30283
14
32
3075
30562
—
34
32
3055
30535
53
266
2996
29980
140
1057
2738
27365
General health counselling
SPAT1312 [2001700413]
SPAT1312 [2001700413]
1.2e-01
8.3e-02
1.4e+00
2.7e+00
5.4e-01
3.7e-01
1.4e-01
cases:7.71%
controls:6.93%
cases:3.01%
controls:2.78%
cases:1.13%
controls:0.28%
cases:0.29%
controls:0.02%
cases:0.55%
controls:0.32%
cases:3.84%
controls:2.69%
cases:9.59%
controls:8.47%
238
2118
2848
28459
93
850
2996
29744
35
87
3054
30507
9
6
3080
30588
17
98
3072
30469
117
814
2932
29432
276
2408
2602
26014
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
19072-8 [3016431]
9.3e-02
3.2e-01
1.5e+00
—
2.0e+00
5.6e-01
3.7e-01
cases:3.37%
controls:3.08%
cases:2.04%
controls:1.49%
cases:1.00%
controls:0.22%
—
—
cases:1.52%
controls:0.21%
cases:2.62%
controls:1.52%
cases:6.85%
controls:4.81%
104
942
2982
29635
63
456
3026
30138
31
68
3058
30526
—
47
64
3042
30503
80
460
2969
29786
197
1367
2681
27055
Bilateral
ZXA10 [2001311348]
ZXA10 [2001311348]
-6.5e-01
—
—
—
2.8e+00
1.6e+00
3.2e-01
cases:0.55%
controls:1.05%
—
—
—
—
—
—
cases:0.49%
controls:0.03%
cases:1.44%
controls:0.29%
cases:1.81%
controls:1.32%
17
322
3069
30255
—
—
—
15
9
3074
30558
44
88
3005
30158
52
375
2826
28047
ondansetron; oral, parenteral, rectal
A04AA01 [21600493]
A04AA01 [21600493]
1.6e-01
9.1e-01
—
—
2.6e+00
1.8e+00
7.4e-01
cases:0.29%
controls:0.25%
cases:0.32%
controls:0.13%
—
—
—
—
cases:0.23%
controls:0.02%
cases:0.59%
controls:0.10%
cases:0.80%
controls:0.38%
9
76
3077
30501
10
40
3079
30554
—
—
7
5
3082
30562
18
30
3031
30216
23
109
2855
28313
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
14749-6 [3013826]
-6.8e-02
2.3e-01
1.9e+00
—
2.0e+00
5.4e-01
2.1e-01
cases:3.76%
controls:4.01%
cases:2.53%
controls:2.02%
cases:1.68%
controls:0.26%
—
—
cases:1.62%
controls:0.22%
cases:3.25%
controls:1.91%
cases:9.00%
controls:7.45%
116
1227
2970
29350
78
618
3011
29976
52
80
3037
30514
—
50
68
3039
30499
99
578
2950
29668
259
2118
2619
26304
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
51480-2 [3031040]
9.1e-02
2.7e-01
2.0e+00
—
1.4e+00
5.4e-01
4.1e-01
cases:6.48%
controls:5.95%
cases:4.24%
controls:3.27%
cases:3.76%
controls:0.52%
—
—
cases:1.97%
controls:0.47%
cases:5.41%
controls:3.23%
cases:16.44%
controls:11.58%
200
1820
2886
28757
131
1001
2958
29593
116
160
2973
30434
—
61
144
3028
30423
165
976
2884
29270
473
3291
2405
25131
sulfamethoxazole and trimethoprim
J01EE01 [21602961]
J01EE01 [21602961]
7.5e-01
1.5e+00
—
—
—
2.0e+00
8.6e-01
cases:0.45%
controls:0.22%
cases:0.52%
controls:0.11%
—
—
—
—
—
—
cases:0.59%
controls:0.08%
cases:0.76%
controls:0.32%
14
66
3072
30511
16
35
3073
30559
—
—
—
18
25
3031
30221
22
92
2856
28330
Bacterial infection, unspecified
A49.9 [45590816]
A49.9 [45590816]
7.6e-01
1.6e+00
—
—
—
1.9e+00
8.7e-01
cases:0.49%
controls:0.23%
cases:0.45%
controls:0.09%
—
—
—
—
—
—
cases:0.56%
controls:0.09%
cases:0.87%
controls:0.37%
15
70
3071
30507
14
28
3075
30566
—
—
—
17
26
3032
30220
25
104
2853
28318
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
53292-9 [3041096]
4.2e-01
3.2e-01
2.2e+00
—
1.3e+00
3.8e-01
4.1e-01
cases:3.24%
controls:2.15%
cases:1.46%
controls:1.07%
cases:1.17%
controls:0.13%
—
—
cases:0.52%
controls:0.15%
cases:1.80%
controls:1.24%
cases:7.23%
controls:4.93%
100
658
2986
29919
45
326
3044
30268
36
39
3053
30555
—
16
45
3073
30522
55
374
2994
29872
208
1400
2670
27022
Abdominal ultrasound examination
JN3AE [2001305555]
JN3AE [2001305555]
2.1e-01
4.7e-01
3.0e+00
1.0e+50
—
1.3e+00
4.2e-01
cases:1.56%
controls:1.26%
cases:0.58%
controls:0.37%
cases:0.65%
controls:0.03%
cases:1.88%
controls:0.00%
—
—
cases:1.05%
controls:0.29%
cases:1.95%
controls:1.29%
48
385
3038
30192
18
112
3071
30482
20
10
3069
30584
58
0
3031
30594
—
32
88
3017
30158
56
367
2822
28055
Acute suppurative otitis media
H66.0 [45572040]
H66.0 [45572040]
3.0e-02
1.7e-01
1.8e+00
—
2.4e+00
8.0e-01
3.2e-01
cases:1.36%
controls:1.32%
cases:0.49%
controls:0.41%
cases:0.23%
controls:0.04%
—
—
cases:0.29%
controls:0.03%
cases:0.69%
controls:0.31%
cases:1.84%
controls:1.35%
42
404
3044
30173
15
125
3074
30469
7
11
3082
30583
—
9
8
3080
30559
21
94
3028
30152
53
383
2825
28039
codeine; oral
R05DA04 [21603399]
R05DA04 [21603399]
5.8e-01
3.6e-01
2.3e+00
—
—
7.6e-01
5.8e-01
cases:1.91%
controls:1.08%
cases:0.45%
controls:0.32%
cases:0.32%
controls:0.03%
—
—
—
—
cases:0.85%
controls:0.40%
cases:2.74%
controls:1.56%
59
330
3027
30247
14
97
3075
30497
10
10
3079
30584
—
—
26
121
3023
30125
79
443
2799
27979
Other specified counselling
Z71.8 [45581061]
Z71.8 [45581061]
2.0e-01
5.0e-01
1.8e+00
—
1.1e+00
5.4e-01
3.0e-01
cases:2.92%
controls:2.41%
cases:1.88%
controls:1.15%
cases:0.91%
controls:0.15%
—
—
cases:0.45%
controls:0.15%
cases:2.30%
controls:1.35%
cases:6.81%
controls:5.15%
90
736
2996
29841
58
351
3031
30243
28
47
3061
30547
—
14
47
3075
30520
70
409
2979
29837
196
1464
2682
26958
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
34531-4 [3044640]
-6.0e-03
-5.9e-02
1.3e+00
—
2.0e+00
8.3e-01
3.2e-01
cases:1.94%
controls:1.96%
cases:0.91%
controls:0.96%
cases:0.39%
controls:0.10%
—
—
cases:0.65%
controls:0.09%
cases:1.61%
controls:0.70%
cases:4.31%
controls:3.16%
60
598
3026
29979
28
294
3061
30300
12
32
3077
30562
—
20
26
3069
30541
49
213
3000
30033
124
899
2754
27523
cetirizine; oral
R06AE07 [21603497]
R06AE07 [21603497]
2.8e-01
4.4e-01
1.3e+00
—
1.2e+00
5.2e-01
4.1e-01
cases:11.57%
controls:9.00%
cases:5.31%
controls:3.49%
cases:1.62%
controls:0.44%
—
—
cases:1.36%
controls:0.42%
cases:5.54%
controls:3.37%
cases:12.33%
controls:8.56%
357
2751
2729
27826
164
1068
2925
29526
50
135
3039
30459
—
42
129
3047
30438
169
1020
2880
29226
355
2432
2523
25990
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
24357-6 [3037467]
6.4e-02
1.6e-01
2.0e+00
—
1.3e+00
4.9e-01
4.3e-01
cases:6.61%
controls:6.22%
cases:3.98%
controls:3.41%
cases:3.40%
controls:0.49%
—
—
cases:1.68%
controls:0.49%
cases:5.38%
controls:3.36%
cases:16.47%
controls:11.39%
204
1903
2882
28674
123
1043
2966
29551
105
150
2984
30444
—
52
149
3037
30418
164
1017
2885
29229
474
3238
2404
25184
Emergency Room and Inpatient Visit
ERIP [262]
ERIP [262]
8.1e-02
2.8e-01
1.7e+00
—
2.4e+00
5.2e-01
2.7e-01
cases:1.75%
controls:1.62%
cases:0.97%
controls:0.74%
cases:0.62%
controls:0.11%
—
—
cases:1.33%
controls:0.12%
cases:1.41%
controls:0.84%
cases:4.41%
controls:3.41%
54
494
3032
30083
30
225
3059
30369
19
35
3070
30559
—
41
37
3048
30530
43
254
3006
29992
127
968
2751
27454
Abdominal CT examination
JN3AD [2001305554]
JN3AD [2001305554]
2.1e-01
—
2.5e+00
1.0e+50
—
1.6e+00
4.0e-01
cases:0.23%
controls:0.18%
—
—
cases:0.19%
controls:0.02%
cases:0.16%
controls:0.00%
—
—
cases:0.39%
controls:0.08%
cases:0.56%
controls:0.37%
7
56
3079
30521
—
6
5
3083
30589
5
0
3084
30594
—
12
24
3037
30222
16
106
2862
28316
Paranasal sinuses X-ray examination without contrast
DM1AA [2001301740]
DM1AA [2001301740]
-9.2e-03
2.3e+00
—
1.0e+50
—
—
1.8e+00
cases:0.19%
controls:0.20%
cases:0.23%
controls:0.02%
—
—
cases:0.23%
controls:0.00%
—
—
—
—
cases:0.45%
controls:0.08%
6
60
3080
30517
7
7
3082
30587
—
7
0
3082
30594
—
—
13
22
2865
28400
Bacteria identified in Urine by Culture
630-4 [3026008]
630-4 [3026008]
-1.9e-02
3.6e-01
1.7e+00
—
1.4e+00
6.5e-01
3.0e-01
cases:2.07%
controls:2.11%
cases:1.36%
controls:0.95%
cases:0.81%
controls:0.15%
—
—
cases:0.45%
controls:0.11%
cases:1.87%
controls:0.99%
cases:5.73%
controls:4.33%
64
646
3022
29931
42
290
3047
30304
25
46
3064
30548
—
14
34
3075
30533
57
299
2992
29947
165
1231
2713
27191
clarithromycin; oral, parenteral
J01FA09 [21602977]
J01FA09 [21602977]
1.5e-01
4.7e-01
2.5e+00
—
9.1e-01
7.6e-01
7.1e-01
cases:3.63%
controls:3.15%
cases:1.29%
controls:0.81%
cases:0.58%
controls:0.05%
—
—
cases:0.16%
controls:0.07%
cases:1.67%
controls:0.79%
cases:5.11%
controls:2.58%
112
963
2974
29614
40
249
3049
30345
18
14
3071
30580
—
5
20
3084
30547
51
238
2998
30008
147
733
2731
27689
cefadroxil; oral
J01DB05 [21602874]
J01DB05 [21602874]
2.0e-01
3.6e-01
2.9e+00
—
1.3e+00
6.8e-01
4.6e-01
cases:2.92%
controls:2.39%
cases:0.84%
controls:0.59%
cases:0.81%
controls:0.05%
—
—
cases:0.16%
controls:0.05%
cases:1.02%
controls:0.52%
cases:2.61%
controls:1.67%
90
731
2996
29846
26
181
3063
30413
25
14
3064
30580
—
5
14
3084
30553
31
157
3018
30089
75
474
2803
27948
Hypertrophy of tonsils
J35.1 [45601127]
J35.1 [45601127]
-7.0e-02
1.4e+00
—
—
—
2.9e+00
1.1e+00
cases:0.26%
controls:0.28%
cases:0.23%
controls:0.06%
—
—
—
—
—
—
cases:0.85%
controls:0.05%
cases:0.76%
controls:0.25%
8
85
3078
30492
7
17
3082
30577
—
—
—
26
15
3023
30231
22
71
2856
28351
Urinary tract infection, site not specified
N39.0 [45548665]
N39.0 [45548665]
3.2e-01
9.5e-01
1.6e+00
—
—
9.3e-01
4.8e-01
cases:1.20%
controls:0.87%
cases:0.84%
controls:0.33%
cases:0.26%
controls:0.05%
—
—
—
—
cases:0.95%
controls:0.38%
cases:2.36%
controls:1.48%
37
267
3049
30310
26
100
3063
30494
8
16
3081
30578
—
—
29
114
3020
30132
68
420
2810
28002
Supine thorax X-ray examination
GD1QA [2001303648]
GD1QA [2001303648]
4.8e-01
1.2e+00
2.6e+00
—
—
1.2e+00
1.4e+00
cases:0.29%
controls:0.18%
cases:0.23%
controls:0.07%
cases:0.26%
controls:0.02%
—
—
—
—
cases:0.23%
controls:0.07%
cases:0.80%
controls:0.21%
9
55
3077
30522
7
21
3082
30573
8
6
3081
30588
—
—
7
21
3042
30225
23
59
2855
28363
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
2705-2 [3024354]
1.9e-01
3.8e-01
1.9e+00
1.0e+50
2.0e+00
6.2e-01
3.6e-01
cases:0.94%
controls:0.78%
cases:0.39%
controls:0.26%
cases:0.29%
controls:0.04%
cases:0.26%
controls:0.00%
cases:0.29%
controls:0.04%
cases:0.46%
controls:0.25%
cases:1.25%
controls:0.88%
29
239
3057
30338
12
81
3077
30513
9
13
3080
30581
8
0
3081
30594
9
12
3080
30555
14
75
3035
30171
36
249
2842
28173
Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
38917-1 [3042194]
38917-1 [3042194]
8.1e-01
—
—
1.0e+50
—
2.3e+00
1.6e+00
cases:0.23%
controls:0.10%
—
—
—
—
cases:0.16%
controls:0.00%
—
—
cases:0.30%
controls:0.03%
cases:0.49%
controls:0.09%
7
31
3079
30546
—
—
5
0
3084
30594
—
9
9
3040
30237
14
27
2864
28395
tacrolimus; oral, parenteral
L04AD02 [21603925]
L04AD02 [21603925]
8.6e-01
1.2e+00
2.3e+00
—
—
1.6e+00
1.0e+00
cases:0.16%
controls:0.07%
cases:0.23%
controls:0.07%
cases:0.19%
controls:0.02%
—
—
—
—
cases:0.26%
controls:0.05%
cases:0.24%
controls:0.09%
5
21
3081
30556
7
20
3082
30574
6
6
3083
30588
—
—
8
16
3041
30230
7
25
2871
28397
Acute otitis media/myringitis
H71 [2002000526]
H71 [2002000526]
—
-1.0e+50
—
—
—
2.3e+00
1.6e+00
—
—
cases:0.00%
controls:0.03%
—
—
—
—
—
—
cases:0.20%
controls:0.02%
cases:0.42%
controls:0.08%
—
0
8
3089
30586
—
—
—
6
6
3043
30240
12
24
2866
28398
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
60026-2 [40763086]
3.2e-01
3.3e-01
2.2e+00
—
1.3e+00
4.0e-01
3.1e-01
cases:4.15%
controls:3.05%
cases:2.10%
controls:1.52%
cases:1.85%
controls:0.20%
—
—
cases:0.81%
controls:0.22%
cases:2.59%
controls:1.75%
cases:9.42%
controls:7.06%
128
933
2958
29644
65
464
3024
30130
57
61
3032
30533
—
25
66
3064
30501
79
530
2970
29716
271
2008
2607
26414
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
2021-4 [3021447]
1.3e-01
2.9e-01
1.9e+00
1.0e+50
2.0e+00
6.9e-01
3.6e-01
cases:0.94%
controls:0.82%
cases:0.39%
controls:0.29%
cases:0.29%
controls:0.05%
cases:0.32%
controls:0.00%
cases:0.42%
controls:0.06%
cases:0.56%
controls:0.28%
cases:1.39%
controls:0.97%
29
252
3057
30325
12
89
3077
30505
9
14
3080
30580
10
0
3079
30594
13
17
3076
30550
17
85
3032
30161
40
276
2838
28146
Hypertrophy of adenoids
J35.2 [45552887]
J35.2 [45552887]
5.8e-01
—
—
—
—
2.4e+00
1.4e+00
cases:0.39%
controls:0.22%
—
—
—
—
—
—
—
—
cases:0.30%
controls:0.03%
cases:0.42%
controls:0.10%
12
67
3074
30510
—
—
—
—
9
8
3040
30238
12
28
2866
28394
pH of Venous blood
2746-6 [3012544]
2746-6 [3012544]
1.4e-01
2.3e-01
1.8e+00
1.0e+50
2.0e+00
6.5e-01
4.0e-01
cases:0.94%
controls:0.82%
cases:0.36%
controls:0.28%
cases:0.32%
controls:0.05%
cases:0.29%
controls:0.00%
cases:0.42%
controls:0.06%
cases:0.52%
controls:0.27%
cases:1.36%
controls:0.91%
29
250
3057
30327
11
87
3078
30507
10
16
3079
30578
9
0
3080
30594
13
17
3076
30550
16
83
3033
30163
39
260
2839
28162
Base excess in Venous blood by calculation
1927-3 [3002032]
1927-3 [3002032]
8.9e-02
3.0e-01
1.8e+00
1.0e+50
2.0e+00
6.5e-01
3.6e-01
cases:0.91%
controls:0.83%
cases:0.39%
controls:0.29%
cases:0.32%
controls:0.05%
cases:0.32%
controls:0.00%
cases:0.42%
controls:0.06%
cases:0.52%
controls:0.27%
cases:1.36%
controls:0.95%
28
254
3058
30323
12
88
3077
30506
10
16
3079
30578
10
0
3079
30594
13
17
3076
30550
16
83
3033
30163
39
271
2839
28151
Pain localized to other parts of lower abdomen
R10.3 [45534426]
R10.3 [45534426]
3.2e-01
6.6e-01
1.6e+00
—
—
9.6e-01
6.7e-01
cases:3.14%
controls:2.30%
cases:1.68%
controls:0.88%
cases:0.42%
controls:0.09%
—
—
—
—
cases:2.30%
controls:0.90%
cases:7.51%
controls:3.97%
97
704
2989
29873
52
269
3037
30325
13
27
3076
30567
—
—
70
271
2979
29975
216
1128
2662
27294
Urate [Moles/volume] in Serum or Plasma
14933-6 [3026493]
14933-6 [3026493]
3.3e-01
4.3e-01
1.5e+00
—
2.4e+00
1.0e+00
4.8e-01
cases:1.30%
controls:0.94%
cases:0.68%
controls:0.44%
cases:0.23%
controls:0.05%
—
—
cases:0.42%
controls:0.04%
cases:1.05%
controls:0.39%
cases:2.61%
controls:1.64%
40
286
3046
30291
21
136
3068
30458
7
15
3082
30579
—
13
12
3076
30555
32
118
3017
30128
75
465
2803
27957
Pain in throat
R07.0 [45592406]
R07.0 [45592406]
4.5e-01
1.4e+00
—
1.0e+50
—
1.5e+00
9.6e-01
cases:0.81%
controls:0.52%
cases:0.62%
controls:0.15%
—
—
cases:0.45%
controls:0.00%
—
—
cases:0.89%
controls:0.21%
cases:2.19%
controls:0.85%
25
158
3061
30419
19
45
3070
30549
—
14
0
3075
30594
—
27
63
3022
30183
63
242
2815
28180
Headache
N01 [2002000720]
N01 [2002000720]
3.1e-01
7.1e-01
1.6e+00
—
3.2e-01
7.4e-01
4.8e-01
cases:5.41%
controls:4.03%
cases:2.33%
controls:1.16%
cases:0.78%
controls:0.16%
—
—
cases:0.19%
controls:0.14%
cases:2.20%
controls:1.06%
cases:4.73%
controls:2.99%
167
1231
2919
29346
72
356
3017
30238
24
48
3065
30546
—
6
43
3083
30524
67
322
2982
29924
136
850
2742
27572
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
50949-7 [3029937]
1.9e-01
3.9e-01
2.1e+00
—
1.4e+00
3.4e-01
3.0e-01
cases:2.79%
controls:2.33%
cases:1.65%
controls:1.12%
cases:1.20%
controls:0.14%
—
—
cases:0.65%
controls:0.16%
cases:1.84%
controls:1.31%
cases:6.64%
controls:4.99%
86
711
3000
29866
51
343
3038
30251
37
44
3052
30550
—
20
49
3069
30518
56
397
2993
29849
191
1418
2687
27004
Irritable bowel syndrome with diarrhoea
K58.0 [45596336]
K58.0 [45596336]
1.6e-01
1.4e+00
—
—
—
1.3e+00
1.2e+00
cases:0.45%
controls:0.39%
cases:0.36%
controls:0.09%
—
—
—
—
—
—
cases:0.43%
controls:0.12%
cases:1.67%
controls:0.52%
14
118
3072
30459
11
28
3078
30566
—
—
—
13
36
3036
30210
48
149
2830
28273
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
890-4 [3001079]
-3.5e-02
-2.3e-01
1.1e+00
—
1.6e+00
8.0e-01
3.4e-01
cases:3.01%
controls:3.12%
cases:1.23%
controls:1.55%
cases:0.49%
controls:0.17%
—
—
cases:0.84%
controls:0.17%
cases:2.85%
controls:1.30%
cases:7.44%
controls:5.42%
93
953
2993
29624
38
474
3051
30120
15
51
3074
30543
—
26
53
3063
30514
87
394
2962
29852
214
1541
2664
26881
Fear sexually transm dis female
X23 [2002001308]
X23 [2002001308]
2.3e-01
8.2e-01
1.5e+00
—
—
9.2e-01
5.8e-01
cases:1.26%
controls:1.01%
cases:1.17%
controls:0.52%
cases:0.32%
controls:0.08%
—
—
—
—
cases:1.54%
controls:0.62%
cases:4.66%
controls:2.66%
39
308
3047
30269
36
158
3053
30436
10
23
3079
30571
—
—
47
188
3002
30058
134
755
2744
27667
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 [3029187]
33762-6 [3029187]
2.8e-01
5.3e-01
1.9e+00
1.0e+50
1.8e+00
3.7e-01
1.2e-01
cases:0.87%
controls:0.66%
cases:0.62%
controls:0.36%
cases:0.23%
controls:0.03%
cases:0.16%
controls:0.00%
cases:0.29%
controls:0.05%
cases:0.59%
controls:0.41%
cases:1.49%
controls:1.33%
27
203
3059
30374
19
111
3070
30483
7
10
3082
30584
5
0
3084
30594
9
15
3080
30552
18
124
3031
30122
43
378
2835
28044
Other Crohn disease
K50.8 [45533599]
K50.8 [45533599]
1.3e+00
1.1e+00
1.1e+00
—
1.8e+00
8.6e-01
1.4e+00
cases:0.58%
controls:0.16%
cases:0.42%
controls:0.14%
cases:0.16%
controls:0.05%
—
—
cases:0.23%
controls:0.04%
cases:0.33%
controls:0.14%
cases:0.73%
controls:0.19%
18
50
3068
30527
13
44
3076
30550
5
16
3084
30578
—
7
12
3082
30555
10
42
3039
30204
21
54
2857
28368
Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
40976-3 [3040853]
40976-3 [3040853]
1.0e+00
—
—
—
—
1.8e+00
1.8e+00
cases:0.26%
controls:0.09%
—
—
—
—
—
—
—
—
cases:0.23%
controls:0.04%
cases:0.56%
controls:0.09%
8
29
3078
30548
—
—
—
—
7
11
3042
30235
16
25
2862
28397
Thyrotropin [Units/volume] in Serum or Plasma
3016-3 [3009201]
3016-3 [3009201]
6.5e-02
6.4e-02
9.2e-01
2.1e+00
6.1e-01
1.3e-01
1.3e-01
cases:10.86%
controls:10.25%
cases:6.83%
controls:6.43%
cases:2.40%
controls:0.96%
cases:0.19%
controls:0.02%
cases:1.52%
controls:0.83%
cases:7.71%
controls:6.82%
cases:22.27%
controls:20.12%
335
3133
2751
27444
211
1968
2878
28626
74
295
3015
30299
6
7
3083
30587
47
254
3042
30313
235
2062
2814
28184
641
5718
2237
22704
General anesthesia, balanced
WX408 [2001310808]
WX408 [2001310808]
-1.9e-01
-1.5e-02
1.6e+00
1.0e+50
1.9e+00
9.7e-01
7.9e-01
cases:1.94%
controls:2.35%
cases:0.62%
controls:0.62%
cases:0.19%
controls:0.04%
cases:0.19%
controls:0.00%
cases:0.29%
controls:0.05%
cases:1.25%
controls:0.48%
cases:3.47%
controls:1.61%
60
719
3026
29858
19
191
3070
30403
6
12
3083
30582
6
0
3083
30594
9
14
3080
30553
38
144
3011
30102
100
457
2778
27965
short-acting sulfonamides - combinations
J01EB20 [21602943]
J01EB20 [21602943]
1.1e-01
1.5e-01
2.9e+00
—
—
4.9e-01
7.2e-01
cases:1.78%
controls:1.60%
cases:0.45%
controls:0.39%
cases:0.29%
controls:0.02%
—
—
—
—
cases:0.56%
controls:0.34%
cases:2.26%
controls:1.11%
55
488
3031
30089
14
120
3075
30474
9
5
3080
30589
—
—
17
104
3032
30142
65
316
2813
28106
long-acting sulfonamides - combinations
J01ED20 [21602959]
J01ED20 [21602959]
1.1e-01
1.5e-01
2.9e+00
—
—
4.9e-01
7.2e-01
cases:1.78%
controls:1.60%
cases:0.45%
controls:0.39%
cases:0.29%
controls:0.02%
—
—
—
—
cases:0.56%
controls:0.34%
cases:2.26%
controls:1.11%
55
488
3031
30089
14
120
3075
30474
9
5
3080
30589
—
—
17
104
3032
30142
65
316
2813
28106
diphenhydramine, combinations
R06AA52 [21603454]
R06AA52 [21603454]
1.1e-01
1.5e-01
2.9e+00
—
—
4.9e-01
7.2e-01
cases:1.78%
controls:1.60%
cases:0.45%
controls:0.39%
cases:0.29%
controls:0.02%
—
—
—
—
cases:0.56%
controls:0.34%
cases:2.26%
controls:1.11%
55
488
3031
30089
14
120
3075
30474
9
5
3080
30589
—
—
17
104
3032
30142
65
316
2813
28106
cough suppressants and mucolytics
R05FB01 [21603441]
R05FB01 [21603441]
1.1e-01
1.5e-01
2.9e+00
—
—
4.9e-01
7.2e-01
cases:1.78%
controls:1.60%
cases:0.45%
controls:0.39%
cases:0.29%
controls:0.02%
—
—
—
—
cases:0.56%
controls:0.34%
cases:2.26%
controls:1.11%
55
488
3031
30089
14
120
3075
30474
9
5
3080
30589
—
—
17
104
3032
30142
65
316
2813
28106
intermediate-acting sulfonamides - combinations
J01EC20 [21602948]
J01EC20 [21602948]
1.1e-01
1.5e-01
2.9e+00
—
—
4.9e-01
7.2e-01
cases:1.78%
controls:1.60%
cases:0.45%
controls:0.39%
cases:0.29%
controls:0.02%
—
—
—
—
cases:0.56%
controls:0.34%
cases:2.26%
controls:1.11%
55
488
3031
30089
14
120
3075
30474
9
5
3080
30589
—
—
17
104
3032
30142
65
316
2813
28106
pH of Urine
2756-5 [3015736]
2756-5 [3015736]
2.1e-01
2.9e-01
2.1e+00
—
1.2e+00
2.2e-01
3.1e-01
cases:3.76%
controls:3.06%
cases:2.17%
controls:1.63%
cases:1.75%
controls:0.22%
—
—
cases:0.78%
controls:0.24%
cases:2.26%
controls:1.83%
cases:9.90%
controls:7.45%
116
935
2970
29642
67
499
3022
30095
54
66
3035
30528
—
24
74
3065
30493
69
554
2980
29692
285
2117
2593
26305
dextromethorphan, combinations; oral
N07XX59 [43534835]
N07XX59 [43534835]
2.7e-01
2.4e-01
2.8e+00
—
—
4.4e-01
7.8e-01
cases:2.46%
controls:1.88%
cases:0.55%
controls:0.43%
cases:0.32%
controls:0.02%
—
—
—
—
cases:0.59%
controls:0.38%
cases:2.43%
controls:1.13%
76
576
3010
30001
17
133
3072
30461
10
6
3079
30588
—
—
18
115
3031
30131
70
322
2808
28100
hydroxyethylpromethazine, combinations
R06AD55 [21603490]
R06AD55 [21603490]
2.7e-01
2.4e-01
2.8e+00
—
—
4.4e-01
7.8e-01
cases:2.46%
controls:1.88%
cases:0.55%
controls:0.43%
cases:0.32%
controls:0.02%
—
—
—
—
cases:0.59%
controls:0.38%
cases:2.43%
controls:1.13%
76
576
3010
30001
17
133
3072
30461
10
6
3079
30588
—
—
18
115
3031
30131
70
322
2808
28100
promethazine, combinations
R06AD52 [21603489]
R06AD52 [21603489]
2.7e-01
2.4e-01
2.8e+00
—
—
4.4e-01
7.8e-01
cases:2.46%
controls:1.88%
cases:0.55%
controls:0.43%
cases:0.32%
controls:0.02%
—
—
—
—
cases:0.59%
controls:0.38%
cases:2.43%
controls:1.13%
76
576
3010
30001
17
133
3072
30461
10
6
3079
30588
—
—
18
115
3031
30131
70
322
2808
28100
cough suppressants and expectorants
R05FB02 [21603442]
R05FB02 [21603442]
2.7e-01
2.4e-01
2.8e+00
—
—
4.4e-01
7.8e-01
cases:2.46%
controls:1.88%
cases:0.55%
controls:0.43%
cases:0.32%
controls:0.02%
—
—
—
—
cases:0.59%
controls:0.38%
cases:2.43%
controls:1.13%
76
576
3010
30001
17
133
3072
30461
10
6
3079
30588
—
—
18
115
3031
30131
70
322
2808
28100
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
25428-4 [3009261]
2.4e-01
3.0e-01
2.0e+00
—
1.3e+00
3.4e-01
3.1e-01
cases:4.67%
controls:3.73%
cases:2.65%
controls:1.98%
cases:2.10%
controls:0.29%
—
—
cases:1.10%
controls:0.31%
cases:3.28%
controls:2.35%
cases:11.85%
controls:8.99%
144
1139
2942
29438
82
607
3007
29987
65
88
3024
30506
—
34
96
3055
30471
100
712
2949
29534
341
2556
2537
25866
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
5802-4 [3021601]
2.7e-01
3.0e-01
2.0e+00
—
1.2e+00
3.1e-01
2.9e-01
cases:4.70%
controls:3.63%
cases:2.62%
controls:1.95%
cases:2.10%
controls:0.28%
—
—
cases:1.07%
controls:0.31%
cases:3.12%
controls:2.31%
cases:11.43%
controls:8.81%
145
1109
2941
29468
81
598
3008
29996
65
85
3024
30509
—
33
95
3056
30472
95
699
2954
29547
329
2505
2549
25917
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
2514-8 [3035350]
2.5e-01
3.0e-01
2.0e+00
—
1.3e+00
2.6e-01
2.8e-01
cases:4.70%
controls:3.69%
cases:2.69%
controls:2.00%
cases:2.14%
controls:0.29%
—
—
cases:1.13%
controls:0.32%
cases:3.05%
controls:2.38%
cases:11.50%
controls:8.96%
145
1127
2941
29450
83
611
3006
29983
66
89
3023
30505
—
35
98
3054
30469
93
719
2956
29527
331
2548
2547
25874
dextromethorphan; oral
R05DA09 [21603404]
R05DA09 [21603404]
2.6e-01
2.6e-01
2.8e+00
—
—
4.9e-01
7.5e-01
cases:2.50%
controls:1.94%
cases:0.58%
controls:0.45%
cases:0.32%
controls:0.02%
—
—
—
—
cases:0.66%
controls:0.40%
cases:2.54%
controls:1.22%
77
592
3009
29985
18
138
3071
30456
10
6
3079
30588
—
—
20
122
3029
30124
73
346
2805
28076
azithromycin; oral, parenteral
J01FA10 [21602978]
J01FA10 [21602978]
2.4e-01
4.9e-01
1.8e+00
—
7.9e-01
5.3e-01
4.8e-01
cases:12.70%
controls:10.31%
cases:4.08%
controls:2.54%
cases:1.81%
controls:0.30%
—
—
cases:0.52%
controls:0.24%
cases:4.26%
controls:2.57%
cases:13.97%
controls:9.13%
392
3154
2694
27423
126
777
2963
29817
56
91
3033
30503
—
16
72
3073
30495
130
776
2919
29470
402
2595
2476
25827
Protein [Presence] in Urine by Test strip
20454-5 [3014051]
20454-5 [3014051]
3.7e-01
3.1e-01
2.0e+00
—
1.2e+00
3.0e-01
3.4e-01
cases:2.11%
controls:1.47%
cases:1.17%
controls:0.86%
cases:0.97%
controls:0.13%
—
—
cases:0.45%
controls:0.14%
cases:1.38%
controls:1.03%
cases:5.84%
controls:4.22%
65
448
3021
30129
36
262
3053
30332
30
40
3059
30554
—
14
42
3075
30525
42
311
3007
29935
168
1199
2710
27223
phenylpropanolamine, combinations; oral
R01BA51 [21603212]
R01BA51 [21603212]
2.8e-01
1.6e-01
2.8e+00
—
—
3.9e-01
7.4e-01
cases:2.59%
controls:1.97%
cases:0.55%
controls:0.47%
cases:0.32%
controls:0.02%
—
—
—
—
cases:0.59%
controls:0.40%
cases:2.50%
controls:1.21%
80
601
3006
29976
17
144
3072
30450
10
6
3079
30588
—
—
18
121
3031
30125
72
343
2806
28079
opium derivatives and expectorants
R05FA02 [21603439]
R05FA02 [21603439]
2.8e-01
1.6e-01
2.8e+00
—
—
3.9e-01
7.4e-01
cases:2.59%
controls:1.97%
cases:0.55%
controls:0.47%
cases:0.32%
controls:0.02%
—
—
—
—
cases:0.59%
controls:0.40%
cases:2.50%
controls:1.21%
80
601
3006
29976
17
144
3072
30450
10
6
3079
30588
—
—
18
121
3031
30125
72
343
2806
28079
Immunohistochemistry procedure
117617002 [4035726]
117617002 [4035726]
1.7e-01
9.1e-01
—
—
—
2.5e+00
1.0e+00
cases:0.32%
controls:0.27%
cases:0.26%
controls:0.10%
—
—
—
—
—
—
cases:0.49%
controls:0.04%
cases:0.66%
controls:0.24%
10
84
3076
30493
8
32
3081
30562
—
—
—
15
12
3034
30234
19
69
2859
28353
Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
21416-3 [3003510]
21416-3 [3003510]
2.1e-01
6.4e-01
1.5e+00
—
6.0e-01
8.3e-01
5.5e-01
cases:4.41%
controls:3.60%
cases:3.43%
controls:1.83%
cases:1.07%
controls:0.24%
—
—
cases:0.42%
controls:0.23%
cases:4.49%
controls:2.01%
cases:12.72%
controls:7.77%
136
1100
2950
29477
106
560
2983
30034
33
74
3056
30520
—
13
71
3076
30496
137
608
2912
29638
366
2208
2512
26214
Chest pain, unspecified
R07.4 [45558450]
R07.4 [45558450]
7.2e-01
1.0e+00
1.7e+00
—
—
1.0e+00
7.4e-01
cases:1.59%
controls:0.78%
cases:0.87%
controls:0.32%
cases:0.16%
controls:0.03%
—
—
—
—
cases:0.82%
controls:0.29%
cases:2.40%
controls:1.15%
49
239
3037
30338
27
98
3062
30496
5
9
3084
30585
—
—
25
88
3024
30158
69
328
2809
28094
Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7853-5 [3015635]
7853-5 [3015635]
1.9e-01
1.5e+00
—
1.0e+50
—
2.0e+00
7.9e-01
cases:0.29%
controls:0.24%
cases:0.39%
controls:0.09%
—
—
cases:0.81%
controls:0.00%
—
—
cases:0.36%
controls:0.05%
cases:0.56%
controls:0.25%
9
74
3077
30503
12
27
3077
30567
—
25
0
3064
30594
—
11
15
3038
30231
16
72
2862
28350
Blood transfusion
WW500 [2001310603]
WW500 [2001310603]
3.5e-01
1.9e+00
—
—
—
—
1.5e+00
cases:0.16%
controls:0.11%
cases:0.23%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.45%
controls:0.10%
5
35
3081
30542
7
10
3082
30584
—
—
—
—
13
28
2865
28394
Smooth muscle Ab [Titer] in Serum
8095-2 [3007566]
8095-2 [3007566]
—
—
3.5e+00
1.0e+50
—
4.7e-01
2.0e-01
—
—
—
—
cases:0.52%
controls:0.02%
cases:0.16%
controls:0.00%
—
—
cases:0.16%
controls:0.10%
cases:0.28%
controls:0.23%
—
—
16
5
3073
30589
5
0
3084
30594
—
5
31
3044
30215
8
65
2870
28357
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
7852-7 [3010130]
7852-7 [3010130]
2.1e-01
1.6e+00
—
1.0e+50
—
1.9e+00
6.4e-01
cases:0.29%
controls:0.24%
cases:0.39%
controls:0.08%
—
—
cases:0.78%
controls:0.00%
—
—
cases:0.33%
controls:0.05%
cases:0.45%
controls:0.24%
9
72
3077
30505
12
25
3077
30569
—
24
0
3065
30594
—
10
15
3039
30231
13
68
2865
28354
pseudoephedrine, combinations; oral
R01BA52 [21603213]
R01BA52 [21603213]
3.1e-01
4.1e-01
1.8e+00
—
7.9e-01
4.9e-01
4.7e-01
cases:10.08%
controls:7.62%
cases:4.24%
controls:2.85%
cases:1.39%
controls:0.24%
—
—
cases:0.65%
controls:0.29%
cases:4.69%
controls:2.93%
cases:15.88%
controls:10.59%
311
2330
2775
28247
131
872
2958
29722
43
74
3046
30520
—
20
90
3069
30477
143
885
2906
29361
457
3009
2421
25413
Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6357-8 [3024950]
6357-8 [3024950]
1.0e-01
6.0e-01
1.5e+00
—
7.7e-01
7.7e-01
5.7e-01
cases:4.57%
controls:4.14%
cases:3.72%
controls:2.07%
cases:1.17%
controls:0.26%
—
—
cases:0.55%
controls:0.26%
cases:4.76%
controls:2.26%
cases:14.00%
controls:8.41%
141
1267
2945
29310
115
634
2974
29960
36
81
3053
30513
—
17
78
3072
30489
145
685
2904
29561
403
2389
2475
26033
General Surgery
2 [38004447]
2 [38004447]
3.3e-01
3.3e-01
1.2e+00
—
7.8e-01
4.8e-01
2.8e-01
cases:12.35%
controls:9.23%
cases:4.14%
controls:3.01%
cases:1.23%
controls:0.36%
—
—
cases:0.81%
controls:0.37%
cases:4.79%
controls:3.01%
cases:12.93%
controls:10.08%
381
2821
2705
27756
128
920
2961
29674
38
111
3051
30483
—
25
114
3064
30453
146
911
2903
29335
372
2864
2506
25558
Administration of medicine
SPAT1254 [2001700355]
SPAT1254 [2001700355]
3.2e-01
7.0e-01
1.2e+00
—
6.8e-01
6.6e-01
5.3e-01
cases:4.47%
controls:3.27%
cases:2.04%
controls:1.02%
cases:0.45%
controls:0.14%
—
—
cases:0.26%
controls:0.13%
cases:1.90%
controls:0.99%
cases:3.47%
controls:2.07%
138
1001
2948
29576
63
313
3026
30281
14
42
3075
30552
—
8
40
3081
30527
58
299
2991
29947
100
588
2778
27834
Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22246-3 [3017918]
22246-3 [3017918]
8.3e-02
1.4e+00
—
1.0e+50
—
2.0e+00
7.0e-01
cases:0.26%
controls:0.24%
cases:0.39%
controls:0.09%
—
—
cases:0.81%
controls:0.00%
—
—
cases:0.36%
controls:0.05%
cases:0.56%
controls:0.28%
8
73
3078
30504
12
29
3077
30565
—
25
0
3064
30594
—
11
15
3038
30231
16
79
2862
28343
Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
24111-7 [3011371]
24111-7 [3011371]
1.4e-01
6.7e-01
1.6e+00
—
5.6e-01
6.6e-01
5.0e-01
cases:1.72%
controls:1.49%
cases:1.94%
controls:1.00%
cases:0.49%
controls:0.10%
—
—
cases:0.19%
controls:0.11%
cases:1.97%
controls:1.03%
cases:7.23%
controls:4.52%
53
457
3033
30120
60
307
3029
30287
15
31
3074
30563
—
6
34
3083
30533
60
311
2989
29935
208
1285
2670
27137
Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]
5794-3 [3011397]
-1.6e-02
3.6e-01
1.9e+00
—
1.5e+00
3.4e-01
1.9e-01
cases:1.52%
controls:1.55%
cases:1.17%
controls:0.81%
cases:0.94%
controls:0.14%
—
—
cases:0.55%
controls:0.13%
cases:1.34%
controls:0.96%
cases:4.66%
controls:3.89%
47
473
3039
30104
36
249
3053
30345
29
42
3060
30552
—
17
39
3072
30528
41
290
3008
29956
134
1105
2744
27317
Ulcerative (chronic) rectosigmoiditis
K51.3 [45533603]
K51.3 [45533603]
1.7e+00
1.4e+00
—
—
—
1.5e+00
1.7e+00
cases:0.29%
controls:0.05%
cases:0.19%
controls:0.05%
—
—
—
—
—
—
cases:0.20%
controls:0.04%
cases:0.49%
controls:0.09%
9
16
3077
30561
6
15
3083
30579
—
—
—
6
13
3043
30233
14
26
2864
28396
Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
31374-2 [3007080]
31374-2 [3007080]
1.2e-01
1.6e+00
—
1.0e+50
—
1.8e+00
8.0e-01
cases:0.39%
controls:0.35%
cases:0.49%
controls:0.10%
—
—
cases:1.72%
controls:0.00%
—
—
cases:0.49%
controls:0.08%
cases:0.69%
controls:0.31%
12
106
3074
30471
15
30
3074
30564
—
53
0
3036
30594
—
15
25
3034
30221
20
89
2858
28333
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
J01MA02 [21603009]
2.4e-01
6.0e-01
1.7e+00
—
1.2e+00
6.0e-01
4.9e-01
cases:2.82%
controls:2.23%
cases:1.26%
controls:0.70%
cases:0.52%
controls:0.09%
—
—
cases:0.23%
controls:0.07%
cases:1.28%
controls:0.71%
cases:5.21%
controls:3.27%
87
682
2999
29895
39
214
3050
30380
16
29
3073
30565
—
7
21
3082
30546
39
214
3010
30032
150
928
2728
27494
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
14675-3 [3036481]
3.1e-01
3.6e-01
—
—
2.2e+00
1.2e+00
3.2e-01
cases:1.00%
controls:0.74%
cases:0.45%
controls:0.32%
—
—
—
—
cases:0.26%
controls:0.03%
cases:0.85%
controls:0.26%
cases:1.49%
controls:1.09%
31
226
3055
30351
14
97
3075
30497
—
—
8
9
3081
30558
26
79
3023
30167
43
310
2835
28112
fluconazole; oral, parenteral
J02AC01 [21603080]
J02AC01 [21603080]
-9.7e-02
2.0e-01
1.4e+00
—
1.3e+00
6.6e-01
1.6e-01
cases:4.67%
controls:5.11%
cases:2.53%
controls:2.08%
cases:0.81%
controls:0.21%
—
—
cases:1.04%
controls:0.27%
cases:4.10%
controls:2.16%
cases:10.08%
controls:8.70%
144
1564
2942
29013
78
637
3011
29957
25
64
3064
30530
—
32
84
3057
30483
125
652
2924
29594
290
2472
2588
25950
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
77397-8 [46236098]
-4.7e-02
1.1e-01
1.4e+00
1.0e+50
2.0e+00
9.3e-01
4.4e-01
cases:1.20%
controls:1.26%
cases:0.71%
controls:0.64%
cases:0.29%
controls:0.07%
cases:0.16%
controls:0.00%
cases:0.49%
controls:0.07%
cases:1.18%
controls:0.47%
cases:3.30%
controls:2.15%
37
384
3049
30193
22
195
3067
30399
9
22
3080
30572
5
0
3084
30594
15
21
3074
30546
36
142
3013
30104
95
611
2783
27811
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
19875-4 [3001668]
7.6e-01
1.2e+00
—
—
—
9.9e-01
1.4e+00
cases:1.26%
controls:0.60%
cases:0.62%
controls:0.19%
—
—
—
—
—
—
cases:0.43%
controls:0.16%
cases:1.46%
controls:0.37%
39
182
3047
30395
19
58
3070
30536
—
—
—
13
48
3036
30198
42
105
2836
28317
FEV1/FVC --post bronchodilation
69970-2 [42868459]
69970-2 [42868459]
7.6e-01
1.2e+00
—
—
—
9.9e-01
1.4e+00
cases:1.26%
controls:0.60%
cases:0.62%
controls:0.19%
—
—
—
—
—
—
cases:0.43%
controls:0.16%
cases:1.46%
controls:0.37%
39
182
3047
30395
19
58
3070
30536
—
—
—
13
48
3036
30198
42
105
2836
28317
FEV1 percent change
69983-5 [42868472]
69983-5 [42868472]
7.6e-01
1.2e+00
—
—
—
9.9e-01
1.4e+00
cases:1.26%
controls:0.60%
cases:0.62%
controls:0.19%
—
—
—
—
—
—
cases:0.43%
controls:0.16%
cases:1.46%
controls:0.37%
39
182
3047
30395
19
58
3070
30536
—
—
—
13
48
3036
30198
42
105
2836
28317
FVC percent change Respiratory system
69982-7 [42868471]
69982-7 [42868471]
7.6e-01
1.2e+00
—
—
—
9.9e-01
1.4e+00
cases:1.26%
controls:0.60%
cases:0.62%
controls:0.19%
—
—
—
—
—
—
cases:0.43%
controls:0.16%
cases:1.46%
controls:0.37%
39
182
3047
30395
19
58
3070
30536
—
—
—
13
48
3036
30198
42
105
2836
28317
FEV1 --post bronchodilation
20155-8 [3023550]
20155-8 [3023550]
7.6e-01
1.2e+00
—
—
—
9.9e-01
1.4e+00
cases:1.26%
controls:0.60%
cases:0.62%
controls:0.19%
—
—
—
—
—
—
cases:0.43%
controls:0.16%
cases:1.46%
controls:0.37%
39
182
3047
30395
19
58
3070
30536
—
—
—
13
48
3036
30198
42
105
2836
28317
saccharomyces boulardii; oral
A07FA02 [21600670]
A07FA02 [21600670]
4.8e-01
4.2e-02
2.4e+00
—
1.8e+00
7.6e-01
8.4e-01
cases:1.07%
controls:0.66%
cases:0.26%
controls:0.25%
cases:0.23%
controls:0.02%
—
—
cases:0.19%
controls:0.03%
cases:0.46%
controls:0.21%
cases:1.60%
controls:0.70%
33
203
3053
30374
8
76
3081
30518
7
6
3082
30588
—
6
10
3083
30557
14
65
3035
30181
46
198
2832
28224
Feeling ill
A05 [2002000146]
A05 [2002000146]
2.5e-01
5.0e-01
2.1e+00
—
1.2e+00
7.5e-01
4.6e-01
cases:3.24%
controls:2.53%
cases:1.13%
controls:0.69%
cases:0.65%
controls:0.08%
—
—
cases:0.26%
controls:0.08%
cases:1.51%
controls:0.72%
cases:2.54%
controls:1.62%
100
774
2986
29803
35
212
3054
30382
20
25
3069
30569
—
8
23
3081
30544
46
217
3003
30029
73
460
2805
27962
Treatment-related counselling outside office
SPAT1249 [2001700350]
SPAT1249 [2001700350]
8.5e-02
1.5e-01
1.5e+00
—
1.4e+00
4.0e-01
1.3e-01
cases:5.90%
controls:5.45%
cases:2.98%
controls:2.57%
cases:1.23%
controls:0.29%
—
—
cases:1.33%
controls:0.32%
cases:3.71%
controls:2.51%
cases:9.83%
controls:8.77%
182
1665
2904
28912
92
785
2997
29809
38
89
3051
30505
—
41
98
3048
30469
113
760
2936
29486
283
2492
2595
25930
Sprain and strain of other and unspecified parts of foot
S93.6 [45579778]
S93.6 [45579778]
9.6e-01
—
—
—
—
2.0e+00
1.3e+00
cases:0.36%
controls:0.14%
—
—
—
—
—
—
—
—
cases:0.26%
controls:0.04%
cases:0.49%
controls:0.13%
11
42
3075
30535
—
—
—
—
8
11
3041
30235
14
38
2864
28384
Diverticular disease of large intestine without perforation or abscess
K57.3 [45567316]
K57.3 [45567316]
4.8e-01
1.7e+00
—
—
—
1.6e+00
4.8e-01
cases:0.23%
controls:0.14%
cases:0.26%
controls:0.05%
—
—
—
—
—
—
cases:0.30%
controls:0.06%
cases:0.31%
controls:0.19%
7
43
3079
30534
8
15
3081
30579
—
—
—
9
18
3040
30228
9
55
2869
28367
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
2000-8 [3015377]
1.2e-01
-2.5e-03
1.5e+00
—
1.8e+00
4.2e-01
3.1e-01
cases:2.07%
controls:1.85%
cases:0.91%
controls:0.91%
cases:0.52%
controls:0.12%
—
—
cases:0.58%
controls:0.10%
cases:1.44%
controls:0.95%
cases:3.86%
controls:2.87%
64
566
3022
30011
28
278
3061
30316
16
37
3073
30557
—
18
30
3071
30537
44
287
3005
29959
111
815
2767
27607
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
207NI0002X [38003841]
1.6e-01
3.5e-01
4.7e-01
2.3e+00
5.9e-01
4.9e-01
4.2e-01
cases:6.51%
controls:5.58%
cases:3.27%
controls:2.32%
cases:0.71%
controls:0.45%
cases:0.19%
controls:0.02%
cases:0.68%
controls:0.38%
cases:3.84%
controls:2.38%
cases:11.19%
controls:7.63%
201
1707
2885
28870
101
710
2988
29884
22
137
3067
30457
6
6
3083
30588
21
115
3068
30452
117
721
2932
29525
322
2170
2556
26252
ethylmorphine; oral
R05DA01 [21603397]
R05DA01 [21603397]
3.5e-01
6.9e-01
2.0e+00
—
—
7.6e-01
4.5e-01
cases:1.94%
controls:1.38%
cases:0.74%
controls:0.38%
cases:0.26%
controls:0.04%
—
—
—
—
cases:0.79%
controls:0.37%
cases:3.06%
controls:1.97%
60
422
3026
30155
23
115
3066
30479
8
11
3081
30583
—
—
24
112
3025
30134
88
561
2790
27861
One hour or less
ZXE00 [2001311394]
ZXE00 [2001311394]
6.4e-03
2.7e-01
1.1e+00
—
1.6e+00
1.0e+00
5.7e-01
cases:4.24%
controls:4.22%
cases:1.62%
controls:1.24%
cases:0.32%
controls:0.11%
—
—
cases:0.52%
controls:0.10%
cases:3.02%
controls:1.13%
cases:5.87%
controls:3.40%
131
1290
2955
29287
50
378
3039
30216
10
33
3079
30561
—
16
32
3073
30535
92
341
2957
29905
169
966
2709
27456
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
3255-7 [3016407]
3255-7 [3016407]
-2.2e-01
9.6e-02
—
—
3.2e+00
1.2e+00
7.6e-01
cases:0.23%
controls:0.28%
cases:0.19%
controls:0.18%
—
—
—
—
cases:0.39%
controls:0.02%
cases:0.30%
controls:0.09%
cases:0.69%
controls:0.33%
7
86
3079
30491
6
54
3083
30540
—
—
12
5
3077
30562
9
27
3040
30219
20
93
2858
28329
Ulcerative colitis, unspecified
K51.9 [45605941]
K51.9 [45605941]
1.1e+00
9.4e-01
1.8e+00
—
—
1.2e+00
8.8e-01
cases:0.65%
controls:0.23%
cases:0.29%
controls:0.11%
cases:0.19%
controls:0.03%
—
—
—
—
cases:0.39%
controls:0.12%
cases:0.69%
controls:0.29%
20
69
3066
30508
9
35
3080
30559
6
10
3083
30584
—
—
12
35
3037
30211
20
82
2858
28340
Choriogonadotropin [Units/volume] in Serum or Plasma
19080-1 [3018171]
19080-1 [3018171]
-6.5e-03
4.7e-01
1.6e+00
—
1.2e+00
9.2e-01
6.3e-01
cases:1.17%
controls:1.17%
cases:0.87%
controls:0.55%
cases:0.49%
controls:0.10%
—
—
cases:0.29%
controls:0.09%
cases:1.44%
controls:0.58%
cases:4.59%
controls:2.49%
36
359
3050
30218
27
167
3062
30427
15
30
3074
30564
—
9
26
3080
30541
44
175
3005
30071
132
708
2746
27714
Specific gravity of Urine by Refractometry
5810-7 [3019150]
5810-7 [3019150]
-3.6e-02
8.8e-02
1.9e+00
—
1.2e+00
2.5e-01
6.4e-02
cases:1.98%
controls:2.05%
cases:1.20%
controls:1.10%
cases:1.04%
controls:0.15%
—
—
cases:0.55%
controls:0.16%
cases:1.57%
controls:1.23%
cases:5.14%
controls:4.84%
61
626
3025
29951
37
336
3052
30258
32
46
3057
30548
—
17
50
3072
30517
48
372
3001
29874
148
1375
2730
27047
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
T81.0 [45599741]
T81.0 [45599741]
3.5e-02
—
—
—
—
1.9e+00
1.2e+00
cases:0.23%
controls:0.22%
—
—
—
—
—
—
—
—
cases:0.33%
controls:0.05%
cases:0.83%
controls:0.25%
7
67
3079
30510
—
—
—
—
10
15
3039
30231
24
71
2854
28351
aciclovir; oral, parenteral
J05AB01 [21603131]
J05AB01 [21603131]
1.0e-01
6.8e-01
1.6e+00
—
1.0e+00
8.5e-01
6.8e-02
cases:1.62%
controls:1.46%
cases:1.23%
controls:0.63%
cases:0.49%
controls:0.10%
—
—
cases:0.16%
controls:0.06%
cases:1.57%
controls:0.68%
cases:2.85%
controls:2.67%
50
447
3036
30130
38
192
3051
30402
15
31
3074
30563
—
5
18
3084
30549
48
206
3001
30040
82
758
2796
27664
Outpatient Visit
OP [9202]
OP [9202]
-1.8e-01
-2.2e-01
8.2e-03
2.7e+00
7.9e-01
1.1e-01
2.7e-03
cases:51.56%
controls:56.13%
cases:33.76%
controls:38.74%
cases:10.39%
controls:10.32%
cases:7.12%
controls:0.51%
cases:19.97%
controls:10.17%
cases:41.03%
controls:38.35%
cases:65.22%
controls:65.16%
1591
17162
1495
13415
1043
11853
2046
18741
321
3156
2768
27438
220
157
2869
30437
617
3110
2472
27457
1251
11598
1798
18648
1877
18519
1001
9903
salbutamol; oral, parenteral
R03CC02 [21603312]
R03CC02 [21603312]
2.8e-01
2.7e-01
2.4e+00
—
—
4.4e-01
6.9e-01
cases:3.05%
controls:2.31%
cases:0.68%
controls:0.52%
cases:0.32%
controls:0.03%
—
—
—
—
cases:0.69%
controls:0.44%
cases:2.54%
controls:1.29%
94
706
2992
29871
21
159
3068
30435
10
9
3079
30585
—
—
21
134
3028
30112
73
367
2805
28055
Paranasal sinuses X-ray examination in one projection
DM1QA [2001301761]
DM1QA [2001301761]
6.0e-01
7.7e-01
—
1.0e+50
—
1.9e+00
1.2e+00
cases:0.42%
controls:0.23%
cases:0.16%
controls:0.08%
—
—
cases:0.36%
controls:0.00%
—
—
cases:0.33%
controls:0.05%
cases:0.63%
controls:0.19%
13
71
3073
30506
5
23
3084
30571
—
11
0
3078
30594
—
10
15
3039
30231
18
54
2860
28368
Cardiac arrhythmia, unspecified
I49.9 [45581778]
I49.9 [45581778]
1.1e+00
1.2e+00
—
—
—
5.4e-01
7.5e-01
cases:1.04%
controls:0.35%
cases:0.42%
controls:0.12%
—
—
—
—
—
—
cases:0.30%
controls:0.17%
cases:1.49%
controls:0.71%
32
108
3054
30469
13
37
3076
30557
—
—
—
9
52
3040
30194
43
203
2835
28219
sulfadiazine and trimethoprim
J01EE02 [21602962]
J01EE02 [21602962]
-4.8e-03
1.4e-01
1.8e+00
—
8.2e-01
7.3e-01
5.4e-01
cases:4.21%
controls:4.23%
cases:0.97%
controls:0.84%
cases:0.55%
controls:0.09%
—
—
cases:0.26%
controls:0.11%
cases:1.41%
controls:0.68%
cases:3.72%
controls:2.20%
130
1294
2956
29283
30
258
3059
30336
17
28
3072
30566
—
8
35
3081
30532
43
207
3006
30039
107
624
2771
27798
Hepatitis B virus core IgM Ab [Presence] in Serum
31204-1 [3013527]
31204-1 [3013527]
—
—
3.1e+00
—
—
—
3.5e-01
—
—
—
—
cases:0.42%
controls:0.02%
—
—
—
—
—
—
cases:0.66%
controls:0.47%
—
—
13
6
3076
30588
—
—
—
19
133
2859
28289
Crohn disease, unspecified
K50.9 [45562490]
K50.9 [45562490]
1.4e+00
1.3e+00
2.1e+00
—
—
1.5e+00
1.7e+00
cases:0.49%
controls:0.12%
cases:0.23%
controls:0.06%
cases:0.16%
controls:0.02%
—
—
—
—
cases:0.23%
controls:0.05%
cases:0.63%
controls:0.12%
15
37
3071
30540
7
19
3082
30575
5
6
3084
30588
—
—
7
15
3042
30231
18
34
2860
28388
Crohn disease of small intestine
K50.0 [45596324]
K50.0 [45596324]
5.0e-01
6.5e-01
—
—
1.4e+00
1.6e+00
1.5e+00
cases:0.26%
controls:0.16%
cases:0.19%
controls:0.10%
—
—
—
—
cases:0.16%
controls:0.04%
cases:0.36%
controls:0.08%
cases:0.66%
controls:0.15%
8
48
3078
30529
6
31
3083
30563
—
—
5
12
3084
30555
11
23
3038
30223
19
43
2859
28379
Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
21613-5 [3006093]
21613-5 [3006093]
1.4e-01
5.6e-01
1.4e+00
—
6.6e-01
6.2e-01
4.5e-01
cases:2.27%
controls:1.99%
cases:2.27%
controls:1.30%
cases:0.55%
controls:0.14%
—
—
cases:0.29%
controls:0.15%
cases:2.36%
controls:1.29%
cases:8.51%
controls:5.58%
70
607
3016
29970
70
399
3019
30195
17
42
3072
30552
—
9
46
3080
30521
72
390
2977
29856
245
1587
2633
26835
Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
72720-6 [43055554]
72720-6 [43055554]
1.3e-01
4.9e-01
—
—
3.0e+00
7.4e-01
6.5e-01
cases:0.75%
controls:0.66%
cases:0.32%
controls:0.20%
—
—
—
—
cases:0.45%
controls:0.02%
cases:0.26%
controls:0.13%
cases:0.80%
controls:0.42%
23
201
3063
30376
10
61
3079
30533
—
—
14
7
3075
30560
8
38
3041
30208
23
119
2855
28303
Spirometry
127783003 [4133840]
127783003 [4133840]
6.4e-01
—
—
—
—
1.7e+00
1.2e+00
cases:0.58%
controls:0.31%
—
—
—
—
—
—
—
—
cases:0.26%
controls:0.05%
cases:0.42%
controls:0.12%
18
94
3068
30483
—
—
—
—
8
14
3041
30232
12
35
2866
28387
CD3 cells [#/volume] in Blood
8122-4 [3011412]
8122-4 [3011412]
—
—
—
—
—
1.6e+00
1.3e+00
—
—
—
—
—
—
—
—
—
—
cases:0.26%
controls:0.05%
cases:0.45%
controls:0.12%
—
—
—
—
—
8
16
3041
30230
13
34
2865
28388
amoxicillin; oral, parenteral
J01CA04 [21602823]
J01CA04 [21602823]
2.2e-01
2.6e-01
1.9e+00
2.1e+00
2.1e-01
2.8e-01
3.0e-01
cases:27.58%
controls:23.45%
cases:9.19%
controls:7.22%
cases:3.85%
controls:0.62%
cases:0.16%
controls:0.02%
cases:0.87%
controls:0.71%
cases:8.72%
controls:6.72%
cases:27.35%
controls:21.79%
851
7170
2235
23407
284
2209
2805
28385
119
189
2970
30405
5
6
3084
30588
27
218
3062
30349
266
2033
2783
28213
787
6192
2091
22230
oseltamivir; oral
J05AH02 [21603179]
J05AH02 [21603179]
3.3e-01
1.3e+00
—
—
—
1.6e+00
3.7e-01
cases:0.55%
controls:0.40%
cases:0.39%
controls:0.10%
—
—
—
—
—
—
cases:0.33%
controls:0.07%
cases:0.73%
controls:0.50%
17
121
3069
30456
12
32
3077
30562
—
—
—
10
20
3039
30226
21
143
2857
28279
SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
94759-8 [586526]
94759-8 [586526]
8.0e-01
6.1e-01
2.9e+00
1.0e+50
2.1e+00
1.0e+00
5.4e-01
cases:0.42%
controls:0.19%
cases:0.16%
controls:0.09%
cases:0.29%
controls:0.02%
cases:0.26%
controls:0.00%
cases:0.16%
controls:0.02%
cases:0.30%
controls:0.11%
cases:0.80%
controls:0.47%
13
58
3073
30519
5
27
3084
30567
9
5
3080
30589
8
0
3081
30594
5
6
3084
30561
9
32
3040
30214
23
133
2855
28289
Lump/swelling localized
S04 [2002000969]
S04 [2002000969]
1.2e-01
3.6e-02
2.9e+00
—
—
4.0e-01
-2.2e-02
cases:0.84%
controls:0.75%
cases:0.29%
controls:0.28%
cases:0.29%
controls:0.02%
—
—
—
—
cases:0.49%
controls:0.33%
cases:1.49%
controls:1.53%
26
229
3060
30348
9
86
3080
30508
9
5
3080
30589
—
—
15
100
3034
30146
43
434
2835
27988
Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
2039-6 [3003785]
2039-6 [3003785]
—
—
-1.0e+50
—
2.9e+00
—
1.3e-02
—
—
—
—
cases:0.00%
controls:0.03%
—
—
cases:0.29%
controls:0.02%
—
—
cases:0.28%
controls:0.27%
—
—
0
9
3089
30585
—
9
5
3080
30562
—
8
78
2870
28344
Hepatitis B virus core and surface Ab and surface Ag panel - Serum
77190-7 [46237023]
77190-7 [46237023]
-4.2e-01
-5.2e-02
2.9e+00
—
—
1.2e-01
5.1e-01
cases:0.26%
controls:0.39%
cases:0.23%
controls:0.24%
cases:0.45%
controls:0.03%
—
—
—
—
cases:0.20%
controls:0.18%
cases:0.97%
controls:0.58%
8
120
3078
30457
7
73
3082
30521
14
8
3075
30586
—
—
6
53
3043
30193
28
166
2850
28256
pH of Capillary blood
2745-8 [3009343]
2745-8 [3009343]
1.1e-01
4.9e-01
—
—
2.9e+00
6.4e-01
6.8e-01
cases:0.75%
controls:0.67%
cases:0.32%
controls:0.20%
—
—
—
—
cases:0.45%
controls:0.03%
cases:0.26%
controls:0.14%
cases:0.83%
controls:0.43%
23
204
3063
30373
10
61
3079
30533
—
—
14
8
3075
30559
8
42
3041
30204
24
121
2854
28301
Carbon dioxide [Partial pressure] in Capillary blood
2020-6 [3023024]
2020-6 [3023024]
1.1e-01
4.4e-01
—
—
2.9e+00
8.4e-01
7.0e-01
cases:0.75%
controls:0.67%
cases:0.32%
controls:0.21%
—
—
—
—
cases:0.45%
controls:0.03%
cases:0.33%
controls:0.14%
cases:0.87%
controls:0.43%
23
205
3063
30372
10
64
3079
30530
—
—
14
8
3075
30559
10
43
3039
30203
25
123
2853
28299
Ileoscopy through colon
UJF30 [2001305028]
UJF30 [2001305028]
1.0e+00
9.3e-01
-1.0e+50
—
—
1.1e+00
7.5e-01
cases:0.91%
controls:0.33%
cases:0.39%
controls:0.15%
cases:0.00%
controls:0.02%
—
—
—
—
cases:0.52%
controls:0.18%
cases:1.11%
controls:0.53%
28
101
3058
30476
12
47
3077
30547
0
6
3089
30588
—
—
16
54
3033
30192
32
150
2846
28272
ABO and Rh group [Type] in Blood
882-1 [3003694]
882-1 [3003694]
-1.3e-02
-1.3e-01
1.0e+00
1.0e+50
1.8e+00
7.7e-01
2.9e-01
cases:2.72%
controls:2.76%
cases:1.07%
controls:1.22%
cases:0.29%
controls:0.11%
cases:0.36%
controls:0.00%
cases:0.65%
controls:0.11%
cases:2.13%
controls:1.00%
cases:6.36%
controls:4.83%
84
843
3002
29734
33
372
3056
30222
9
33
3080
30561
11
0
3078
30594
20
34
3069
30533
65
301
2984
29945
183
1372
2695
27050
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
30248-9 [3015399]
2.5e-01
9.1e-02
1.5e-01
—
1.9e+00
5.6e-01
3.9e-01
cases:2.53%
controls:1.98%
cases:1.17%
controls:1.07%
cases:0.19%
controls:0.17%
—
—
cases:0.68%
controls:0.10%
cases:1.90%
controls:1.09%
cases:4.62%
controls:3.17%
78
604
3008
29973
36
326
3053
30268
6
51
3083
30543
—
21
32
3068
30535
58
331
2991
29915
133
901
2745
27521
chlorphenamine, combinations
R06AB54 [21603468]
R06AB54 [21603468]
3.5e-01
3.8e-01
2.3e+00
—
—
5.6e-01
5.3e-01
cases:3.18%
controls:2.27%
cases:0.97%
controls:0.66%
cases:0.45%
controls:0.05%
—
—
—
—
cases:1.05%
controls:0.60%
cases:3.68%
controls:2.21%
98
694
2988
29883
30
203
3059
30391
14
14
3075
30580
—
—
32
182
3017
30064
106
627
2772
27795
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
380
1220
3.33
94.67
1.2
1.3
45.57
37.02
u/ml
0.47
28
26
359
1155
3.31
88.99
1.3
1.3
190.23
231.03
u/ml
1.97
210
707
2130
16821
1.55
40.70
6.7
6.4
31.66
30.12
%
7.71
2027
16143
167
542
3.17
40.43
4.5
3.3
5453.76
878.14
u/ml
1.74
45
21
195
699
2.88
39.66
5.6
5.7
534.59
437.63
iu/ml
0.19
22
65
2384
19457
1.54
38.06
8.8
9.0
3.88
3.99
e9/l
1.69
2101
17023
1890
14715
1.53
37.30
6.5
5.5
11.32
10.52
umol/l
2.01
1774
13900
2080
16557
1.52
36.79
6.5
6.3
54.09
55.87
%
8.96
1998
15988
240
996
2.50
36.53
1.3
1.4
29.21
23.87
u/ml
0.23
11
15
2242
18165
1.52
36.22
6.6
6.4
2.15
2.01
e9/l
3.28
2036
16398
2234
18136
1.51
35.39
6.8
6.8
0.17
0.18
e9/l
2.57
2004
16215
2172
17551
1.50
35.04
6.6
6.5
0.04
0.04
e9/l
1.64
1924
15461
2170
17546
1.50
34.80
6.6
6.5
0.56
0.54
e9/l
2.18
1924
15466
146
479
3.12
34.72
1.3
1.1
0.51
1.22
—
7
27
226
938
2.49
34.38
1.3
1.4
135.66
144.76
au/ml
0.45
53
252
2710
23120
1.50
32.14
8.1
6.9
77.29
73.73
u/l
3.98
2604
22031
1275
9420
1.51
30.56
2.7
2.5
55.09
57.11
u/l
0.74
1196
8821
2787
24029
1.50
30.42
4.2
3.8
8.44
8.16
mm/h
0.69
2655
22788
3765
35171
1.84
25.64
14.0
10.8
20.85
20.55
mg/l
0.24
3220
27707
608
3960
1.63
24.76
1.8
1.8
—
—
—
0
0
3565
32913
1.63
24.06
12.3
10.6
3.91
3.91
mmol/l
0.10
3490
32019
3556
32842
1.61
23.58
12.2
10.5
139.43
139.57
mmol/l
4.34
3493
32045
455
2783
1.71
23.52
2.9
2.6
11.00
10.53
g/l
1.91
424
2590
867
6210
1.50
23.02
2.8
2.4
7.18
7.99
e6/l
0.79
787
5590
1891
15659
1.38
22.39
10.8
9.4
0.00
0.00
e9/l
0.47
1535
12852
1209
9374
1.41
20.76
3.2
2.9
66.32
89.74
e6/l
0.26
935
6840
361
2141
1.75
20.76
1.8
1.8
1.47
1.25
g/l
1.37
333
2019
3426
31653
1.49
19.73
11.0
9.2
98.62
98.27
ml/min/173m2
0.46
3075
27981
1309
10435
1.37
18.59
6.8
7.1
1.09
1.09
inr
0.10
1093
8639
3845
36589
1.78
18.49
10.8
9.0
30.67
27.03
u/l
8.17
3778
35790
1466
11912
1.36
18.39
3.8
3.4
29.37
65.88
e6/l
5.19
1024
7576
2516
22181
1.35
18.18
4.5
3.9
1382.36
1553.71
e6/l
0.06
39
249
2938
26578
1.37
17.60
3.4
3.0
38.47
35.61
u/l
1.80
2840
25666
3829
36456
1.73
17.52
14.2
11.8
70.79
70.48
umol/l
0.36
3801
36045
89
333
2.71
16.83
3.8
3.2
1.26
1.30
%
0.06
79
304
1150
9107
1.36
16.64
2.7
2.6
22.95
67.94
ng/l
0.89
505
4044
2163
18795
1.32
16.49
3.6
3.2
0.00
5.02
estimate
3.46
512
3893
1040
8120
1.38
16.41
3.1
2.8
0.25
0.28
e6/l
0.37
755
5661
420
2751
1.59
16.37
1.6
1.7
—
—
—
0
0
2143
18610
1.32
16.34
3.6
3.2
0.00
0.00
estimate
1.34
513
3914
1715
14462
1.32
16.06
3.4
3.0
0.01
0.03
estimate
0.83
437
3294
2165
18858
1.31
16.01
3.7
3.3
0.01
0.01
estimate
0.11
499
3779
1424
11701
1.33
15.98
2.6
2.4
—
—
—
0
0
1373
11245
1.33
15.69
3.1
2.6
0.58
0.05
estimate
0.46
445
3242
1517
12608
1.32
15.63
2.7
2.5
—
—
—
0
0
402
2665
1.56
14.84
1.6
1.7
—
—
—
0
0
1409
11665
1.32
14.68
5.4
4.7
37.35
37.59
g/l
0.94
1326
11028
1184
9574
1.33
14.53
1.5
1.4
2.12
2.09
g/l
0.36
837
6380
3391
31695
1.40
14.47
4.2
3.9
—
—
—
0
0
250
1485
1.73
14.26
1.4
1.3
—
—
—
0
0
393
2632
1.55
13.84
5.7
4.6
247.07
229.01
u/l
1.22
387
2518
210
1203
1.79
13.59
1.2
1.2
5.51
4.59
0.64
36
214
957
7569
1.34
13.48
2.1
1.9
0.87
0.91
mg/l
0.18
665
5458
1336
11198
1.29
12.11
6.2
5.9
1.21
1.21
mmol/l
1.86
1248
10485
484
3474
1.45
12.09
3.5
2.7
9.58
6.63
umol/l
2.06
418
2980
304
1986
1.57
11.94
2.3
2.2
0.43
0.35
e6/l
0.20
285
1861
181
1043
1.77
11.52
1.2
1.4
130.00
92.89
titre
0.35
26
121
1496
12795
1.27
11.30
6.8
6.2
1.21
1.21
mmol/l
0.47
1300
11203
1190
9900
1.28
11.26
3.7
3.2
0.16
0.00
estimate
0.51
486
3727
1388
11782
1.27
11.13
3.7
3.1
34.28
30.00
u/l
2.56
1338
11235
802
6350
1.33
10.93
3.3
2.7
106.19
109.71
ug/g
0.14
648
5085
3361
31707
1.33
10.86
15.2
13.2
13.23
13.21
%
0.64
3337
31287
833
6668
1.31
10.45
1.3
1.3
19.18
23.22
iu/ml
1.05
223
1742
361
2521
1.47
10.37
2.4
2.3
18.38
17.95
au/ml
0.06
57
353
276
1824
1.55
10.31
1.9
1.7
—
—
—
0
0
180
1074
1.71
10.17
1.4
1.3
—
—
—
0
0
910
7417
1.29
9.91
2.0
2.2
172.79
222.99
u/l
1.04
869
7092
120
639
1.90
9.90
1.3
1.2
—
—
—
0
0
1981
17663
1.23
9.88
5.0
4.5
6.18
6.25
mmol/l
0.66
1839
16010
863
6990
1.30
9.85
2.3
2.2
—
—
—
0
0
4032
39496
2.07
9.79
20.1
16.7
258.35
261.63
e9/l
2.94
3987
38847
341
2382
1.47
9.79
1.3
1.3
32.78
39.21
au/ml
0.29
19
129
4035
39537
2.10
9.77
20.1
16.7
6.79
6.75
e9/l
0.58
3990
38812
4033
39514
2.07
9.71
20.0
16.5
89.39
89.46
fl
0.47
4015
39228
762
6081
1.31
9.70
1.3
1.3
7.15
8.35
u/ml
0.28
337
2528
4035
39541
2.09
9.70
20.2
16.7
137.36
137.50
g/l
0.27
4018
39259
344
2415
1.46
9.62
2.7
2.6
0.23
0.23
g/l
0.42
326
2261
4033
39520
2.07
9.60
20.4
16.9
40.89
41.50
%
1.75
4015
39214
4033
39524
2.06
9.53
20.0
16.6
4.61
4.61
e12/l
0.16
3987
38832
104
536
1.96
9.46
3.3
3.0
2.00
2.01
mmol/l
0.02
69
304
253
1676
1.54
9.37
3.0
3.0
76.35
71.76
e9/l
0.73
183
1169
847
6892
1.29
9.27
2.6
2.3
326.01
323.31
umol/l
0.36
781
6376
186
1149
1.65
9.24
1.8
1.7
5.64
9.57
iu/ml
0.86
12
46
910
7483
1.28
9.15
4.4
3.9
95.10
94.60
%
0.29
883
7309
994
8263
1.27
9.14
2.5
2.3
—
—
—
0
0
79
375
2.13
9.00
1.4
1.3
47.00
91.00
—
7
12
127
713
1.81
8.90
1.7
1.7
—
—
—
0
0
3412
32477
1.30
8.74
5.3
5.0
1.70
1.75
mu/l
1.73
3279
31115
116
653
1.80
8.10
1.1
1.1
2.77
2.62
0.07
25
138
118
668
1.79
8.08
1.7
1.7
—
—
—
0
0
583
4592
1.31
8.07
2.6
2.6
5.52
3.74
e6/l
1.43
263
2041
1286
11183
1.22
7.57
1.4
1.4
1.45
1.74
u/ml
0.36
399
3181
81
416
1.97
7.52
1.9
1.8
—
—
—
0
0
238
1633
1.49
7.51
3.5
3.2
5.14
5.12
kpa
0.24
228
1576
613
4918
1.29
7.36
2.5
2.5
0.83
1.09
e6/l
0.77
294
2381
592
4730
1.29
7.34
2.6
2.5
6650.70
6934.27
u/l
0.07
220
1902
2261
20785
1.20
7.20
3.5
3.2
89.04
75.86
ug/l
2.17
2151
19888
306
2227
1.40
7.06
1.6
1.7
0.24
0.27
mg/l
0.42
119
1024
491
3846
1.31
7.04
2.5
2.4
29.60
29.19
s
0.93
472
3741
182
1201
1.54
6.93
2.8
2.8
162.89
169.58
%
0.49
163
1159
3004
28395
1.21
6.91
4.6
4.3
14.37
14.36
pmol/l
0.10
2834
26499
1248
10899
1.21
6.90
2.7
2.5
0.00
0.05
1.08
16
118
579
4658
1.28
6.78
2.5
2.3
15.03
15.06
umol/l
0.02
549
4373
143
899
1.61
6.72
1.2
1.1
10.99
16.15
au/ml
1.08
51
267
326
2424
1.37
6.63
2.8
2.6
—
—
—
0
0
42
176
2.40
6.52
1.2
1.2
—
—
—
0
0
481
3797
1.30
6.51
2.6
2.4
24.24
24.61
%
0.23
449
3548
1650
14841
1.19
6.49
2.6
2.4
71.67
70.40
nmol/l
1.16
1567
14067
63
315
2.02
6.37
1.5
1.6
—
—
—
0
0
81
442
1.85
6.34
1.4
1.3
462.86
478.18
titre
—
7
33
47
211
2.24
6.25
4.9
3.2
52.83
54.40
%
0.21
39
188
382
2941
1.33
6.19
2.4
2.5
35.27
53.05
u/l
0.55
328
2510
22
67
3.30
6.13
1.2
1.3
—
—
—
0
0
72
385
1.89
6.02
1.8
1.7
—
—
—
0
0
204
1423
1.46
5.98
3.7
3.2
1.16
1.14
mmol/l
0.04
146
1007
339
2589
1.34
5.82
3.1
3.6
4.69
4.69
pmol/l
0.03
307
2363
249
1811
1.40
5.81
3.4
3.2
1.22
1.23
mmol/l
1.49
210
1553
524
4243
1.27
5.80
2.5
2.3
2.49
2.48
g/l
0.18
481
3944
182
1250
1.48
5.79
1.5
1.6
—
—
—
0
0
64
335
1.92
5.72
1.4
1.6
—
—
—
0
0
3065
29201
1.19
5.68
4.2
4.2
36.25
36.75
mmol/mol
3.22
2934
28098
101
608
1.68
5.68
1.5
1.3
—
—
—
0
0
65
345
1.90
5.58
1.5
1.4
—
—
—
0
0
172
1177
1.48
5.58
1.9
2.0
0.23
0.22
g/l
0.69
166
1129
53
263
2.03
5.52
2.1
2.1
—
—
—
0
0
106
654
1.64
5.44
1.3
1.4
—
—
—
0
0
23
78
2.96
5.41
1.1
1.1
—
—
—
0
0
201
1430
1.43
5.34
2.8
2.3
67.97
67.98
g/l
0.00
196
1360
149
1001
1.51
5.31
1.1
1.1
—
—
—
0
0
389
3074
1.29
5.23
1.5
1.3
248.05
277.60
u/ml
0.15
354
2865
85
501
1.71
5.20
1.1
1.1
1.46
1.45
g/l
0.03
80
461
149
1006
1.50
5.19
1.1
1.1
—
—
—
0
0
57
298
1.93
5.15
1.1
1.1
—
0.62
—
0
5
104
649
1.62
5.13
2.1
2.0
2.74
1.69
ug/l
0.48
95
582
30
121
2.49
5.11
1.9
1.3
—
—
—
0
0
30
122
2.47
5.03
1.9
1.3
—
—
—
0
0
173
1214
1.44
4.97
1.9
2.0
1.19
1.18
g/l
0.28
167
1167
773
6636
1.20
4.91
1.9
1.8
1.36
1.38
%
0.32
718
6030
513
4224
1.25
4.91
4.4
3.8
0.83
0.83
mmol/l
0.08
481
4025
1291
11589
1.17
4.83
1.8
1.8
97.28
97.46
pmol/l
0.05
778
6616
133
891
1.51
4.83
1.6
1.3
—
—
—
0
0
173
1221
1.44
4.83
3.1
2.8
3.55
3.58
g/l
0.10
158
1171
1029
9079
1.18
4.77
3.0
2.9
2.35
2.35
mmol/l
0.16
965
8481
52
272
1.92
4.72
2.0
2.1
12.90
12.48
%
0.16
52
267
540
4497
1.23
4.65
3.3
3.0
765.70
652.08
ng/l
0.30
425
3511
199
1450
1.39
4.65
1.4
1.5
—
—
—
0
0
25
97
2.59
4.63
2.0
1.5
13.28
12.48
u/l
0.23
25
97
36
166
2.18
4.58
1.3
1.5
—
—
—
0
0
410
3318
1.26
4.57
1.6
1.6
1132.93
1133.03
nmol/l
0.00
337
2600
60
333
1.81
4.55
1.1
1.1
—
—
—
0
0
437
3573
1.25
4.46
2.2
2.1
368.28
386.65
nmol/l
1.29
403
3319
88
547
1.62
4.46
1.3
1.4
—
—
—
0
0
146
1016
1.45
4.42
2.2
2.0
—
—
—
0
0
1744
16092
1.15
4.35
2.9
2.7
—
—
estimate
—
0
0
296
2315
1.30
4.34
4.8
4.4
1.47
1.60
mmol/l
0.35
265
1987
82
505
1.64
4.32
1.3
1.5
—
—
—
0
0
940
8296
1.17
4.29
2.3
2.2
2.56
2.54
mg/l
0.13
814
7248
535
4489
1.22
4.29
2.9
3.0
270.80
502.77
ng/l
1.33
259
2395
205
1524
1.36
4.27
1.3
1.3
0.21
0.84
u/ml
—
8
101
63
365
1.74
4.17
1.3
1.4
—
—
—
0
0
177
1291
1.39
4.15
2.8
2.5
97.94
95.51
%
0.83
168
1250
524
4404
1.22
4.13
2.2
2.4
2.41
2.41
mmol/l
0.52
475
3959
162
1165
1.41
4.13
3.2
3.3
1.31
1.40
%
0.50
162
1158
24
97
2.48
4.12
2.0
1.3
—
—
—
0
0
24
97
2.48
4.12
2.0
1.3
—
—
—
0
0
302
2390
1.28
4.06
4.5
4.3
5.87
5.85
kpa
0.11
294
2325
9
14
6.44
3.98
1.2
1.1
—
—
—
0
0
128
888
1.46
3.98
1.5
1.5
31.87
17.88
e6/l
0.56
97
647
113
769
1.48
3.88
1.1
1.1
2.52
2.67
eliau/ml
0.06
67
394
260
2033
1.30
3.85
3.8
3.8
4.76
4.75
kpa
0.04
253
1972
206
1559
1.34
3.85
1.8
1.7
6.81
9.82
u/ml
1.22
68
472
129
904
1.44
3.82
1.6
1.5
995.97
5111.46
e6/l
0.48
101
700
799
7022
1.17
3.81
1.6
1.5
18.54
19.54
nmol/l
1.52
724
6331
631
5440
1.19
3.79
3.7
3.5
2.02
1.59
ug/l
0.69
580
5023
3171
30630
1.15
3.63
3.7
3.5
5.55
5.59
mmol/l
1.13
3020
29025
73
460
1.60
3.57
1.1
1.1
—
—
—
0
0
130
925
1.42
3.56
2.1
2.1
1.36
1.30
g/l
0.32
112
821
188
1423
1.34
3.53
1.7
1.6
0.04
0.19
iu/ml
1.27
34
233
270
2149
1.27
3.51
7.3
8.2
1.35
1.33
mmol/l
0.10
263
2108
936
8380
1.15
3.47
1.6
1.6
—
—
—
0
0
185
1402
1.33
3.46
1.7
2.0
38.58
39.62
u/l
0.35
172
1313
602
5213
1.18
3.43
1.6
1.6
14095647.59
36874471.51
pmol/l
0.77
525
4613
56
334
1.69
3.41
1.9
2.0
0.88
2.30
u/ml
1.90
18
115
60
365
1.65
3.39
1.7
1.4
—
—
—
0
0
400
3345
1.22
3.34
6.7
6.2
1.06
1.06
mmol/l
0.08
379
3137
93
630
1.49
3.32
1.0
1.2
—
—
—
0
0
58
352
1.66
3.32
1.7
1.5
—
—
—
0
0
58
352
1.66
3.32
1.7
1.5
—
—
—
0
0
139
1016
1.38
3.29
1.4
1.4
423.82
451.98
mg/l
0.31
131
972
11
28
3.94
3.28
1.8
1.7
—
—
—
0
0
101
701
1.45
3.20
2.6
2.6
30.74
22.90
iu/ml
—
5
29
183
1402
1.32
3.20
2.3
2.4
4.84
5.38
umol/l
0.33
131
1041
30
150
2.01
3.19
1.2
1.9
—
—
—
0
0
60
372
1.62
3.17
1.7
1.4
—
—
—
0
0
57
349
1.64
3.17
1.6
1.5
—
—
—
0
0
127
923
1.39
3.13
1.9
1.9
—
—
—
0
0
99
688
1.45
3.13
2.0
1.6
—
—
—
0
0
395
3323
1.21
3.12
2.4
2.5
0.68
0.64
ug/l
0.44
183
1559
37
201
1.85
3.11
2.7
2.5
7.89
9.70
mg/l
1.17
30
173
51
305
1.68
3.10
1.3
1.3
1076.92
1102.17
titre
0.05
13
46
56
344
1.64
3.08
1.1
1.1
5.74
6.96
iu/ml
0.26
17
91
14
50
2.81
3.08
1.0
1.0
—
—
—
0
0
3366
32755
1.15
3.07
3.9
3.7
4.64
4.67
mmol/l
1.19
3249
31605
45
261
1.73
3.06
1.3
1.2
9.16
6.80
mm/h
1.00
45
261
25
119
2.11
3.03
7.4
6.9
95.50
73.02
mg/l
0.73
20
89
74
488
1.53
3.03
1.6
1.6
0.00
0.01
g/l
0.78
69
456
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
43
247
1.75
3.03
2.0
1.6
114.16
123.91
%
0.50
43
236
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
33
175
1.89
2.99
1.0
1.2
117.92
112.48
%
0.23
26
162
58
363
1.61
2.98
1.7
1.4
—
—
—
0
0
45
266
1.70
2.88
3.1
2.8
0.60
0.70
e9/l
1.06
45
258
251
2034
1.25
2.85
10.3
8.2
7.06
7.05
mmol/l
0.01
243
1958
47
283
1.67
2.82
2.9
2.7
231.23
201.56
e6/l
0.41
39
225
48
291
1.66
2.81
2.3
2.3
93.10
98.84
%
0.59
42
273
122
900
1.37
2.78
1.3
1.4
3.39
3.57
mmol/l
1.47
112
852
19
84
2.27
2.76
2.9
3.0
1.55
1.36
%
0.16
19
84
52
324
1.61
2.74
1.5
1.6
—
—
—
0
0
65
427
1.53
2.74
1.2
1.1
16.35
16.63
u/ml
0.03
29
184
24
118
2.04
2.71
2.8
2.1
—
—
—
0
0
437
3767
1.18
2.65
1.2
1.3
77.77
148.43
u/ml
5.75
133
1435
3138
30479
1.12
2.64
3.4
3.3
1.27
1.24
mmol/l
1.24
3023
29244
50
312
1.61
2.63
1.2
1.2
—
—
—
0
0
46
281
1.64
2.63
6.4
6.4
10.21
9.94
mg/l
0.16
41
258
488
4253
1.17
2.59
3.0
3.1
22.13
21.18
%
0.56
171
1377
198
1581
1.27
2.58
2.1
2.1
4.77
6.62
iu/ml
0.88
55
401
50
314
1.60
2.57
1.2
1.2
—
—
—
0
0
93
666
1.41
2.56
1.1
1.1
119.23
114.06
%
0.88
81
609
6
11
5.46
2.54
1.3
1.0
282.67
336.55
u/ml
—
6
11
172
1353
1.28
2.54
1.1
1.1
2.76
5.01
eliau/ml
1.11
37
205
18
81
2.23
2.53
3.3
2.5
—
—
—
0
0
18
81
2.23
2.53
3.3
2.5
—
—
—
0
0
61
403
1.52
2.53
1.3
1.5
—
—
titre
—
0
0
10
31
3.23
2.51
2.9
3.4
—
—
—
0
0
3368
32881
1.13
2.51
4.0
4.0
2.80
2.81
mmol/l
0.41
3243
31594
72
494
1.47
2.50
1.1
1.1
96.98
96.23
%
0.09
64
466
354
3014
1.19
2.50
1.1
1.1
—
—
—
0
0
3359
32802
1.13
2.44
14.9
13.3
334.43
334.01
g/l
2.01
3345
32589
226
1848
1.24
2.41
1.4
1.4
—
—
—
0
0
31
175
1.78
2.37
1.0
1.1
90.45
95.32
%
0.36
11
76
52
337
1.55
2.37
1.1
1.2
—
—
—
0
0
34
198
1.72
2.35
1.6
1.7
45.85
37.48
%
0.58
26
129
23
118
1.95
2.35
2.8
2.1
—
—
—
0
0
23
118
1.95
2.35
2.8
2.1
—
—
—
0
0
23
118
1.95
2.35
2.8
2.1
—
—
—
0
0
18
84
2.15
2.34
1.1
1.1
—
—
—
0
0
18
84
2.15
2.34
3.3
2.5
—
—
—
0
0
30
169
1.78
2.32
1.0
1.1
102.20
94.54
%
—
10
74
44
276
1.60
2.31
2.8
2.6
571.72
506.78
e6/l
0.48
36
209
99
731
1.36
2.30
1.1
1.1
—
—
—
0
0
97
714
1.37
2.30
1.2
1.3
3.51
3.62
u/ml
0.05
49
340
3339
32623
1.13
2.30
3.8
3.7
1.41
1.43
mmol/l
2.14
3214
31377
54
356
1.52
2.29
4.1
2.9
6.40
1.77
ratio
0.51
29
195
78
554
1.42
2.28
2.0
2.8
—
—
—
0
0
56
373
1.51
2.27
1.1
1.2
—
—
—
0
0
105
788
1.34
2.21
1.3
1.3
1.76
2.91
u/ml
—
7
50
866
7929
1.12
2.19
2.3
2.1
—
—
—
0
0
131
1017
1.30
2.18
1.3
1.3
7.09
12.61
u/ml
0.51
18
140
65
451
1.45
2.17
1.1
1.1
52.58
37.65
mg/l
1.00
54
369
26
144
1.81
2.14
1.4
1.4
—
—
—
0
0
10
36
2.78
2.13
1.0
2.6
—
—
—
0
0
40
252
1.59
2.09
1.3
1.3
—
47.40
—
0
10
101
762
1.33
2.08
1.4
1.4
311.16
303.18
ug/g
0.14
55
378
105
798
1.32
2.06
1.3
1.3
—
7.10
—
0
8
15
69
2.18
2.04
1.0
1.0
0.01
0.01
u/ml
—
7
42
947
8746
1.11
2.03
3.2
3.1
1.02
1.57
kg/l
1.08
594
5511
49
326
1.51
2.03
1.1
1.2
—
—
—
0
0
81
593
1.37
2.02
1.3
1.2
—
—
—
0
0
49
328
1.50
1.98
1.1
1.2
—
—
—
0
0
47
312
1.51
1.97
1.1
1.2
—
—
—
0
0
48
321
1.50
1.95
1.1
1.2
—
—
—
0
0
40
257
1.56
1.94
2.2
1.9
—
—
—
0
0
129
1017
1.28
1.94
1.3
1.3
1.93
4.21
u/ml
1.90
12
95
97
736
1.33
1.94
3.4
2.6
3.17
2.00
index
0.28
58
402
418
3689
1.15
1.92
2.7
2.3
12.85
12.17
nmol/l
0.97
390
3433
248
2101
1.19
1.91
1.9
2.0
—
—
—
0
0
152
1226
1.25
1.90
1.6
1.6
—
—
—
0
0
18
92
1.96
1.89
1.2
1.1
—
—
—
0
0
39
251
1.56
1.89
1.2
1.2
—
—
—
0
0
999
9293
1.10
1.85
3.6
3.5
9.04
8.81
mmol/l
0.57
885
8354
35
221
1.59
1.84
4.5
3.5
241.57
169.35
umol/l
0.33
14
124
23
130
1.77
1.81
1.0
1.0
—
—
—
0
0
58
410
1.42
1.81
4.1
3.1
29.84
35.00
mg/l
0.41
46
351
98
754
1.31
1.80
1.2
1.3
4.41
3.59
u/ml
0.15
41
296
7
23
3.05
1.80
1.0
1.1
—
—
—
0
0
58
411
1.42
1.79
4.1
3.1
73.51
61.22
mg/l
0.17
47
354
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
67
487
1.38
1.78
5.1
4.2
0.29
0.33
iu/ml
0.81
33
250
130
1039
1.26
1.78
1.1
1.1
0.04
0.31
u/ml
3.91
41
328
61
438
1.40
1.75
1.1
1.1
265.25
226.61
mg/l
0.36
51
380
44
297
1.49
1.74
2.1
1.8
—
—
—
0
0
27
162
1.67
1.74
1.2
1.2
—
—
—
0
0
49
339
1.45
1.72
1.2
1.1
1706.92
1488.47
miu/ml
0.64
49
339
144
1170
1.24
1.72
1.1
1.1
4.97
7.12
u/ml
0.81
82
570
31
197
1.58
1.62
2.5
1.8
—
—
—
0
0
31
197
1.58
1.62
2.5
1.8
—
—
—
0
0
31
197
1.58
1.62
2.5
1.8
—
—
—
0
0
308
2699
1.15
1.60
4.8
4.4
—
—
—
0
0
167
1390
1.21
1.60
2.1
2.2
4.15
7.34
ug/l
2.92
151
1237
49
345
1.43
1.59
1.1
1.3
0.21
0.22
nmol/l
0.04
36
260
44
304
1.45
1.58
1.4
1.3
125.00
184.21
titre
—
8
57
7
26
2.70
1.58
1.1
1.1
—
—
—
0
0
101
798
1.27
1.56
2.3
2.4
456.54
314.03
ug/l
0.27
91
733
153
1267
1.22
1.55
1.1
1.1
3.94
4.38
u/ml
0.13
100
677
63
466
1.36
1.55
1.5
1.7
0.00
0.00
g/l
-0.00
57
419
58
424
1.37
1.53
1.1
1.1
—
—
—
0
0
20
115
1.74
1.52
1.1
1.1
28.33
41.78
iu/ml
0.61
20
115
145
1199
1.22
1.50
2.0
2.2
3.14
3.77
iu/l
0.61
63
546
334
2960
1.14
1.49
1.5
1.4
—
—
—
0
0
184
1558
1.19
1.49
1.7
1.9
0.04
0.45
estimate
0.48
76
590
28
178
1.58
1.48
1.5
1.2
—
—
—
0
0
50
360
1.39
1.46
1.4
1.7
—
—
—
0
0
22
132
1.67
1.45
1.5
1.5
—
—
—
0
0
64
481
1.34
1.44
1.3
1.2
—
—
—
0
0
64
481
1.34
1.44
1.3
1.2
—
—
—
0
0
31
204
1.52
1.42
2.1
2.0
—
—
—
0
0
79
613
1.29
1.42
2.8
2.0
135.36
135.39
g/l
0.00
67
509
75
579
1.30
1.41
1.2
1.3
—
—
—
0
0
191
1633
1.18
1.40
1.8
2.3
29.18
32.27
u/ml
0.14
183
1577
30
198
1.52
1.37
1.2
1.1
—
—
—
0
0
111
903
1.24
1.37
1.3
1.4
15.66
16.74
u/l
0.17
88
774
80
627
1.28
1.35
3.9
4.0
137.46
2173.71
u/ml
0.71
66
541
23
143
1.61
1.35
1.5
1.4
—
—
—
0
0
50
366
1.37
1.34
1.3
1.2
0.69
0.69
ratio
0.00
22
205
12
61
1.97
1.32
1.1
1.9
—
—
—
0
0
26
168
1.55
1.31
1.5
1.6
—
—
—
0
0
18
106
1.70
1.29
2.5
2.7
—
—
—
0
0
28
185
1.52
1.28
1.1
1.2
—
—
—
0
0
5
18
2.78
1.28
32.8
3.1
109.20
99.06
g/l
—
5
18
51
378
1.35
1.28
1.1
1.3
20.94
25.19
u/l
0.21
46
326
12
62
1.94
1.27
1.0
1.2
—
—
—
0
0
8
35
2.29
1.26
1.0
1.1
—
—
—
0
0
245
2160
1.14
1.23
1.5
1.4
—
—
—
0
0
361
3267
1.12
1.19
1.4
1.4
18.00
17.27
iu/l
0.20
294
2708
8
38
2.11
1.18
1.0
1.1
—
—
—
0
0
272
2422
1.13
1.18
1.5
1.5
9.96
8.00
u/l
1.42
216
1957
361
3273
1.11
1.16
1.6
1.7
323.59
300.32
mu/l
0.46
324
2964
235
2077
1.14
1.15
1.4
1.4
—
—
—
0
0
15
87
1.73
1.15
1.0
1.1
—
—
—
0
0
35
249
1.41
1.14
1.4
1.3
1.61
1.42
nmol/l
0.41
29
227
12
65
1.85
1.13
1.1
1.2
—
—
—
0
0
14
80
1.75
1.12
1.1
1.3
—
—
—
0
0
165
1425
1.16
1.12
1.1
1.1
1.13
1.36
u/ml
0.27
84
670
11
58
1.90
1.12
1.3
1.1
—
—
—
0
0
36
259
1.39
1.11
1.6
1.7
45.73
48.01
%
0.13
26
175
38
277
1.38
1.09
4.2
3.9
9.42
9.58
mg/l
0.05
32
228
59
460
1.29
1.09
1.8
2.1
5.74
5.32
mmol/24h
0.34
52
428
12
66
1.82
1.09
6.4
6.5
—
1059.38
—
0
8
8
41
1.95
1.08
1.0
1.1
—
—
—
0
0
23
152
1.52
1.08
5.4
2.9
1.00
0.81
index
0.37
23
152
11
59
1.87
1.07
1.3
1.1
—
—
—
0
0
313
2832
1.11
1.06
1.4
1.3
226.61
229.02
miu/ml
0.04
153
1425
134
1144
1.18
1.06
3.3
2.8
105.47
112.13
ng/l
0.14
106
990
30
211
1.42
1.05
4.8
2.8
15.09
15.18
index
0.02
23
152
32
228
1.41
1.05
1.3
1.7
0.94
0.41
mmol/l
0.33
27
214
655
6137
1.08
1.05
1.6
1.7
3.46
3.50
ratio
0.31
463
4401
225
1999
1.13
1.04
2.8
2.3
81.62
83.23
ml/min/173m2
0.20
89
769
250
2238
1.12
1.03
1.1
1.1
0.56
0.65
ratio
1.17
20
173
141
1215
1.17
1.01
10.0
11.4
23.84
24.11
mmol/l
0.60
136
1196
71
573
1.24
1.00
1.2
1.5
—
—
—
0
0
25
172
1.46
0.99
1.3
2.5
32.24
27.56
umol/l
0.62
25
157
32
231
1.39
0.99
1.1
1.2
—
—
—
0
0
323
2943
1.11
0.98
3.3
3.2
31.56
31.54
%
0.01
260
2255
28
198
1.42
0.97
1.1
1.1
—
—
—
0
0
15
92
1.63
0.97
2.0
2.6
78.20
101.44
ng/l
0.79
15
92
43
328
1.31
0.95
1.1
1.1
311.82
288.08
mg/l
0.68
38
305
167
1465
1.15
0.95
1.1
1.1
1.15
2.21
u/ml
2.51
100
787
41
311
1.32
0.94
1.1
1.1
1.26
1.00
u/l
0.32
15
119
9
51
1.77
0.94
19.9
6.3
6.83
5.53
kpa
—
9
51
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
27
191
1.42
0.94
1.2
1.1
—
—
—
0
0
254
2290
1.12
0.94
8.8
9.1
13.36
13.69
kpa
0.40
245
2207
254
2290
1.12
0.94
8.9
9.1
4.95
5.05
kpa
0.99
245
2207
190
1688
1.13
0.91
1.1
1.1
2.01
2.63
u/ml
0.33
109
926
15
94
1.60
0.90
1.1
1.1
—
—
—
0
0
119
1023
1.17
0.90
1.7
1.6
408.91
363.15
mu/l
0.36
102
841
11
63
1.75
0.90
2.7
5.2
—
—
—
0
0
169
1492
1.14
0.89
1.1
1.1
8.37
7.00
u/ml
0.42
103
868
33
245
1.35
0.88
3.6
3.0
10.00
10.42
mmol/l
0.51
33
238
25
177
1.41
0.88
1.3
1.4
159.00
171.80
mmol/24h
0.40
25
177
513
4799
1.08
0.88
1.5
1.5
3.47
3.40
mmol/l
0.64
327
3108
18
119
1.51
0.88
1.4
1.5
36.85
35.00
g/l
0.21
18
109
13
79
1.65
0.88
3.1
3.4
4.85
4.79
kpa
0.13
13
79
13
79
1.65
0.88
3.1
3.4
10.62
11.37
kpa
0.42
13
79
223
2009
1.12
0.86
9.4
9.7
95.85
96.32
%
0.43
217
1939
73
604
1.21
0.85
2.6
2.9
23.57
23.89
mg/l
0.03
50
393
187
1668
1.13
0.85
4.3
4.1
67.45
70.89
ng/l
0.37
171
1532
24
170
1.41
0.85
2.1
2.1
1.15
1.47
nmol/l
0.70
16
131
20
137
1.46
0.84
1.1
1.2
—
—
—
0
0
18
121
1.49
0.82
1.2
1.1
—
—
—
0
0
8
46
1.74
0.82
1.3
1.1
100.00
89.74
titre
—
8
46
12
73
1.65
0.81
1.5
1.3
—
—
—
0
0
144
1269
1.14
0.80
2.1
1.9
211.30
198.30
pmol/l
0.69
138
1217
27
198
1.37
0.80
2.4
2.8
39.42
44.66
%
0.44
11
97
249
2268
1.10
0.80
8.9
9.1
0.57
0.56
mmol/l
0.02
198
1801
55
446
1.24
0.79
1.4
2.1
—
—
—
0
0
24
173
1.39
0.78
1.8
2.0
31.63
28.64
%
0.50
24
168
0
26
0.00
0.78
0.0
1.2
—
—
—
0
0
18
123
1.47
0.77
1.3
1.2
25.17
13.90
%
—
6
10
25
183
1.37
0.75
1.4
1.6
—
—
—
0
0
14
91
1.54
0.75
3.4
2.7
0.63
0.62
mmol/l
0.15
14
91
5
25
2.00
0.72
1.4
5.6
—
—
—
0
0
9
56
1.61
0.72
19.9
6.0
5.85
5.90
kpa
—
9
51
32
246
1.30
0.72
1.5
1.6
32.21
21.21
mg/l
0.78
14
100
28
211
1.33
0.71
1.3
1.8
—
—
—
0
0
10
61
1.64
0.68
9.7
3.5
33.50
62.00
u/l
—
10
61
28
213
1.32
0.68
1.5
1.4
5.71
6.12
u/l
0.16
23
179
79
677
1.17
0.67
1.8
2.5
—
—
—
0
0
7
43
1.63
0.66
1.1
1.2
—
—
—
0
0
297
2758
1.08
0.66
1.8
1.9
—
—
—
0
0
674
6437
1.06
0.65
4.8
4.4
9.45
11.01
mg/mmol
0.42
444
4350
54
450
1.20
0.64
1.3
1.6
—
—
—
0
0
41
333
1.23
0.62
1.3
1.3
2.21
2.72
u/ml
0.18
23
161
0
20
0.00
0.60
0.0
1.0
—
0.31
—
0
8
1307
12708
1.04
0.60
1.7
1.8
1.42
1.38
mmol/l
0.59
1157
11402
16
114
1.41
0.58
1.9
2.0
—
—
—
0
0
16
114
1.41
0.58
1.9
2.0
—
—
—
0
0
0
23
0.00
0.58
0.0
1.1
—
0.66
—
0
10
64
548
1.17
0.58
1.9
1.5
0.55
0.52
e9/l
0.44
64
548
164
1494
1.10
0.57
4.1
4.4
5.69
40.48
ug/l
0.80
119
1077
8
54
1.48
0.57
1.3
1.8
40.48
43.65
g/l
—
8
54
210
1937
1.09
0.57
1.5
1.7
4.29
3.95
mg/l
0.22
158
1351
19
141
1.35
0.56
1.1
1.2
102.21
93.91
%
0.93
19
141
6
37
1.62
0.55
1.0
1.1
—
—
—
0
0
41
339
1.21
0.54
1.1
1.1
—
—
—
0
0
16
116
1.38
0.54
1.6
1.9
0.29
0.18
nmol/l
—
10
92
9
61
1.48
0.53
1.1
1.3
—
—
—
0
0
15
108
1.39
0.53
1.1
1.9
—
213.60
—
0
5
10
67
1.49
0.49
1.6
1.4
—
—
—
0
0
7
46
1.52
0.48
1.1
1.2
—
—
—
0
0
12
85
1.41
0.46
1.1
1.1
—
—
—
0
0
26
209
1.25
0.46
1.0
1.1
1.84
4.74
nmol/l
—
7
35
141
1294
1.09
0.46
1.4
1.5
0.30
0.45
nmol/l
3.49
109
1043
145
1337
1.09
0.43
12.4
11.3
93.87
94.35
%
0.28
145
1330
5
31
1.61
0.43
15.6
5.2
5.68
6.58
mmol/l
—
5
31
8
57
1.40
0.42
1.1
1.0
—
—
—
0
0
22
176
1.25
0.41
1.1
1.2
0.24
0.28
g/l
1.52
12
141
97
880
1.10
0.41
1.2
1.2
19.51
42.12
u/ml
—
7
68
5
33
1.52
0.41
1.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
41
351
1.17
0.41
1.3
1.7
—
—
—
0
0
115
1053
1.09
0.41
1.8
1.9
—
—
—
0
0
359
3429
1.05
0.39
1.6
1.5
68.26
61.54
ug/l
0.88
313
2936
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
28
233
1.20
0.38
1.3
1.3
65.43
68.03
ug/l
0.09
28
233
18
225
0.80
0.37
1.4
1.6
13.82
2.68
nmol/l
0.41
13
177
93
849
1.10
0.36
1.6
1.6
—
—
—
0
0
9
70
1.29
0.36
1.6
1.3
5.28
5.47
mmol/l
—
9
70
14
179
0.78
0.35
2.1
2.1
17.91
14.93
umol/l
0.38
14
179
6
43
1.40
0.35
1.2
1.1
—
—
—
0
0
36
311
1.16
0.34
1.1
1.2
1.04
1.06
ratio
0.36
25
263
29
247
1.18
0.32
3.7
3.1
44.38
44.89
%
0.04
29
247
29
247
1.18
0.32
7.4
6.3
8.28
8.64
%
0.15
29
247
19
155
1.23
0.32
4.8
3.4
19.53
40.43
u/ml
1.26
19
155
46
408
1.13
0.31
1.3
1.5
357.02
400.62
pmol/l
0.46
41
358
139
1303
1.07
0.31
12.7
11.5
0.65
0.65
%
0.02
139
1291
7
52
1.35
0.31
1.0
1.1
—
—
—
0
0
7
52
1.35
0.31
1.3
1.7
—
—
—
0
0
7
53
1.32
0.30
1.0
1.1
—
—
—
0
0
29
336
0.86
0.30
3.3
2.8
6.57
7.07
mmol/l
0.69
29
326
41
463
0.88
0.30
2.7
3.7
4.89
65.96
u/ml
1.03
41
455
34
296
1.15
0.30
3.0
5.8
6.67
6.81
mmol/l
0.09
28
244
47
419
1.12
0.30
1.6
1.5
1.22
1.35
promille
0.25
36
321
77
706
1.09
0.30
1.1
1.1
117.67
2194.59
iu/ml
0.74
25
185
16
195
0.82
0.28
1.6
1.6
—
—
—
0
0
10
76
1.32
0.28
1.0
1.1
—
—
—
0
0
19
159
1.20
0.26
1.2
1.3
132.63
354.17
u/l
2.02
19
144
232
2223
1.05
0.26
1.1
1.2
0.72
2.35
u/ml
—
6
19
55
501
1.10
0.25
8.6
4.2
3.74
3.81
mmol/l
0.97
55
494
39
349
1.12
0.25
1.1
1.3
—
—
—
0
0
306
2957
1.04
0.24
1.6
1.7
—
—
—
0
0
19
161
1.18
0.24
1.1
1.2
—
9.50
—
0
10
34
381
0.89
0.24
3.8
4.6
112.59
97.96
u/ml
0.06
11
132
7
91
0.77
0.22
1.0
1.1
4.83
6.23
u/ml
—
7
91
14
116
1.21
0.22
1.1
2.4
6.95
7.78
mmol/l
0.76
14
116
59
545
1.08
0.22
1.3
1.7
15360.86
13210.15
e6/l
0.19
43
393
30
267
1.12
0.21
1.2
1.1
124.97
117.57
pmol/l
0.42
30
267
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
8
101
0.79
0.21
2.1
1.2
145.62
119.51
nmol/l
—
8
79
8
103
0.78
0.21
1.4
1.1
—
—
—
0
0
8
103
0.78
0.21
1.1
1.2
—
63.33
—
0
12
5
43
1.16
0.21
1.4
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
3.3
—
—
—
0
0
6
50
1.20
0.19
3.0
3.7
—
—
—
0
0
331
3221
1.03
0.19
1.6
1.5
1.23
1.16
ratio
0.84
205
1946
53
491
1.08
0.19
4.6
2.7
7.59
6.83
pmol/l
0.19
53
491
50
539
0.93
0.18
1.5
1.9
888.80
459.11
pmol/l
—
7
73
129
1234
1.05
0.18
2.8
2.5
1.02
1.02
ratio
0.32
115
1070
644
6329
1.02
0.18
1.6
1.6
953.32
1002.13
mu/l
0.79
574
5499
62
659
0.94
0.16
1.4
1.5
39.53
37.48
nmol/l
0.13
56
609
331
3233
1.03
0.16
1.6
1.5
1.22
1.20
ratio
0.12
207
1973
331
3233
1.03
0.16
1.6
1.5
0.92
0.94
ratio
0.51
205
1958
8
71
1.13
0.16
1.0
1.2
—
—
—
0
0
34
313
1.09
0.15
1.4
1.8
280.14
286.54
mosm/kgh2o
1.42
29
245
22
198
1.11
0.14
1.9
2.9
18.50
163.94
ug/l
0.75
22
179
8
97
0.82
0.13
2.0
2.5
—
—
—
0
0
21
189
1.11
0.13
1.2
1.1
—
—
—
0
0
8
99
0.81
0.13
1.4
1.4
11.69
8.35
ug/l
—
8
99
48
451
1.07
0.13
1.1
1.1
1.89
2.29
u/ml
0.08
13
126
11
94
1.17
0.13
1.1
1.1
—
—
—
0
0
22
200
1.10
0.12
1.2
1.3
75.00
80.05
%
—
5
21
11
95
1.16
0.11
1.1
1.1
—
—
—
0
0
242
2471
0.98
0.11
1.5
1.6
58.56
60.24
ug/l
0.32
242
2471
75
781
0.96
0.11
2.0
1.9
13.05
13.02
%
0.11
75
775
321
3155
1.02
0.11
1.6
1.5
—
—
—
0
0
15
134
1.12
0.10
1.0
1.1
—
—
—
0
0
45
428
1.05
0.09
1.1
1.0
0.68
1.38
u/ml
0.49
12
117
186
1899
0.98
0.09
1.3
1.3
—
—
—
0
0
19
175
1.09
0.08
3.8
2.9
104.75
48.10
mg/l
0.59
13
125
5
63
0.79
0.08
1.2
1.2
1.21
1.18
mmol/l
—
5
63
5
64
0.78
0.08
1.4
1.0
0.05
0.19
u/ml
—
5
64
15
163
0.92
0.07
1.2
1.4
121.53
96.04
nmol/24h
0.32
15
163
21
197
1.07
0.06
1.1
1.4
14970.79
66728.74
e6/l
0.91
14
140
418
4148
1.01
0.05
1.4
1.5
—
—
—
0
0
27
282
0.96
0.04
2.3
2.2
28.06
27.69
mg/l
0.02
18
191
14
133
1.05
0.01
1.1
1.3
72.93
24.99
u/l
0.36
14
117
17
177
0.96
0.01
3.2
4.6
—
—
—
0
0
167
1680
0.99
0.01
1.6
1.6
—
—
—
0
0
27
277
0.97
0.01
1.1
1.0
7.74
15.43
u/ml
1.71
19
178
35
344
1.02
0.00
1.2
1.4
191.81
205.41
pmol/l
0.16
35
344
10
102
0.98
0.00
1.1
1.0
10.77
0.34
u/ml
—
5
49
16
155
1.03
0.00
2.8
1.9
1.30
2.06
u/field
—
10
102
17
165
1.03
0.00
1.2
1.1
14.31
7.06
u/ml
0.28
11
111
21
205
1.02
0.00
2.5
2.6
—
—
—
0
0
23
225
1.02
0.00
1.2
1.3
82.43
71.55
umol/l
1.53
23
225
10
96
1.04
0.00
1.2
1.1
0.76
1.27
mom
—
10
96
10
104
0.96
0.00
1.1
1.1
—
—
—
0
0
15
153
0.98
0.00
1.7
1.5
135.76
135.18
nmol/l
0.03
15
153
10
101
0.99
0.00
1.1
1.0
9.07
4.52
u/ml
—
5
46
163
1629
1.00
0.00
1.3
1.3
3.70
3.82
ug/l
0.09
153
1548
47
473
0.99
0.00
2.6
2.6
181.21
104.34
ug/min
0.43
30
319
63
627
1.00
0.00
1.9
2.5
1.01
0.86
nmol/l
1.24
55
541
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.3
—
94.11
—
0
9
0
5
0.00
0.00
0.0
1.0
—
273.80
—
0
5
5
58
0.86
-0.00
1.6
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
4.8
—
—
—
0
0
6
67
0.90
-0.00
1.5
1.9
2.38
1.52
mg/l
—
6
59
0
7
0.00
-0.00
0.0
5.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
1.10
—
0
6
5
52
0.96
-0.00
1.0
2.3
14.33
27.15
pmol/l
—
5
47
5
52
0.96
-0.00
1.6
2.2
1.08
1.30
umol/l
—
5
36
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint AB1_EBV and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_EBV | 1.492 [1.12, 1.99] | 0.006 |
| Birth year | 1.0 [0.99, 1.01] | 0.947 |
During the follow-up period (1.1.1998 — 31.12.2019), 118 out of 16191 females with AB1_EBV died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_EBV | 1.411 [1.2, 1.65] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.005 |
During the follow-up period (1.1.1998 — 31.12.2019), 218 out of 14786 males with AB1_EBV died.
Mortality risk
Mortality risk for people of age
years, who have AB1_EBV.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.208% | 0.257% |
| 5 | 1.039% | 1.587% |
| 10 | 2.769% | 4.122% |
| 15 | 5.219% | 7.827% |
| 20 | 8.95% | 12.79% |
Relationships between endpoints
↥Index endpoint: AB1_EBV – Infectious mononucleosis
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data